ticker
stringclasses 486
values | company_info
dict | user_prompt
stringlengths 1.25k
23.7k
|
|---|---|---|
ZTS | {
"company_info": {
"description": "Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.",
"name": "Zoetis Inc."
},
"current_date": "2023-10-05",
"financials": {
"financials": "{\"Tax Effect Of Unusual Items\": -7105000.0, \"Tax Rate For Calcs\": 0.203, \"Normalized EBITDA\": 3701000000.0, \"Total Unusual Items\": -35000000.0, \"Total Unusual Items Excluding Goodwill\": -35000000.0, \"Net Income From Continuing Operation Net Minority Interest\": 2344000000.0, \"Reconciled Depreciation\": 491000000.0, \"Reconciled Cost Of Revenue\": 2219000000.0, \"EBITDA\": 3666000000.0, \"EBIT\": 3175000000.0, \"Net Interest Income\": -134000000.0, \"Interest Expense\": 239000000.0, \"Interest Income\": 105000000.0, \"Normalized Income\": 2371895000.0, \"Net Income From Continuing And Discontinued Operation\": 2344000000.0, \"Total Expenses\": 5475000000.0, \"Diluted Average Shares\": 462269000.0, \"Basic Average Shares\": 461172000.0, \"Diluted EPS\": 5.07, \"Basic EPS\": 5.08, \"Diluted NI Availto Com Stockholders\": 2344000000.0, \"Net Income Common Stockholders\": 2344000000.0, \"Net Income\": 2344000000.0, \"Minority Interests\": 4000000.0, \"Net Income Including Noncontrolling Interests\": 2340000000.0, \"Net Income Continuous Operations\": 2340000000.0, \"Tax Provision\": 596000000.0, \"Pretax Income\": 2936000000.0, \"Other Income Expense\": 1000000.0, \"Other Non Operating Income Expenses\": 36000000.0, \"Special Income Charges\": 12000000.0, \"Gain On Sale Of Ppe\": 0.0, \"Gain On Sale Of Business\": 101000000.0, \"Write Off\": 2000000.0, \"Impairment Of Capital Assets\": 35000000.0, \"Restructuring And Mergern Acquisition\": 52000000.0, \"Gain On Sale Of Security\": -47000000.0, \"Net Non Operating Interest Income Expense\": -134000000.0, \"Interest Expense Non Operating\": 239000000.0, \"Interest Income Non Operating\": 105000000.0, \"Operating Income\": 3069000000.0, \"Operating Expense\": 2914000000.0, \"Depreciation Amortization Depletion Income Statement\": 149000000.0, \"Depreciation And Amortization In Income Statement\": 149000000.0, \"Amortization\": 149000000.0, \"Amortization Of Intangibles Income Statement\": 149000000.0, \"Research And Development\": 614000000.0, \"Selling General And Administration\": 2151000000.0, \"Gross Profit\": 5983000000.0, \"Cost Of Revenue\": 2561000000.0, \"Total Revenue\": 8544000000.0, \"Operating Revenue\": 8544000000.0}",
"year": "2023-12-31"
},
"news": {
"news_date": "2023-09-28",
"news_headlines": [
"How The Pieces Add Up: DGRO Targets $58",
"Notable Two Hundred Day Moving Average Cross - ZTS",
"Want Better Returns? Don?t Ignore These 2 Medical Stocks Set to Beat Earnings"
]
},
"price": {
"close": 169.39430236816406,
"close_previous": 171.37384033203125,
"open": 168.59657579050182,
"open_previous": 171.79733388669408,
"previous_date": "2023-09-28",
"price_date": "2023-10-05"
},
"ticker": "ZTS"
} |
You are a seasoned stock market analyst who is trying to predict whether the prices will go down or up over the day, 2023-10-05, for a specific stock, by offering a buy or sell rating.
[Company Name]
Zoetis Inc.
[Company Description]
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
[Price Movement]
It was 169.39430236816406 on 2023-09-28.
The price of the stock on 2023-10-05 started at 168.59657579050182.
[News since 2023-09-28]
How The Pieces Add Up: DGRO Targets $58
Notable Two Hundred Day Moving Average Cross - ZTS
Want Better Returns? Don?t Ignore These 2 Medical Stocks Set to Beat Earnings
[Financials]
Basic EPS: $5.08
Normalized EBITDA: $3.701000e+09
Net Income: $2.344000e+09
Your answer should look like the following
<think>reasoning about why the stock would go down here.
</think><answer>sell</answer>
or
<think>reasoning about why the stock would go up here.
</think><answer>buy</answer>
Please reason about and provide several reasons for why you think the stock would go up or down in the <think></think> tags. Please provide your answer as a single rating, 'buy' or 'sell', in the <answer></answer> tags, with buy meaning that the stock price will go up,
and sell meaning that the stock price will go down.
|
ZTS | {
"company_info": {
"description": "Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.",
"name": "Zoetis Inc."
},
"current_date": "2023-10-06",
"financials": {
"financials": "{\"Tax Effect Of Unusual Items\": -7105000.0, \"Tax Rate For Calcs\": 0.203, \"Normalized EBITDA\": 3701000000.0, \"Total Unusual Items\": -35000000.0, \"Total Unusual Items Excluding Goodwill\": -35000000.0, \"Net Income From Continuing Operation Net Minority Interest\": 2344000000.0, \"Reconciled Depreciation\": 491000000.0, \"Reconciled Cost Of Revenue\": 2219000000.0, \"EBITDA\": 3666000000.0, \"EBIT\": 3175000000.0, \"Net Interest Income\": -134000000.0, \"Interest Expense\": 239000000.0, \"Interest Income\": 105000000.0, \"Normalized Income\": 2371895000.0, \"Net Income From Continuing And Discontinued Operation\": 2344000000.0, \"Total Expenses\": 5475000000.0, \"Diluted Average Shares\": 462269000.0, \"Basic Average Shares\": 461172000.0, \"Diluted EPS\": 5.07, \"Basic EPS\": 5.08, \"Diluted NI Availto Com Stockholders\": 2344000000.0, \"Net Income Common Stockholders\": 2344000000.0, \"Net Income\": 2344000000.0, \"Minority Interests\": 4000000.0, \"Net Income Including Noncontrolling Interests\": 2340000000.0, \"Net Income Continuous Operations\": 2340000000.0, \"Tax Provision\": 596000000.0, \"Pretax Income\": 2936000000.0, \"Other Income Expense\": 1000000.0, \"Other Non Operating Income Expenses\": 36000000.0, \"Special Income Charges\": 12000000.0, \"Gain On Sale Of Ppe\": 0.0, \"Gain On Sale Of Business\": 101000000.0, \"Write Off\": 2000000.0, \"Impairment Of Capital Assets\": 35000000.0, \"Restructuring And Mergern Acquisition\": 52000000.0, \"Gain On Sale Of Security\": -47000000.0, \"Net Non Operating Interest Income Expense\": -134000000.0, \"Interest Expense Non Operating\": 239000000.0, \"Interest Income Non Operating\": 105000000.0, \"Operating Income\": 3069000000.0, \"Operating Expense\": 2914000000.0, \"Depreciation Amortization Depletion Income Statement\": 149000000.0, \"Depreciation And Amortization In Income Statement\": 149000000.0, \"Amortization\": 149000000.0, \"Amortization Of Intangibles Income Statement\": 149000000.0, \"Research And Development\": 614000000.0, \"Selling General And Administration\": 2151000000.0, \"Gross Profit\": 5983000000.0, \"Cost Of Revenue\": 2561000000.0, \"Total Revenue\": 8544000000.0, \"Operating Revenue\": 8544000000.0}",
"year": "2023-12-31"
},
"news": {
"news_date": "2023-09-29",
"news_headlines": [
"Notable Two Hundred Day Moving Average Cross - ZTS",
"Want Better Returns? Don?t Ignore These 2 Medical Stocks Set to Beat Earnings"
]
},
"price": {
"close": 172.92007446289062,
"close_previous": 171.34429931640625,
"open": 169.17763908405152,
"open_previous": 172.92990934775543,
"previous_date": "2023-09-29",
"price_date": "2023-10-06"
},
"ticker": "ZTS"
} |
You are a seasoned stock market analyst who is trying to predict whether the prices will go down or up over the day, 2023-10-06, for a specific stock, by offering a buy or sell rating.
[Company Name]
Zoetis Inc.
[Company Description]
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
[Price Movement]
It was 172.92007446289062 on 2023-09-29.
The price of the stock on 2023-10-06 started at 169.17763908405152.
[News since 2023-09-29]
Notable Two Hundred Day Moving Average Cross - ZTS
Want Better Returns? Don?t Ignore These 2 Medical Stocks Set to Beat Earnings
[Financials]
Basic EPS: $5.08
Normalized EBITDA: $3.701000e+09
Net Income: $2.344000e+09
Your answer should look like the following
<think>reasoning about why the stock would go down here.
</think><answer>sell</answer>
or
<think>reasoning about why the stock would go up here.
</think><answer>buy</answer>
Please reason about and provide several reasons for why you think the stock would go up or down in the <think></think> tags. Please provide your answer as a single rating, 'buy' or 'sell', in the <answer></answer> tags, with buy meaning that the stock price will go up,
and sell meaning that the stock price will go down.
|
ZTS | {
"company_info": {
"description": "Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.",
"name": "Zoetis Inc."
},
"current_date": "2023-10-09",
"financials": {
"financials": "{\"Tax Effect Of Unusual Items\": -7105000.0, \"Tax Rate For Calcs\": 0.203, \"Normalized EBITDA\": 3701000000.0, \"Total Unusual Items\": -35000000.0, \"Total Unusual Items Excluding Goodwill\": -35000000.0, \"Net Income From Continuing Operation Net Minority Interest\": 2344000000.0, \"Reconciled Depreciation\": 491000000.0, \"Reconciled Cost Of Revenue\": 2219000000.0, \"EBITDA\": 3666000000.0, \"EBIT\": 3175000000.0, \"Net Interest Income\": -134000000.0, \"Interest Expense\": 239000000.0, \"Interest Income\": 105000000.0, \"Normalized Income\": 2371895000.0, \"Net Income From Continuing And Discontinued Operation\": 2344000000.0, \"Total Expenses\": 5475000000.0, \"Diluted Average Shares\": 462269000.0, \"Basic Average Shares\": 461172000.0, \"Diluted EPS\": 5.07, \"Basic EPS\": 5.08, \"Diluted NI Availto Com Stockholders\": 2344000000.0, \"Net Income Common Stockholders\": 2344000000.0, \"Net Income\": 2344000000.0, \"Minority Interests\": 4000000.0, \"Net Income Including Noncontrolling Interests\": 2340000000.0, \"Net Income Continuous Operations\": 2340000000.0, \"Tax Provision\": 596000000.0, \"Pretax Income\": 2936000000.0, \"Other Income Expense\": 1000000.0, \"Other Non Operating Income Expenses\": 36000000.0, \"Special Income Charges\": 12000000.0, \"Gain On Sale Of Ppe\": 0.0, \"Gain On Sale Of Business\": 101000000.0, \"Write Off\": 2000000.0, \"Impairment Of Capital Assets\": 35000000.0, \"Restructuring And Mergern Acquisition\": 52000000.0, \"Gain On Sale Of Security\": -47000000.0, \"Net Non Operating Interest Income Expense\": -134000000.0, \"Interest Expense Non Operating\": 239000000.0, \"Interest Income Non Operating\": 105000000.0, \"Operating Income\": 3069000000.0, \"Operating Expense\": 2914000000.0, \"Depreciation Amortization Depletion Income Statement\": 149000000.0, \"Depreciation And Amortization In Income Statement\": 149000000.0, \"Amortization\": 149000000.0, \"Amortization Of Intangibles Income Statement\": 149000000.0, \"Research And Development\": 614000000.0, \"Selling General And Administration\": 2151000000.0, \"Gross Profit\": 5983000000.0, \"Cost Of Revenue\": 2561000000.0, \"Total Revenue\": 8544000000.0, \"Operating Revenue\": 8544000000.0}",
"year": "2023-12-31"
},
"news": {
"news_date": "2023-10-02",
"news_headlines": [
"Notable Two Hundred Day Moving Average Cross - ZTS",
"Want Better Returns? Don?t Ignore These 2 Medical Stocks Set to Beat Earnings",
"Why Zoetis (ZTS) is Poised to Beat Earnings Estimates Again",
"Vanguard Dividend Appreciation ETF Experiences Big Inflow"
]
},
"price": {
"close": 171.9549102783203,
"close_previous": 170.1132354736328,
"open": 170.9799028338696,
"open_previous": 170.57611644571645,
"previous_date": "2023-10-02",
"price_date": "2023-10-09"
},
"ticker": "ZTS"
} |
You are a seasoned stock market analyst who is trying to predict whether the prices will go down or up over the day, 2023-10-09, for a specific stock, by offering a buy or sell rating.
[Company Name]
Zoetis Inc.
[Company Description]
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
[Price Movement]
It was 171.9549102783203 on 2023-10-02.
The price of the stock on 2023-10-09 started at 170.9799028338696.
[News since 2023-10-02]
Notable Two Hundred Day Moving Average Cross - ZTS
Want Better Returns? Don?t Ignore These 2 Medical Stocks Set to Beat Earnings
Why Zoetis (ZTS) is Poised to Beat Earnings Estimates Again
Vanguard Dividend Appreciation ETF Experiences Big Inflow
[Financials]
Basic EPS: $5.08
Normalized EBITDA: $3.701000e+09
Net Income: $2.344000e+09
Your answer should look like the following
<think>reasoning about why the stock would go down here.
</think><answer>sell</answer>
or
<think>reasoning about why the stock would go up here.
</think><answer>buy</answer>
Please reason about and provide several reasons for why you think the stock would go up or down in the <think></think> tags. Please provide your answer as a single rating, 'buy' or 'sell', in the <answer></answer> tags, with buy meaning that the stock price will go up,
and sell meaning that the stock price will go down.
|
ZTS | {
"company_info": {
"description": "Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.",
"name": "Zoetis Inc."
},
"current_date": "2023-10-10",
"financials": {
"financials": "{\"Tax Effect Of Unusual Items\": -7105000.0, \"Tax Rate For Calcs\": 0.203, \"Normalized EBITDA\": 3701000000.0, \"Total Unusual Items\": -35000000.0, \"Total Unusual Items Excluding Goodwill\": -35000000.0, \"Net Income From Continuing Operation Net Minority Interest\": 2344000000.0, \"Reconciled Depreciation\": 491000000.0, \"Reconciled Cost Of Revenue\": 2219000000.0, \"EBITDA\": 3666000000.0, \"EBIT\": 3175000000.0, \"Net Interest Income\": -134000000.0, \"Interest Expense\": 239000000.0, \"Interest Income\": 105000000.0, \"Normalized Income\": 2371895000.0, \"Net Income From Continuing And Discontinued Operation\": 2344000000.0, \"Total Expenses\": 5475000000.0, \"Diluted Average Shares\": 462269000.0, \"Basic Average Shares\": 461172000.0, \"Diluted EPS\": 5.07, \"Basic EPS\": 5.08, \"Diluted NI Availto Com Stockholders\": 2344000000.0, \"Net Income Common Stockholders\": 2344000000.0, \"Net Income\": 2344000000.0, \"Minority Interests\": 4000000.0, \"Net Income Including Noncontrolling Interests\": 2340000000.0, \"Net Income Continuous Operations\": 2340000000.0, \"Tax Provision\": 596000000.0, \"Pretax Income\": 2936000000.0, \"Other Income Expense\": 1000000.0, \"Other Non Operating Income Expenses\": 36000000.0, \"Special Income Charges\": 12000000.0, \"Gain On Sale Of Ppe\": 0.0, \"Gain On Sale Of Business\": 101000000.0, \"Write Off\": 2000000.0, \"Impairment Of Capital Assets\": 35000000.0, \"Restructuring And Mergern Acquisition\": 52000000.0, \"Gain On Sale Of Security\": -47000000.0, \"Net Non Operating Interest Income Expense\": -134000000.0, \"Interest Expense Non Operating\": 239000000.0, \"Interest Income Non Operating\": 105000000.0, \"Operating Income\": 3069000000.0, \"Operating Expense\": 2914000000.0, \"Depreciation Amortization Depletion Income Statement\": 149000000.0, \"Depreciation And Amortization In Income Statement\": 149000000.0, \"Amortization\": 149000000.0, \"Amortization Of Intangibles Income Statement\": 149000000.0, \"Research And Development\": 614000000.0, \"Selling General And Administration\": 2151000000.0, \"Gross Profit\": 5983000000.0, \"Cost Of Revenue\": 2561000000.0, \"Total Revenue\": 8544000000.0, \"Operating Revenue\": 8544000000.0}",
"year": "2023-12-31"
},
"news": {
"news_date": "2023-10-03",
"news_headlines": [
"Want Better Returns? Don?t Ignore These 2 Medical Stocks Set to Beat Earnings",
"Why Zoetis (ZTS) is Poised to Beat Earnings Estimates Again",
"Vanguard Dividend Appreciation ETF Experiences Big Inflow"
]
},
"price": {
"close": 172.9693145751953,
"close_previous": 167.7495880126953,
"open": 171.6496033586799,
"open_previous": 169.21702067240278,
"previous_date": "2023-10-03",
"price_date": "2023-10-10"
},
"ticker": "ZTS"
} |
You are a seasoned stock market analyst who is trying to predict whether the prices will go down or up over the day, 2023-10-10, for a specific stock, by offering a buy or sell rating.
[Company Name]
Zoetis Inc.
[Company Description]
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
[Price Movement]
It was 172.9693145751953 on 2023-10-03.
The price of the stock on 2023-10-10 started at 171.6496033586799.
[News since 2023-10-03]
Want Better Returns? Don?t Ignore These 2 Medical Stocks Set to Beat Earnings
Why Zoetis (ZTS) is Poised to Beat Earnings Estimates Again
Vanguard Dividend Appreciation ETF Experiences Big Inflow
[Financials]
Basic EPS: $5.08
Normalized EBITDA: $3.701000e+09
Net Income: $2.344000e+09
Your answer should look like the following
<think>reasoning about why the stock would go down here.
</think><answer>sell</answer>
or
<think>reasoning about why the stock would go up here.
</think><answer>buy</answer>
Please reason about and provide several reasons for why you think the stock would go up or down in the <think></think> tags. Please provide your answer as a single rating, 'buy' or 'sell', in the <answer></answer> tags, with buy meaning that the stock price will go up,
and sell meaning that the stock price will go down.
|
ZTS | {
"company_info": {
"description": "Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.",
"name": "Zoetis Inc."
},
"current_date": "2023-10-11",
"financials": {
"financials": "{\"Tax Effect Of Unusual Items\": -7105000.0, \"Tax Rate For Calcs\": 0.203, \"Normalized EBITDA\": 3701000000.0, \"Total Unusual Items\": -35000000.0, \"Total Unusual Items Excluding Goodwill\": -35000000.0, \"Net Income From Continuing Operation Net Minority Interest\": 2344000000.0, \"Reconciled Depreciation\": 491000000.0, \"Reconciled Cost Of Revenue\": 2219000000.0, \"EBITDA\": 3666000000.0, \"EBIT\": 3175000000.0, \"Net Interest Income\": -134000000.0, \"Interest Expense\": 239000000.0, \"Interest Income\": 105000000.0, \"Normalized Income\": 2371895000.0, \"Net Income From Continuing And Discontinued Operation\": 2344000000.0, \"Total Expenses\": 5475000000.0, \"Diluted Average Shares\": 462269000.0, \"Basic Average Shares\": 461172000.0, \"Diluted EPS\": 5.07, \"Basic EPS\": 5.08, \"Diluted NI Availto Com Stockholders\": 2344000000.0, \"Net Income Common Stockholders\": 2344000000.0, \"Net Income\": 2344000000.0, \"Minority Interests\": 4000000.0, \"Net Income Including Noncontrolling Interests\": 2340000000.0, \"Net Income Continuous Operations\": 2340000000.0, \"Tax Provision\": 596000000.0, \"Pretax Income\": 2936000000.0, \"Other Income Expense\": 1000000.0, \"Other Non Operating Income Expenses\": 36000000.0, \"Special Income Charges\": 12000000.0, \"Gain On Sale Of Ppe\": 0.0, \"Gain On Sale Of Business\": 101000000.0, \"Write Off\": 2000000.0, \"Impairment Of Capital Assets\": 35000000.0, \"Restructuring And Mergern Acquisition\": 52000000.0, \"Gain On Sale Of Security\": -47000000.0, \"Net Non Operating Interest Income Expense\": -134000000.0, \"Interest Expense Non Operating\": 239000000.0, \"Interest Income Non Operating\": 105000000.0, \"Operating Income\": 3069000000.0, \"Operating Expense\": 2914000000.0, \"Depreciation Amortization Depletion Income Statement\": 149000000.0, \"Depreciation And Amortization In Income Statement\": 149000000.0, \"Amortization\": 149000000.0, \"Amortization Of Intangibles Income Statement\": 149000000.0, \"Research And Development\": 614000000.0, \"Selling General And Administration\": 2151000000.0, \"Gross Profit\": 5983000000.0, \"Cost Of Revenue\": 2561000000.0, \"Total Revenue\": 8544000000.0, \"Operating Revenue\": 8544000000.0}",
"year": "2023-12-31"
},
"news": {
"news_date": "2023-10-04",
"news_headlines": [
"Why Zoetis (ZTS) is Poised to Beat Earnings Estimates Again",
"Vanguard Dividend Appreciation ETF Experiences Big Inflow",
"JAZZ or ZTS: Which Is the Better Value Stock Right Now?"
]
},
"price": {
"close": 174.26930236816406,
"close_previous": 168.3996124267578,
"open": 173.98370231991655,
"open_previous": 168.52763278819305,
"previous_date": "2023-10-04",
"price_date": "2023-10-11"
},
"ticker": "ZTS"
} |
You are a seasoned stock market analyst who is trying to predict whether the prices will go down or up over the day, 2023-10-11, for a specific stock, by offering a buy or sell rating.
[Company Name]
Zoetis Inc.
[Company Description]
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
[Price Movement]
It was 174.26930236816406 on 2023-10-04.
The price of the stock on 2023-10-11 started at 173.98370231991655.
[News since 2023-10-04]
Why Zoetis (ZTS) is Poised to Beat Earnings Estimates Again
Vanguard Dividend Appreciation ETF Experiences Big Inflow
JAZZ or ZTS: Which Is the Better Value Stock Right Now?
[Financials]
Basic EPS: $5.08
Normalized EBITDA: $3.701000e+09
Net Income: $2.344000e+09
Your answer should look like the following
<think>reasoning about why the stock would go down here.
</think><answer>sell</answer>
or
<think>reasoning about why the stock would go up here.
</think><answer>buy</answer>
Please reason about and provide several reasons for why you think the stock would go up or down in the <think></think> tags. Please provide your answer as a single rating, 'buy' or 'sell', in the <answer></answer> tags, with buy meaning that the stock price will go up,
and sell meaning that the stock price will go down.
|
ZTS | {
"company_info": {
"description": "Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.",
"name": "Zoetis Inc."
},
"current_date": "2023-10-12",
"financials": {
"financials": "{\"Tax Effect Of Unusual Items\": -7105000.0, \"Tax Rate For Calcs\": 0.203, \"Normalized EBITDA\": 3701000000.0, \"Total Unusual Items\": -35000000.0, \"Total Unusual Items Excluding Goodwill\": -35000000.0, \"Net Income From Continuing Operation Net Minority Interest\": 2344000000.0, \"Reconciled Depreciation\": 491000000.0, \"Reconciled Cost Of Revenue\": 2219000000.0, \"EBITDA\": 3666000000.0, \"EBIT\": 3175000000.0, \"Net Interest Income\": -134000000.0, \"Interest Expense\": 239000000.0, \"Interest Income\": 105000000.0, \"Normalized Income\": 2371895000.0, \"Net Income From Continuing And Discontinued Operation\": 2344000000.0, \"Total Expenses\": 5475000000.0, \"Diluted Average Shares\": 462269000.0, \"Basic Average Shares\": 461172000.0, \"Diluted EPS\": 5.07, \"Basic EPS\": 5.08, \"Diluted NI Availto Com Stockholders\": 2344000000.0, \"Net Income Common Stockholders\": 2344000000.0, \"Net Income\": 2344000000.0, \"Minority Interests\": 4000000.0, \"Net Income Including Noncontrolling Interests\": 2340000000.0, \"Net Income Continuous Operations\": 2340000000.0, \"Tax Provision\": 596000000.0, \"Pretax Income\": 2936000000.0, \"Other Income Expense\": 1000000.0, \"Other Non Operating Income Expenses\": 36000000.0, \"Special Income Charges\": 12000000.0, \"Gain On Sale Of Ppe\": 0.0, \"Gain On Sale Of Business\": 101000000.0, \"Write Off\": 2000000.0, \"Impairment Of Capital Assets\": 35000000.0, \"Restructuring And Mergern Acquisition\": 52000000.0, \"Gain On Sale Of Security\": -47000000.0, \"Net Non Operating Interest Income Expense\": -134000000.0, \"Interest Expense Non Operating\": 239000000.0, \"Interest Income Non Operating\": 105000000.0, \"Operating Income\": 3069000000.0, \"Operating Expense\": 2914000000.0, \"Depreciation Amortization Depletion Income Statement\": 149000000.0, \"Depreciation And Amortization In Income Statement\": 149000000.0, \"Amortization\": 149000000.0, \"Amortization Of Intangibles Income Statement\": 149000000.0, \"Research And Development\": 614000000.0, \"Selling General And Administration\": 2151000000.0, \"Gross Profit\": 5983000000.0, \"Cost Of Revenue\": 2561000000.0, \"Total Revenue\": 8544000000.0, \"Operating Revenue\": 8544000000.0}",
"year": "2023-12-31"
},
"news": {
"news_date": "2023-10-05",
"news_headlines": [
"Why Zoetis (ZTS) is Poised to Beat Earnings Estimates Again",
"Vanguard Dividend Appreciation ETF Experiences Big Inflow",
"JAZZ or ZTS: Which Is the Better Value Stock Right Now?",
"The Top 7 Stocks to Own During a Downturn"
]
},
"price": {
"close": 171.66929626464844,
"close_previous": 169.39430236816406,
"open": 174.15112384824334,
"open_previous": 168.59657579050182,
"previous_date": "2023-10-05",
"price_date": "2023-10-12"
},
"ticker": "ZTS"
} |
You are a seasoned stock market analyst who is trying to predict whether the prices will go down or up over the day, 2023-10-12, for a specific stock, by offering a buy or sell rating.
[Company Name]
Zoetis Inc.
[Company Description]
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
[Price Movement]
It was 171.66929626464844 on 2023-10-05.
The price of the stock on 2023-10-12 started at 174.15112384824334.
[News since 2023-10-05]
Why Zoetis (ZTS) is Poised to Beat Earnings Estimates Again
Vanguard Dividend Appreciation ETF Experiences Big Inflow
JAZZ or ZTS: Which Is the Better Value Stock Right Now?
The Top 7 Stocks to Own During a Downturn
[Financials]
Basic EPS: $5.08
Normalized EBITDA: $3.701000e+09
Net Income: $2.344000e+09
Your answer should look like the following
<think>reasoning about why the stock would go down here.
</think><answer>sell</answer>
or
<think>reasoning about why the stock would go up here.
</think><answer>buy</answer>
Please reason about and provide several reasons for why you think the stock would go up or down in the <think></think> tags. Please provide your answer as a single rating, 'buy' or 'sell', in the <answer></answer> tags, with buy meaning that the stock price will go up,
and sell meaning that the stock price will go down.
|
ZTS | {
"company_info": {
"description": "Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.",
"name": "Zoetis Inc."
},
"current_date": "2023-10-13",
"financials": {
"financials": "{\"Tax Effect Of Unusual Items\": -7105000.0, \"Tax Rate For Calcs\": 0.203, \"Normalized EBITDA\": 3701000000.0, \"Total Unusual Items\": -35000000.0, \"Total Unusual Items Excluding Goodwill\": -35000000.0, \"Net Income From Continuing Operation Net Minority Interest\": 2344000000.0, \"Reconciled Depreciation\": 491000000.0, \"Reconciled Cost Of Revenue\": 2219000000.0, \"EBITDA\": 3666000000.0, \"EBIT\": 3175000000.0, \"Net Interest Income\": -134000000.0, \"Interest Expense\": 239000000.0, \"Interest Income\": 105000000.0, \"Normalized Income\": 2371895000.0, \"Net Income From Continuing And Discontinued Operation\": 2344000000.0, \"Total Expenses\": 5475000000.0, \"Diluted Average Shares\": 462269000.0, \"Basic Average Shares\": 461172000.0, \"Diluted EPS\": 5.07, \"Basic EPS\": 5.08, \"Diluted NI Availto Com Stockholders\": 2344000000.0, \"Net Income Common Stockholders\": 2344000000.0, \"Net Income\": 2344000000.0, \"Minority Interests\": 4000000.0, \"Net Income Including Noncontrolling Interests\": 2340000000.0, \"Net Income Continuous Operations\": 2340000000.0, \"Tax Provision\": 596000000.0, \"Pretax Income\": 2936000000.0, \"Other Income Expense\": 1000000.0, \"Other Non Operating Income Expenses\": 36000000.0, \"Special Income Charges\": 12000000.0, \"Gain On Sale Of Ppe\": 0.0, \"Gain On Sale Of Business\": 101000000.0, \"Write Off\": 2000000.0, \"Impairment Of Capital Assets\": 35000000.0, \"Restructuring And Mergern Acquisition\": 52000000.0, \"Gain On Sale Of Security\": -47000000.0, \"Net Non Operating Interest Income Expense\": -134000000.0, \"Interest Expense Non Operating\": 239000000.0, \"Interest Income Non Operating\": 105000000.0, \"Operating Income\": 3069000000.0, \"Operating Expense\": 2914000000.0, \"Depreciation Amortization Depletion Income Statement\": 149000000.0, \"Depreciation And Amortization In Income Statement\": 149000000.0, \"Amortization\": 149000000.0, \"Amortization Of Intangibles Income Statement\": 149000000.0, \"Research And Development\": 614000000.0, \"Selling General And Administration\": 2151000000.0, \"Gross Profit\": 5983000000.0, \"Cost Of Revenue\": 2561000000.0, \"Total Revenue\": 8544000000.0, \"Operating Revenue\": 8544000000.0}",
"year": "2023-12-31"
},
"news": {
"news_date": "2023-10-06",
"news_headlines": [
"Why Zoetis (ZTS) is Poised to Beat Earnings Estimates Again",
"Vanguard Dividend Appreciation ETF Experiences Big Inflow",
"JAZZ or ZTS: Which Is the Better Value Stock Right Now?",
"The Top 7 Stocks to Own During a Downturn"
]
},
"price": {
"close": 171.73822021484375,
"close_previous": 172.92007446289062,
"open": 170.792757204078,
"open_previous": 169.17763908405152,
"previous_date": "2023-10-06",
"price_date": "2023-10-13"
},
"ticker": "ZTS"
} |
You are a seasoned stock market analyst who is trying to predict whether the prices will go down or up over the day, 2023-10-13, for a specific stock, by offering a buy or sell rating.
[Company Name]
Zoetis Inc.
[Company Description]
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
[Price Movement]
It was 171.73822021484375 on 2023-10-06.
The price of the stock on 2023-10-13 started at 170.792757204078.
[News since 2023-10-06]
Why Zoetis (ZTS) is Poised to Beat Earnings Estimates Again
Vanguard Dividend Appreciation ETF Experiences Big Inflow
JAZZ or ZTS: Which Is the Better Value Stock Right Now?
The Top 7 Stocks to Own During a Downturn
[Financials]
Basic EPS: $5.08
Normalized EBITDA: $3.701000e+09
Net Income: $2.344000e+09
Your answer should look like the following
<think>reasoning about why the stock would go down here.
</think><answer>sell</answer>
or
<think>reasoning about why the stock would go up here.
</think><answer>buy</answer>
Please reason about and provide several reasons for why you think the stock would go up or down in the <think></think> tags. Please provide your answer as a single rating, 'buy' or 'sell', in the <answer></answer> tags, with buy meaning that the stock price will go up,
and sell meaning that the stock price will go down.
|
ZTS | {
"company_info": {
"description": "Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.",
"name": "Zoetis Inc."
},
"current_date": "2023-10-16",
"financials": {
"financials": "{\"Tax Effect Of Unusual Items\": -7105000.0, \"Tax Rate For Calcs\": 0.203, \"Normalized EBITDA\": 3701000000.0, \"Total Unusual Items\": -35000000.0, \"Total Unusual Items Excluding Goodwill\": -35000000.0, \"Net Income From Continuing Operation Net Minority Interest\": 2344000000.0, \"Reconciled Depreciation\": 491000000.0, \"Reconciled Cost Of Revenue\": 2219000000.0, \"EBITDA\": 3666000000.0, \"EBIT\": 3175000000.0, \"Net Interest Income\": -134000000.0, \"Interest Expense\": 239000000.0, \"Interest Income\": 105000000.0, \"Normalized Income\": 2371895000.0, \"Net Income From Continuing And Discontinued Operation\": 2344000000.0, \"Total Expenses\": 5475000000.0, \"Diluted Average Shares\": 462269000.0, \"Basic Average Shares\": 461172000.0, \"Diluted EPS\": 5.07, \"Basic EPS\": 5.08, \"Diluted NI Availto Com Stockholders\": 2344000000.0, \"Net Income Common Stockholders\": 2344000000.0, \"Net Income\": 2344000000.0, \"Minority Interests\": 4000000.0, \"Net Income Including Noncontrolling Interests\": 2340000000.0, \"Net Income Continuous Operations\": 2340000000.0, \"Tax Provision\": 596000000.0, \"Pretax Income\": 2936000000.0, \"Other Income Expense\": 1000000.0, \"Other Non Operating Income Expenses\": 36000000.0, \"Special Income Charges\": 12000000.0, \"Gain On Sale Of Ppe\": 0.0, \"Gain On Sale Of Business\": 101000000.0, \"Write Off\": 2000000.0, \"Impairment Of Capital Assets\": 35000000.0, \"Restructuring And Mergern Acquisition\": 52000000.0, \"Gain On Sale Of Security\": -47000000.0, \"Net Non Operating Interest Income Expense\": -134000000.0, \"Interest Expense Non Operating\": 239000000.0, \"Interest Income Non Operating\": 105000000.0, \"Operating Income\": 3069000000.0, \"Operating Expense\": 2914000000.0, \"Depreciation Amortization Depletion Income Statement\": 149000000.0, \"Depreciation And Amortization In Income Statement\": 149000000.0, \"Amortization\": 149000000.0, \"Amortization Of Intangibles Income Statement\": 149000000.0, \"Research And Development\": 614000000.0, \"Selling General And Administration\": 2151000000.0, \"Gross Profit\": 5983000000.0, \"Cost Of Revenue\": 2561000000.0, \"Total Revenue\": 8544000000.0, \"Operating Revenue\": 8544000000.0}",
"year": "2023-12-31"
},
"news": {
"news_date": "2023-10-09",
"news_headlines": [
"JAZZ or ZTS: Which Is the Better Value Stock Right Now?",
"The Top 7 Stocks to Own During a Downturn"
]
},
"price": {
"close": 172.52609252929688,
"close_previous": 171.9549102783203,
"open": 172.35866975813857,
"open_previous": 170.9799028338696,
"previous_date": "2023-10-09",
"price_date": "2023-10-16"
},
"ticker": "ZTS"
} |
You are a seasoned stock market analyst who is trying to predict whether the prices will go down or up over the day, 2023-10-16, for a specific stock, by offering a buy or sell rating.
[Company Name]
Zoetis Inc.
[Company Description]
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
[Price Movement]
It was 172.52609252929688 on 2023-10-09.
The price of the stock on 2023-10-16 started at 172.35866975813857.
[News since 2023-10-09]
JAZZ or ZTS: Which Is the Better Value Stock Right Now?
The Top 7 Stocks to Own During a Downturn
[Financials]
Basic EPS: $5.08
Normalized EBITDA: $3.701000e+09
Net Income: $2.344000e+09
Your answer should look like the following
<think>reasoning about why the stock would go down here.
</think><answer>sell</answer>
or
<think>reasoning about why the stock would go up here.
</think><answer>buy</answer>
Please reason about and provide several reasons for why you think the stock would go up or down in the <think></think> tags. Please provide your answer as a single rating, 'buy' or 'sell', in the <answer></answer> tags, with buy meaning that the stock price will go up,
and sell meaning that the stock price will go down.
|
ZTS | {
"company_info": {
"description": "Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.",
"name": "Zoetis Inc."
},
"current_date": "2023-10-17",
"financials": {
"financials": "{\"Tax Effect Of Unusual Items\": -7105000.0, \"Tax Rate For Calcs\": 0.203, \"Normalized EBITDA\": 3701000000.0, \"Total Unusual Items\": -35000000.0, \"Total Unusual Items Excluding Goodwill\": -35000000.0, \"Net Income From Continuing Operation Net Minority Interest\": 2344000000.0, \"Reconciled Depreciation\": 491000000.0, \"Reconciled Cost Of Revenue\": 2219000000.0, \"EBITDA\": 3666000000.0, \"EBIT\": 3175000000.0, \"Net Interest Income\": -134000000.0, \"Interest Expense\": 239000000.0, \"Interest Income\": 105000000.0, \"Normalized Income\": 2371895000.0, \"Net Income From Continuing And Discontinued Operation\": 2344000000.0, \"Total Expenses\": 5475000000.0, \"Diluted Average Shares\": 462269000.0, \"Basic Average Shares\": 461172000.0, \"Diluted EPS\": 5.07, \"Basic EPS\": 5.08, \"Diluted NI Availto Com Stockholders\": 2344000000.0, \"Net Income Common Stockholders\": 2344000000.0, \"Net Income\": 2344000000.0, \"Minority Interests\": 4000000.0, \"Net Income Including Noncontrolling Interests\": 2340000000.0, \"Net Income Continuous Operations\": 2340000000.0, \"Tax Provision\": 596000000.0, \"Pretax Income\": 2936000000.0, \"Other Income Expense\": 1000000.0, \"Other Non Operating Income Expenses\": 36000000.0, \"Special Income Charges\": 12000000.0, \"Gain On Sale Of Ppe\": 0.0, \"Gain On Sale Of Business\": 101000000.0, \"Write Off\": 2000000.0, \"Impairment Of Capital Assets\": 35000000.0, \"Restructuring And Mergern Acquisition\": 52000000.0, \"Gain On Sale Of Security\": -47000000.0, \"Net Non Operating Interest Income Expense\": -134000000.0, \"Interest Expense Non Operating\": 239000000.0, \"Interest Income Non Operating\": 105000000.0, \"Operating Income\": 3069000000.0, \"Operating Expense\": 2914000000.0, \"Depreciation Amortization Depletion Income Statement\": 149000000.0, \"Depreciation And Amortization In Income Statement\": 149000000.0, \"Amortization\": 149000000.0, \"Amortization Of Intangibles Income Statement\": 149000000.0, \"Research And Development\": 614000000.0, \"Selling General And Administration\": 2151000000.0, \"Gross Profit\": 5983000000.0, \"Cost Of Revenue\": 2561000000.0, \"Total Revenue\": 8544000000.0, \"Operating Revenue\": 8544000000.0}",
"year": "2023-12-31"
},
"news": {
"news_date": "2023-10-10",
"news_headlines": [
"JAZZ or ZTS: Which Is the Better Value Stock Right Now?",
"The Top 7 Stocks to Own During a Downturn",
"Validea's Top Health Care Stocks Based On Martin Zweig - 10/16/2023"
]
},
"price": {
"close": 171.62005615234375,
"close_previous": 172.9693145751953,
"open": 170.251114451305,
"open_previous": 171.6496033586799,
"previous_date": "2023-10-10",
"price_date": "2023-10-17"
},
"ticker": "ZTS"
} |
You are a seasoned stock market analyst who is trying to predict whether the prices will go down or up over the day, 2023-10-17, for a specific stock, by offering a buy or sell rating.
[Company Name]
Zoetis Inc.
[Company Description]
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
[Price Movement]
It was 171.62005615234375 on 2023-10-10.
The price of the stock on 2023-10-17 started at 170.251114451305.
[News since 2023-10-10]
JAZZ or ZTS: Which Is the Better Value Stock Right Now?
The Top 7 Stocks to Own During a Downturn
Validea's Top Health Care Stocks Based On Martin Zweig - 10/16/2023
[Financials]
Basic EPS: $5.08
Normalized EBITDA: $3.701000e+09
Net Income: $2.344000e+09
Your answer should look like the following
<think>reasoning about why the stock would go down here.
</think><answer>sell</answer>
or
<think>reasoning about why the stock would go up here.
</think><answer>buy</answer>
Please reason about and provide several reasons for why you think the stock would go up or down in the <think></think> tags. Please provide your answer as a single rating, 'buy' or 'sell', in the <answer></answer> tags, with buy meaning that the stock price will go up,
and sell meaning that the stock price will go down.
|
ZTS | {
"company_info": {
"description": "Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.",
"name": "Zoetis Inc."
},
"current_date": "2023-10-18",
"financials": {
"financials": "{\"Tax Effect Of Unusual Items\": -7105000.0, \"Tax Rate For Calcs\": 0.203, \"Normalized EBITDA\": 3701000000.0, \"Total Unusual Items\": -35000000.0, \"Total Unusual Items Excluding Goodwill\": -35000000.0, \"Net Income From Continuing Operation Net Minority Interest\": 2344000000.0, \"Reconciled Depreciation\": 491000000.0, \"Reconciled Cost Of Revenue\": 2219000000.0, \"EBITDA\": 3666000000.0, \"EBIT\": 3175000000.0, \"Net Interest Income\": -134000000.0, \"Interest Expense\": 239000000.0, \"Interest Income\": 105000000.0, \"Normalized Income\": 2371895000.0, \"Net Income From Continuing And Discontinued Operation\": 2344000000.0, \"Total Expenses\": 5475000000.0, \"Diluted Average Shares\": 462269000.0, \"Basic Average Shares\": 461172000.0, \"Diluted EPS\": 5.07, \"Basic EPS\": 5.08, \"Diluted NI Availto Com Stockholders\": 2344000000.0, \"Net Income Common Stockholders\": 2344000000.0, \"Net Income\": 2344000000.0, \"Minority Interests\": 4000000.0, \"Net Income Including Noncontrolling Interests\": 2340000000.0, \"Net Income Continuous Operations\": 2340000000.0, \"Tax Provision\": 596000000.0, \"Pretax Income\": 2936000000.0, \"Other Income Expense\": 1000000.0, \"Other Non Operating Income Expenses\": 36000000.0, \"Special Income Charges\": 12000000.0, \"Gain On Sale Of Ppe\": 0.0, \"Gain On Sale Of Business\": 101000000.0, \"Write Off\": 2000000.0, \"Impairment Of Capital Assets\": 35000000.0, \"Restructuring And Mergern Acquisition\": 52000000.0, \"Gain On Sale Of Security\": -47000000.0, \"Net Non Operating Interest Income Expense\": -134000000.0, \"Interest Expense Non Operating\": 239000000.0, \"Interest Income Non Operating\": 105000000.0, \"Operating Income\": 3069000000.0, \"Operating Expense\": 2914000000.0, \"Depreciation Amortization Depletion Income Statement\": 149000000.0, \"Depreciation And Amortization In Income Statement\": 149000000.0, \"Amortization\": 149000000.0, \"Amortization Of Intangibles Income Statement\": 149000000.0, \"Research And Development\": 614000000.0, \"Selling General And Administration\": 2151000000.0, \"Gross Profit\": 5983000000.0, \"Cost Of Revenue\": 2561000000.0, \"Total Revenue\": 8544000000.0, \"Operating Revenue\": 8544000000.0}",
"year": "2023-12-31"
},
"news": {
"news_date": "2023-10-11",
"news_headlines": [
"The Top 7 Stocks to Own During a Downturn",
"Validea's Top Health Care Stocks Based On Martin Zweig - 10/16/2023",
"Noteworthy Tuesday Option Activity: RBLX, ZTS, STT"
]
},
"price": {
"close": 166.9715576171875,
"close_previous": 174.26930236816406,
"open": 170.3003573245487,
"open_previous": 173.98370231991655,
"previous_date": "2023-10-11",
"price_date": "2023-10-18"
},
"ticker": "ZTS"
} |
You are a seasoned stock market analyst who is trying to predict whether the prices will go down or up over the day, 2023-10-18, for a specific stock, by offering a buy or sell rating.
[Company Name]
Zoetis Inc.
[Company Description]
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
[Price Movement]
It was 166.9715576171875 on 2023-10-11.
The price of the stock on 2023-10-18 started at 170.3003573245487.
[News since 2023-10-11]
The Top 7 Stocks to Own During a Downturn
Validea's Top Health Care Stocks Based On Martin Zweig - 10/16/2023
Noteworthy Tuesday Option Activity: RBLX, ZTS, STT
[Financials]
Basic EPS: $5.08
Normalized EBITDA: $3.701000e+09
Net Income: $2.344000e+09
Your answer should look like the following
<think>reasoning about why the stock would go down here.
</think><answer>sell</answer>
or
<think>reasoning about why the stock would go up here.
</think><answer>buy</answer>
Please reason about and provide several reasons for why you think the stock would go up or down in the <think></think> tags. Please provide your answer as a single rating, 'buy' or 'sell', in the <answer></answer> tags, with buy meaning that the stock price will go up,
and sell meaning that the stock price will go down.
|
ZTS | {
"company_info": {
"description": "Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.",
"name": "Zoetis Inc."
},
"current_date": "2023-10-19",
"financials": {
"financials": "{\"Tax Effect Of Unusual Items\": -7105000.0, \"Tax Rate For Calcs\": 0.203, \"Normalized EBITDA\": 3701000000.0, \"Total Unusual Items\": -35000000.0, \"Total Unusual Items Excluding Goodwill\": -35000000.0, \"Net Income From Continuing Operation Net Minority Interest\": 2344000000.0, \"Reconciled Depreciation\": 491000000.0, \"Reconciled Cost Of Revenue\": 2219000000.0, \"EBITDA\": 3666000000.0, \"EBIT\": 3175000000.0, \"Net Interest Income\": -134000000.0, \"Interest Expense\": 239000000.0, \"Interest Income\": 105000000.0, \"Normalized Income\": 2371895000.0, \"Net Income From Continuing And Discontinued Operation\": 2344000000.0, \"Total Expenses\": 5475000000.0, \"Diluted Average Shares\": 462269000.0, \"Basic Average Shares\": 461172000.0, \"Diluted EPS\": 5.07, \"Basic EPS\": 5.08, \"Diluted NI Availto Com Stockholders\": 2344000000.0, \"Net Income Common Stockholders\": 2344000000.0, \"Net Income\": 2344000000.0, \"Minority Interests\": 4000000.0, \"Net Income Including Noncontrolling Interests\": 2340000000.0, \"Net Income Continuous Operations\": 2340000000.0, \"Tax Provision\": 596000000.0, \"Pretax Income\": 2936000000.0, \"Other Income Expense\": 1000000.0, \"Other Non Operating Income Expenses\": 36000000.0, \"Special Income Charges\": 12000000.0, \"Gain On Sale Of Ppe\": 0.0, \"Gain On Sale Of Business\": 101000000.0, \"Write Off\": 2000000.0, \"Impairment Of Capital Assets\": 35000000.0, \"Restructuring And Mergern Acquisition\": 52000000.0, \"Gain On Sale Of Security\": -47000000.0, \"Net Non Operating Interest Income Expense\": -134000000.0, \"Interest Expense Non Operating\": 239000000.0, \"Interest Income Non Operating\": 105000000.0, \"Operating Income\": 3069000000.0, \"Operating Expense\": 2914000000.0, \"Depreciation Amortization Depletion Income Statement\": 149000000.0, \"Depreciation And Amortization In Income Statement\": 149000000.0, \"Amortization\": 149000000.0, \"Amortization Of Intangibles Income Statement\": 149000000.0, \"Research And Development\": 614000000.0, \"Selling General And Administration\": 2151000000.0, \"Gross Profit\": 5983000000.0, \"Cost Of Revenue\": 2561000000.0, \"Total Revenue\": 8544000000.0, \"Operating Revenue\": 8544000000.0}",
"year": "2023-12-31"
},
"news": {
"news_date": "2023-10-12",
"news_headlines": [
"Validea's Top Health Care Stocks Based On Martin Zweig - 10/16/2023",
"Noteworthy Tuesday Option Activity: RBLX, ZTS, STT"
]
},
"price": {
"close": 165.49427795410156,
"close_previous": 171.66929626464844,
"open": 167.28671314826323,
"open_previous": 174.15112384824334,
"previous_date": "2023-10-12",
"price_date": "2023-10-19"
},
"ticker": "ZTS"
} |
You are a seasoned stock market analyst who is trying to predict whether the prices will go down or up over the day, 2023-10-19, for a specific stock, by offering a buy or sell rating.
[Company Name]
Zoetis Inc.
[Company Description]
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
[Price Movement]
It was 165.49427795410156 on 2023-10-12.
The price of the stock on 2023-10-19 started at 167.28671314826323.
[News since 2023-10-12]
Validea's Top Health Care Stocks Based On Martin Zweig - 10/16/2023
Noteworthy Tuesday Option Activity: RBLX, ZTS, STT
[Financials]
Basic EPS: $5.08
Normalized EBITDA: $3.701000e+09
Net Income: $2.344000e+09
Your answer should look like the following
<think>reasoning about why the stock would go down here.
</think><answer>sell</answer>
or
<think>reasoning about why the stock would go up here.
</think><answer>buy</answer>
Please reason about and provide several reasons for why you think the stock would go up or down in the <think></think> tags. Please provide your answer as a single rating, 'buy' or 'sell', in the <answer></answer> tags, with buy meaning that the stock price will go up,
and sell meaning that the stock price will go down.
|
ZTS | {
"company_info": {
"description": "Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.",
"name": "Zoetis Inc."
},
"current_date": "2023-10-20",
"financials": {
"financials": "{\"Tax Effect Of Unusual Items\": -7105000.0, \"Tax Rate For Calcs\": 0.203, \"Normalized EBITDA\": 3701000000.0, \"Total Unusual Items\": -35000000.0, \"Total Unusual Items Excluding Goodwill\": -35000000.0, \"Net Income From Continuing Operation Net Minority Interest\": 2344000000.0, \"Reconciled Depreciation\": 491000000.0, \"Reconciled Cost Of Revenue\": 2219000000.0, \"EBITDA\": 3666000000.0, \"EBIT\": 3175000000.0, \"Net Interest Income\": -134000000.0, \"Interest Expense\": 239000000.0, \"Interest Income\": 105000000.0, \"Normalized Income\": 2371895000.0, \"Net Income From Continuing And Discontinued Operation\": 2344000000.0, \"Total Expenses\": 5475000000.0, \"Diluted Average Shares\": 462269000.0, \"Basic Average Shares\": 461172000.0, \"Diluted EPS\": 5.07, \"Basic EPS\": 5.08, \"Diluted NI Availto Com Stockholders\": 2344000000.0, \"Net Income Common Stockholders\": 2344000000.0, \"Net Income\": 2344000000.0, \"Minority Interests\": 4000000.0, \"Net Income Including Noncontrolling Interests\": 2340000000.0, \"Net Income Continuous Operations\": 2340000000.0, \"Tax Provision\": 596000000.0, \"Pretax Income\": 2936000000.0, \"Other Income Expense\": 1000000.0, \"Other Non Operating Income Expenses\": 36000000.0, \"Special Income Charges\": 12000000.0, \"Gain On Sale Of Ppe\": 0.0, \"Gain On Sale Of Business\": 101000000.0, \"Write Off\": 2000000.0, \"Impairment Of Capital Assets\": 35000000.0, \"Restructuring And Mergern Acquisition\": 52000000.0, \"Gain On Sale Of Security\": -47000000.0, \"Net Non Operating Interest Income Expense\": -134000000.0, \"Interest Expense Non Operating\": 239000000.0, \"Interest Income Non Operating\": 105000000.0, \"Operating Income\": 3069000000.0, \"Operating Expense\": 2914000000.0, \"Depreciation Amortization Depletion Income Statement\": 149000000.0, \"Depreciation And Amortization In Income Statement\": 149000000.0, \"Amortization\": 149000000.0, \"Amortization Of Intangibles Income Statement\": 149000000.0, \"Research And Development\": 614000000.0, \"Selling General And Administration\": 2151000000.0, \"Gross Profit\": 5983000000.0, \"Cost Of Revenue\": 2561000000.0, \"Total Revenue\": 8544000000.0, \"Operating Revenue\": 8544000000.0}",
"year": "2023-12-31"
},
"news": {
"news_date": "2023-10-13",
"news_headlines": [
"Validea's Top Health Care Stocks Based On Martin Zweig - 10/16/2023",
"Noteworthy Tuesday Option Activity: RBLX, ZTS, STT",
"Relative Strength Alert For Zoetis"
]
},
"price": {
"close": 164.55868530273438,
"close_previous": 171.73822021484375,
"open": 165.08065492536085,
"open_previous": 170.792757204078,
"previous_date": "2023-10-13",
"price_date": "2023-10-20"
},
"ticker": "ZTS"
} |
You are a seasoned stock market analyst who is trying to predict whether the prices will go down or up over the day, 2023-10-20, for a specific stock, by offering a buy or sell rating.
[Company Name]
Zoetis Inc.
[Company Description]
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
[Price Movement]
It was 164.55868530273438 on 2023-10-13.
The price of the stock on 2023-10-20 started at 165.08065492536085.
[News since 2023-10-13]
Validea's Top Health Care Stocks Based On Martin Zweig - 10/16/2023
Noteworthy Tuesday Option Activity: RBLX, ZTS, STT
Relative Strength Alert For Zoetis
[Financials]
Basic EPS: $5.08
Normalized EBITDA: $3.701000e+09
Net Income: $2.344000e+09
Your answer should look like the following
<think>reasoning about why the stock would go down here.
</think><answer>sell</answer>
or
<think>reasoning about why the stock would go up here.
</think><answer>buy</answer>
Please reason about and provide several reasons for why you think the stock would go up or down in the <think></think> tags. Please provide your answer as a single rating, 'buy' or 'sell', in the <answer></answer> tags, with buy meaning that the stock price will go up,
and sell meaning that the stock price will go down.
|
ZTS | {
"company_info": {
"description": "Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.",
"name": "Zoetis Inc."
},
"current_date": "2023-10-23",
"financials": {
"financials": "{\"Tax Effect Of Unusual Items\": -7105000.0, \"Tax Rate For Calcs\": 0.203, \"Normalized EBITDA\": 3701000000.0, \"Total Unusual Items\": -35000000.0, \"Total Unusual Items Excluding Goodwill\": -35000000.0, \"Net Income From Continuing Operation Net Minority Interest\": 2344000000.0, \"Reconciled Depreciation\": 491000000.0, \"Reconciled Cost Of Revenue\": 2219000000.0, \"EBITDA\": 3666000000.0, \"EBIT\": 3175000000.0, \"Net Interest Income\": -134000000.0, \"Interest Expense\": 239000000.0, \"Interest Income\": 105000000.0, \"Normalized Income\": 2371895000.0, \"Net Income From Continuing And Discontinued Operation\": 2344000000.0, \"Total Expenses\": 5475000000.0, \"Diluted Average Shares\": 462269000.0, \"Basic Average Shares\": 461172000.0, \"Diluted EPS\": 5.07, \"Basic EPS\": 5.08, \"Diluted NI Availto Com Stockholders\": 2344000000.0, \"Net Income Common Stockholders\": 2344000000.0, \"Net Income\": 2344000000.0, \"Minority Interests\": 4000000.0, \"Net Income Including Noncontrolling Interests\": 2340000000.0, \"Net Income Continuous Operations\": 2340000000.0, \"Tax Provision\": 596000000.0, \"Pretax Income\": 2936000000.0, \"Other Income Expense\": 1000000.0, \"Other Non Operating Income Expenses\": 36000000.0, \"Special Income Charges\": 12000000.0, \"Gain On Sale Of Ppe\": 0.0, \"Gain On Sale Of Business\": 101000000.0, \"Write Off\": 2000000.0, \"Impairment Of Capital Assets\": 35000000.0, \"Restructuring And Mergern Acquisition\": 52000000.0, \"Gain On Sale Of Security\": -47000000.0, \"Net Non Operating Interest Income Expense\": -134000000.0, \"Interest Expense Non Operating\": 239000000.0, \"Interest Income Non Operating\": 105000000.0, \"Operating Income\": 3069000000.0, \"Operating Expense\": 2914000000.0, \"Depreciation Amortization Depletion Income Statement\": 149000000.0, \"Depreciation And Amortization In Income Statement\": 149000000.0, \"Amortization\": 149000000.0, \"Amortization Of Intangibles Income Statement\": 149000000.0, \"Research And Development\": 614000000.0, \"Selling General And Administration\": 2151000000.0, \"Gross Profit\": 5983000000.0, \"Cost Of Revenue\": 2561000000.0, \"Total Revenue\": 8544000000.0, \"Operating Revenue\": 8544000000.0}",
"year": "2023-12-31"
},
"news": {
"news_date": "2023-10-16",
"news_headlines": [
"Validea's Top Health Care Stocks Based On Martin Zweig - 10/16/2023",
"Noteworthy Tuesday Option Activity: RBLX, ZTS, STT",
"Relative Strength Alert For Zoetis"
]
},
"price": {
"close": 163.9776153564453,
"close_previous": 172.52609252929688,
"open": 164.05640520317502,
"open_previous": 172.35866975813857,
"previous_date": "2023-10-16",
"price_date": "2023-10-23"
},
"ticker": "ZTS"
} |
You are a seasoned stock market analyst who is trying to predict whether the prices will go down or up over the day, 2023-10-23, for a specific stock, by offering a buy or sell rating.
[Company Name]
Zoetis Inc.
[Company Description]
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
[Price Movement]
It was 163.9776153564453 on 2023-10-16.
The price of the stock on 2023-10-23 started at 164.05640520317502.
[News since 2023-10-16]
Validea's Top Health Care Stocks Based On Martin Zweig - 10/16/2023
Noteworthy Tuesday Option Activity: RBLX, ZTS, STT
Relative Strength Alert For Zoetis
[Financials]
Basic EPS: $5.08
Normalized EBITDA: $3.701000e+09
Net Income: $2.344000e+09
Your answer should look like the following
<think>reasoning about why the stock would go down here.
</think><answer>sell</answer>
or
<think>reasoning about why the stock would go up here.
</think><answer>buy</answer>
Please reason about and provide several reasons for why you think the stock would go up or down in the <think></think> tags. Please provide your answer as a single rating, 'buy' or 'sell', in the <answer></answer> tags, with buy meaning that the stock price will go up,
and sell meaning that the stock price will go down.
|
ZTS | {
"company_info": {
"description": "Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.",
"name": "Zoetis Inc."
},
"current_date": "2023-10-24",
"financials": {
"financials": "{\"Tax Effect Of Unusual Items\": -7105000.0, \"Tax Rate For Calcs\": 0.203, \"Normalized EBITDA\": 3701000000.0, \"Total Unusual Items\": -35000000.0, \"Total Unusual Items Excluding Goodwill\": -35000000.0, \"Net Income From Continuing Operation Net Minority Interest\": 2344000000.0, \"Reconciled Depreciation\": 491000000.0, \"Reconciled Cost Of Revenue\": 2219000000.0, \"EBITDA\": 3666000000.0, \"EBIT\": 3175000000.0, \"Net Interest Income\": -134000000.0, \"Interest Expense\": 239000000.0, \"Interest Income\": 105000000.0, \"Normalized Income\": 2371895000.0, \"Net Income From Continuing And Discontinued Operation\": 2344000000.0, \"Total Expenses\": 5475000000.0, \"Diluted Average Shares\": 462269000.0, \"Basic Average Shares\": 461172000.0, \"Diluted EPS\": 5.07, \"Basic EPS\": 5.08, \"Diluted NI Availto Com Stockholders\": 2344000000.0, \"Net Income Common Stockholders\": 2344000000.0, \"Net Income\": 2344000000.0, \"Minority Interests\": 4000000.0, \"Net Income Including Noncontrolling Interests\": 2340000000.0, \"Net Income Continuous Operations\": 2340000000.0, \"Tax Provision\": 596000000.0, \"Pretax Income\": 2936000000.0, \"Other Income Expense\": 1000000.0, \"Other Non Operating Income Expenses\": 36000000.0, \"Special Income Charges\": 12000000.0, \"Gain On Sale Of Ppe\": 0.0, \"Gain On Sale Of Business\": 101000000.0, \"Write Off\": 2000000.0, \"Impairment Of Capital Assets\": 35000000.0, \"Restructuring And Mergern Acquisition\": 52000000.0, \"Gain On Sale Of Security\": -47000000.0, \"Net Non Operating Interest Income Expense\": -134000000.0, \"Interest Expense Non Operating\": 239000000.0, \"Interest Income Non Operating\": 105000000.0, \"Operating Income\": 3069000000.0, \"Operating Expense\": 2914000000.0, \"Depreciation Amortization Depletion Income Statement\": 149000000.0, \"Depreciation And Amortization In Income Statement\": 149000000.0, \"Amortization\": 149000000.0, \"Amortization Of Intangibles Income Statement\": 149000000.0, \"Research And Development\": 614000000.0, \"Selling General And Administration\": 2151000000.0, \"Gross Profit\": 5983000000.0, \"Cost Of Revenue\": 2561000000.0, \"Total Revenue\": 8544000000.0, \"Operating Revenue\": 8544000000.0}",
"year": "2023-12-31"
},
"news": {
"news_date": "2023-10-17",
"news_headlines": [
"Noteworthy Tuesday Option Activity: RBLX, ZTS, STT",
"Relative Strength Alert For Zoetis",
"Should You Invest in the VanEck Agribusiness ETF (MOO)?"
]
},
"price": {
"close": 164.5882110595703,
"close_previous": 171.62005615234375,
"open": 164.10564393134672,
"open_previous": 170.251114451305,
"previous_date": "2023-10-17",
"price_date": "2023-10-24"
},
"ticker": "ZTS"
} |
You are a seasoned stock market analyst who is trying to predict whether the prices will go down or up over the day, 2023-10-24, for a specific stock, by offering a buy or sell rating.
[Company Name]
Zoetis Inc.
[Company Description]
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
[Price Movement]
It was 164.5882110595703 on 2023-10-17.
The price of the stock on 2023-10-24 started at 164.10564393134672.
[News since 2023-10-17]
Noteworthy Tuesday Option Activity: RBLX, ZTS, STT
Relative Strength Alert For Zoetis
Should You Invest in the VanEck Agribusiness ETF (MOO)?
[Financials]
Basic EPS: $5.08
Normalized EBITDA: $3.701000e+09
Net Income: $2.344000e+09
Your answer should look like the following
<think>reasoning about why the stock would go down here.
</think><answer>sell</answer>
or
<think>reasoning about why the stock would go up here.
</think><answer>buy</answer>
Please reason about and provide several reasons for why you think the stock would go up or down in the <think></think> tags. Please provide your answer as a single rating, 'buy' or 'sell', in the <answer></answer> tags, with buy meaning that the stock price will go up,
and sell meaning that the stock price will go down.
|
ZTS | {
"company_info": {
"description": "Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.",
"name": "Zoetis Inc."
},
"current_date": "2023-10-25",
"financials": {
"financials": "{\"Tax Effect Of Unusual Items\": -7105000.0, \"Tax Rate For Calcs\": 0.203, \"Normalized EBITDA\": 3701000000.0, \"Total Unusual Items\": -35000000.0, \"Total Unusual Items Excluding Goodwill\": -35000000.0, \"Net Income From Continuing Operation Net Minority Interest\": 2344000000.0, \"Reconciled Depreciation\": 491000000.0, \"Reconciled Cost Of Revenue\": 2219000000.0, \"EBITDA\": 3666000000.0, \"EBIT\": 3175000000.0, \"Net Interest Income\": -134000000.0, \"Interest Expense\": 239000000.0, \"Interest Income\": 105000000.0, \"Normalized Income\": 2371895000.0, \"Net Income From Continuing And Discontinued Operation\": 2344000000.0, \"Total Expenses\": 5475000000.0, \"Diluted Average Shares\": 462269000.0, \"Basic Average Shares\": 461172000.0, \"Diluted EPS\": 5.07, \"Basic EPS\": 5.08, \"Diluted NI Availto Com Stockholders\": 2344000000.0, \"Net Income Common Stockholders\": 2344000000.0, \"Net Income\": 2344000000.0, \"Minority Interests\": 4000000.0, \"Net Income Including Noncontrolling Interests\": 2340000000.0, \"Net Income Continuous Operations\": 2340000000.0, \"Tax Provision\": 596000000.0, \"Pretax Income\": 2936000000.0, \"Other Income Expense\": 1000000.0, \"Other Non Operating Income Expenses\": 36000000.0, \"Special Income Charges\": 12000000.0, \"Gain On Sale Of Ppe\": 0.0, \"Gain On Sale Of Business\": 101000000.0, \"Write Off\": 2000000.0, \"Impairment Of Capital Assets\": 35000000.0, \"Restructuring And Mergern Acquisition\": 52000000.0, \"Gain On Sale Of Security\": -47000000.0, \"Net Non Operating Interest Income Expense\": -134000000.0, \"Interest Expense Non Operating\": 239000000.0, \"Interest Income Non Operating\": 105000000.0, \"Operating Income\": 3069000000.0, \"Operating Expense\": 2914000000.0, \"Depreciation Amortization Depletion Income Statement\": 149000000.0, \"Depreciation And Amortization In Income Statement\": 149000000.0, \"Amortization\": 149000000.0, \"Amortization Of Intangibles Income Statement\": 149000000.0, \"Research And Development\": 614000000.0, \"Selling General And Administration\": 2151000000.0, \"Gross Profit\": 5983000000.0, \"Cost Of Revenue\": 2561000000.0, \"Total Revenue\": 8544000000.0, \"Operating Revenue\": 8544000000.0}",
"year": "2023-12-31"
},
"news": {
"news_date": "2023-10-18",
"news_headlines": [
"Relative Strength Alert For Zoetis",
"Should You Invest in the VanEck Agribusiness ETF (MOO)?"
]
},
"price": {
"close": 161.1904754638672,
"close_previous": 166.9715576171875,
"open": 163.05184226078853,
"open_previous": 170.3003573245487,
"previous_date": "2023-10-18",
"price_date": "2023-10-25"
},
"ticker": "ZTS"
} |
You are a seasoned stock market analyst who is trying to predict whether the prices will go down or up over the day, 2023-10-25, for a specific stock, by offering a buy or sell rating.
[Company Name]
Zoetis Inc.
[Company Description]
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
[Price Movement]
It was 161.1904754638672 on 2023-10-18.
The price of the stock on 2023-10-25 started at 163.05184226078853.
[News since 2023-10-18]
Relative Strength Alert For Zoetis
Should You Invest in the VanEck Agribusiness ETF (MOO)?
[Financials]
Basic EPS: $5.08
Normalized EBITDA: $3.701000e+09
Net Income: $2.344000e+09
Your answer should look like the following
<think>reasoning about why the stock would go down here.
</think><answer>sell</answer>
or
<think>reasoning about why the stock would go up here.
</think><answer>buy</answer>
Please reason about and provide several reasons for why you think the stock would go up or down in the <think></think> tags. Please provide your answer as a single rating, 'buy' or 'sell', in the <answer></answer> tags, with buy meaning that the stock price will go up,
and sell meaning that the stock price will go down.
|
ZTS | {
"company_info": {
"description": "Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.",
"name": "Zoetis Inc."
},
"current_date": "2023-10-26",
"financials": {
"financials": "{\"Tax Effect Of Unusual Items\": -7105000.0, \"Tax Rate For Calcs\": 0.203, \"Normalized EBITDA\": 3701000000.0, \"Total Unusual Items\": -35000000.0, \"Total Unusual Items Excluding Goodwill\": -35000000.0, \"Net Income From Continuing Operation Net Minority Interest\": 2344000000.0, \"Reconciled Depreciation\": 491000000.0, \"Reconciled Cost Of Revenue\": 2219000000.0, \"EBITDA\": 3666000000.0, \"EBIT\": 3175000000.0, \"Net Interest Income\": -134000000.0, \"Interest Expense\": 239000000.0, \"Interest Income\": 105000000.0, \"Normalized Income\": 2371895000.0, \"Net Income From Continuing And Discontinued Operation\": 2344000000.0, \"Total Expenses\": 5475000000.0, \"Diluted Average Shares\": 462269000.0, \"Basic Average Shares\": 461172000.0, \"Diluted EPS\": 5.07, \"Basic EPS\": 5.08, \"Diluted NI Availto Com Stockholders\": 2344000000.0, \"Net Income Common Stockholders\": 2344000000.0, \"Net Income\": 2344000000.0, \"Minority Interests\": 4000000.0, \"Net Income Including Noncontrolling Interests\": 2340000000.0, \"Net Income Continuous Operations\": 2340000000.0, \"Tax Provision\": 596000000.0, \"Pretax Income\": 2936000000.0, \"Other Income Expense\": 1000000.0, \"Other Non Operating Income Expenses\": 36000000.0, \"Special Income Charges\": 12000000.0, \"Gain On Sale Of Ppe\": 0.0, \"Gain On Sale Of Business\": 101000000.0, \"Write Off\": 2000000.0, \"Impairment Of Capital Assets\": 35000000.0, \"Restructuring And Mergern Acquisition\": 52000000.0, \"Gain On Sale Of Security\": -47000000.0, \"Net Non Operating Interest Income Expense\": -134000000.0, \"Interest Expense Non Operating\": 239000000.0, \"Interest Income Non Operating\": 105000000.0, \"Operating Income\": 3069000000.0, \"Operating Expense\": 2914000000.0, \"Depreciation Amortization Depletion Income Statement\": 149000000.0, \"Depreciation And Amortization In Income Statement\": 149000000.0, \"Amortization\": 149000000.0, \"Amortization Of Intangibles Income Statement\": 149000000.0, \"Research And Development\": 614000000.0, \"Selling General And Administration\": 2151000000.0, \"Gross Profit\": 5983000000.0, \"Cost Of Revenue\": 2561000000.0, \"Total Revenue\": 8544000000.0, \"Operating Revenue\": 8544000000.0}",
"year": "2023-12-31"
},
"news": {
"news_date": "2023-10-19",
"news_headlines": [
"Relative Strength Alert For Zoetis",
"Should You Invest in the VanEck Agribusiness ETF (MOO)?"
]
},
"price": {
"close": 155.6753387451172,
"close_previous": 165.49427795410156,
"open": 159.81170818492478,
"open_previous": 167.28671314826323,
"previous_date": "2023-10-19",
"price_date": "2023-10-26"
},
"ticker": "ZTS"
} |
You are a seasoned stock market analyst who is trying to predict whether the prices will go down or up over the day, 2023-10-26, for a specific stock, by offering a buy or sell rating.
[Company Name]
Zoetis Inc.
[Company Description]
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
[Price Movement]
It was 155.6753387451172 on 2023-10-19.
The price of the stock on 2023-10-26 started at 159.81170818492478.
[News since 2023-10-19]
Relative Strength Alert For Zoetis
Should You Invest in the VanEck Agribusiness ETF (MOO)?
[Financials]
Basic EPS: $5.08
Normalized EBITDA: $3.701000e+09
Net Income: $2.344000e+09
Your answer should look like the following
<think>reasoning about why the stock would go down here.
</think><answer>sell</answer>
or
<think>reasoning about why the stock would go up here.
</think><answer>buy</answer>
Please reason about and provide several reasons for why you think the stock would go up or down in the <think></think> tags. Please provide your answer as a single rating, 'buy' or 'sell', in the <answer></answer> tags, with buy meaning that the stock price will go up,
and sell meaning that the stock price will go down.
|
ZTS | {
"company_info": {
"description": "Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.",
"name": "Zoetis Inc."
},
"current_date": "2023-10-27",
"financials": {
"financials": "{\"Tax Effect Of Unusual Items\": -7105000.0, \"Tax Rate For Calcs\": 0.203, \"Normalized EBITDA\": 3701000000.0, \"Total Unusual Items\": -35000000.0, \"Total Unusual Items Excluding Goodwill\": -35000000.0, \"Net Income From Continuing Operation Net Minority Interest\": 2344000000.0, \"Reconciled Depreciation\": 491000000.0, \"Reconciled Cost Of Revenue\": 2219000000.0, \"EBITDA\": 3666000000.0, \"EBIT\": 3175000000.0, \"Net Interest Income\": -134000000.0, \"Interest Expense\": 239000000.0, \"Interest Income\": 105000000.0, \"Normalized Income\": 2371895000.0, \"Net Income From Continuing And Discontinued Operation\": 2344000000.0, \"Total Expenses\": 5475000000.0, \"Diluted Average Shares\": 462269000.0, \"Basic Average Shares\": 461172000.0, \"Diluted EPS\": 5.07, \"Basic EPS\": 5.08, \"Diluted NI Availto Com Stockholders\": 2344000000.0, \"Net Income Common Stockholders\": 2344000000.0, \"Net Income\": 2344000000.0, \"Minority Interests\": 4000000.0, \"Net Income Including Noncontrolling Interests\": 2340000000.0, \"Net Income Continuous Operations\": 2340000000.0, \"Tax Provision\": 596000000.0, \"Pretax Income\": 2936000000.0, \"Other Income Expense\": 1000000.0, \"Other Non Operating Income Expenses\": 36000000.0, \"Special Income Charges\": 12000000.0, \"Gain On Sale Of Ppe\": 0.0, \"Gain On Sale Of Business\": 101000000.0, \"Write Off\": 2000000.0, \"Impairment Of Capital Assets\": 35000000.0, \"Restructuring And Mergern Acquisition\": 52000000.0, \"Gain On Sale Of Security\": -47000000.0, \"Net Non Operating Interest Income Expense\": -134000000.0, \"Interest Expense Non Operating\": 239000000.0, \"Interest Income Non Operating\": 105000000.0, \"Operating Income\": 3069000000.0, \"Operating Expense\": 2914000000.0, \"Depreciation Amortization Depletion Income Statement\": 149000000.0, \"Depreciation And Amortization In Income Statement\": 149000000.0, \"Amortization\": 149000000.0, \"Amortization Of Intangibles Income Statement\": 149000000.0, \"Research And Development\": 614000000.0, \"Selling General And Administration\": 2151000000.0, \"Gross Profit\": 5983000000.0, \"Cost Of Revenue\": 2561000000.0, \"Total Revenue\": 8544000000.0, \"Operating Revenue\": 8544000000.0}",
"year": "2023-12-31"
},
"news": {
"news_date": "2023-10-20",
"news_headlines": [
"Should You Invest in the VanEck Agribusiness ETF (MOO)?",
"JAZZ vs. ZTS: Which Stock Is the Better Value Option?",
"Zoetis (ZTS) Reports Next Week: Wall Street Expects Earnings Growth"
]
},
"price": {
"close": 153.66622924804688,
"close_previous": 164.55868530273438,
"open": 155.53743927144782,
"open_previous": 165.08065492536085,
"previous_date": "2023-10-20",
"price_date": "2023-10-27"
},
"ticker": "ZTS"
} |
You are a seasoned stock market analyst who is trying to predict whether the prices will go down or up over the day, 2023-10-27, for a specific stock, by offering a buy or sell rating.
[Company Name]
Zoetis Inc.
[Company Description]
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
[Price Movement]
It was 153.66622924804688 on 2023-10-20.
The price of the stock on 2023-10-27 started at 155.53743927144782.
[News since 2023-10-20]
Should You Invest in the VanEck Agribusiness ETF (MOO)?
JAZZ vs. ZTS: Which Stock Is the Better Value Option?
Zoetis (ZTS) Reports Next Week: Wall Street Expects Earnings Growth
[Financials]
Basic EPS: $5.08
Normalized EBITDA: $3.701000e+09
Net Income: $2.344000e+09
Your answer should look like the following
<think>reasoning about why the stock would go down here.
</think><answer>sell</answer>
or
<think>reasoning about why the stock would go up here.
</think><answer>buy</answer>
Please reason about and provide several reasons for why you think the stock would go up or down in the <think></think> tags. Please provide your answer as a single rating, 'buy' or 'sell', in the <answer></answer> tags, with buy meaning that the stock price will go up,
and sell meaning that the stock price will go down.
|
ZTS | {
"company_info": {
"description": "Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.",
"name": "Zoetis Inc."
},
"current_date": "2023-10-30",
"financials": {
"financials": "{\"Tax Effect Of Unusual Items\": -7105000.0, \"Tax Rate For Calcs\": 0.203, \"Normalized EBITDA\": 3701000000.0, \"Total Unusual Items\": -35000000.0, \"Total Unusual Items Excluding Goodwill\": -35000000.0, \"Net Income From Continuing Operation Net Minority Interest\": 2344000000.0, \"Reconciled Depreciation\": 491000000.0, \"Reconciled Cost Of Revenue\": 2219000000.0, \"EBITDA\": 3666000000.0, \"EBIT\": 3175000000.0, \"Net Interest Income\": -134000000.0, \"Interest Expense\": 239000000.0, \"Interest Income\": 105000000.0, \"Normalized Income\": 2371895000.0, \"Net Income From Continuing And Discontinued Operation\": 2344000000.0, \"Total Expenses\": 5475000000.0, \"Diluted Average Shares\": 462269000.0, \"Basic Average Shares\": 461172000.0, \"Diluted EPS\": 5.07, \"Basic EPS\": 5.08, \"Diluted NI Availto Com Stockholders\": 2344000000.0, \"Net Income Common Stockholders\": 2344000000.0, \"Net Income\": 2344000000.0, \"Minority Interests\": 4000000.0, \"Net Income Including Noncontrolling Interests\": 2340000000.0, \"Net Income Continuous Operations\": 2340000000.0, \"Tax Provision\": 596000000.0, \"Pretax Income\": 2936000000.0, \"Other Income Expense\": 1000000.0, \"Other Non Operating Income Expenses\": 36000000.0, \"Special Income Charges\": 12000000.0, \"Gain On Sale Of Ppe\": 0.0, \"Gain On Sale Of Business\": 101000000.0, \"Write Off\": 2000000.0, \"Impairment Of Capital Assets\": 35000000.0, \"Restructuring And Mergern Acquisition\": 52000000.0, \"Gain On Sale Of Security\": -47000000.0, \"Net Non Operating Interest Income Expense\": -134000000.0, \"Interest Expense Non Operating\": 239000000.0, \"Interest Income Non Operating\": 105000000.0, \"Operating Income\": 3069000000.0, \"Operating Expense\": 2914000000.0, \"Depreciation Amortization Depletion Income Statement\": 149000000.0, \"Depreciation And Amortization In Income Statement\": 149000000.0, \"Amortization\": 149000000.0, \"Amortization Of Intangibles Income Statement\": 149000000.0, \"Research And Development\": 614000000.0, \"Selling General And Administration\": 2151000000.0, \"Gross Profit\": 5983000000.0, \"Cost Of Revenue\": 2561000000.0, \"Total Revenue\": 8544000000.0, \"Operating Revenue\": 8544000000.0}",
"year": "2023-12-31"
},
"news": {
"news_date": "2023-10-23",
"news_headlines": [
"Should You Invest in the VanEck Agribusiness ETF (MOO)?",
"JAZZ vs. ZTS: Which Stock Is the Better Value Option?",
"Zoetis (ZTS) Reports Next Week: Wall Street Expects Earnings Growth",
"Top Research Reports for Costco, Pfizer & IBM",
"Ex-Dividend Reminder: Zoetis, Synchrony Financial and Realty Income"
]
},
"price": {
"close": 154.6215362548828,
"close_previous": 163.9776153564453,
"open": 154.74957163514463,
"open_previous": 164.05640520317502,
"previous_date": "2023-10-23",
"price_date": "2023-10-30"
},
"ticker": "ZTS"
} |
You are a seasoned stock market analyst who is trying to predict whether the prices will go down or up over the day, 2023-10-30, for a specific stock, by offering a buy or sell rating.
[Company Name]
Zoetis Inc.
[Company Description]
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
[Price Movement]
It was 154.6215362548828 on 2023-10-23.
The price of the stock on 2023-10-30 started at 154.74957163514463.
[News since 2023-10-23]
Should You Invest in the VanEck Agribusiness ETF (MOO)?
JAZZ vs. ZTS: Which Stock Is the Better Value Option?
Zoetis (ZTS) Reports Next Week: Wall Street Expects Earnings Growth
Top Research Reports for Costco, Pfizer & IBM
Ex-Dividend Reminder: Zoetis, Synchrony Financial and Realty Income
[Financials]
Basic EPS: $5.08
Normalized EBITDA: $3.701000e+09
Net Income: $2.344000e+09
Your answer should look like the following
<think>reasoning about why the stock would go down here.
</think><answer>sell</answer>
or
<think>reasoning about why the stock would go up here.
</think><answer>buy</answer>
Please reason about and provide several reasons for why you think the stock would go up or down in the <think></think> tags. Please provide your answer as a single rating, 'buy' or 'sell', in the <answer></answer> tags, with buy meaning that the stock price will go up,
and sell meaning that the stock price will go down.
|
ZTS | {
"company_info": {
"description": "Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.",
"name": "Zoetis Inc."
},
"current_date": "2023-10-31",
"financials": {
"financials": "{\"Tax Effect Of Unusual Items\": -7105000.0, \"Tax Rate For Calcs\": 0.203, \"Normalized EBITDA\": 3701000000.0, \"Total Unusual Items\": -35000000.0, \"Total Unusual Items Excluding Goodwill\": -35000000.0, \"Net Income From Continuing Operation Net Minority Interest\": 2344000000.0, \"Reconciled Depreciation\": 491000000.0, \"Reconciled Cost Of Revenue\": 2219000000.0, \"EBITDA\": 3666000000.0, \"EBIT\": 3175000000.0, \"Net Interest Income\": -134000000.0, \"Interest Expense\": 239000000.0, \"Interest Income\": 105000000.0, \"Normalized Income\": 2371895000.0, \"Net Income From Continuing And Discontinued Operation\": 2344000000.0, \"Total Expenses\": 5475000000.0, \"Diluted Average Shares\": 462269000.0, \"Basic Average Shares\": 461172000.0, \"Diluted EPS\": 5.07, \"Basic EPS\": 5.08, \"Diluted NI Availto Com Stockholders\": 2344000000.0, \"Net Income Common Stockholders\": 2344000000.0, \"Net Income\": 2344000000.0, \"Minority Interests\": 4000000.0, \"Net Income Including Noncontrolling Interests\": 2340000000.0, \"Net Income Continuous Operations\": 2340000000.0, \"Tax Provision\": 596000000.0, \"Pretax Income\": 2936000000.0, \"Other Income Expense\": 1000000.0, \"Other Non Operating Income Expenses\": 36000000.0, \"Special Income Charges\": 12000000.0, \"Gain On Sale Of Ppe\": 0.0, \"Gain On Sale Of Business\": 101000000.0, \"Write Off\": 2000000.0, \"Impairment Of Capital Assets\": 35000000.0, \"Restructuring And Mergern Acquisition\": 52000000.0, \"Gain On Sale Of Security\": -47000000.0, \"Net Non Operating Interest Income Expense\": -134000000.0, \"Interest Expense Non Operating\": 239000000.0, \"Interest Income Non Operating\": 105000000.0, \"Operating Income\": 3069000000.0, \"Operating Expense\": 2914000000.0, \"Depreciation Amortization Depletion Income Statement\": 149000000.0, \"Depreciation And Amortization In Income Statement\": 149000000.0, \"Amortization\": 149000000.0, \"Amortization Of Intangibles Income Statement\": 149000000.0, \"Research And Development\": 614000000.0, \"Selling General And Administration\": 2151000000.0, \"Gross Profit\": 5983000000.0, \"Cost Of Revenue\": 2561000000.0, \"Total Revenue\": 8544000000.0, \"Operating Revenue\": 8544000000.0}",
"year": "2023-12-31"
},
"news": {
"news_date": "2023-10-24",
"news_headlines": [
"JAZZ vs. ZTS: Which Stock Is the Better Value Option?",
"Zoetis (ZTS) Reports Next Week: Wall Street Expects Earnings Growth",
"Top Research Reports for Costco, Pfizer & IBM",
"Ex-Dividend Reminder: Zoetis, Synchrony Financial and Realty Income",
"Stifel Maintains Zoetis Inc - (ZTS) Buy Recommendation",
"Validea Detailed Fundamental Analysis - ZTS",
"We Did The Math SUSA Can Go To $105"
]
},
"price": {
"close": 154.9917449951172,
"close_previous": 164.5882110595703,
"open": 155.495215941311,
"open_previous": 164.10564393134672,
"previous_date": "2023-10-24",
"price_date": "2023-10-31"
},
"ticker": "ZTS"
} |
You are a seasoned stock market analyst who is trying to predict whether the prices will go down or up over the day, 2023-10-31, for a specific stock, by offering a buy or sell rating.
[Company Name]
Zoetis Inc.
[Company Description]
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
[Price Movement]
It was 154.9917449951172 on 2023-10-24.
The price of the stock on 2023-10-31 started at 155.495215941311.
[News since 2023-10-24]
JAZZ vs. ZTS: Which Stock Is the Better Value Option?
Zoetis (ZTS) Reports Next Week: Wall Street Expects Earnings Growth
Top Research Reports for Costco, Pfizer & IBM
Ex-Dividend Reminder: Zoetis, Synchrony Financial and Realty Income
Stifel Maintains Zoetis Inc - (ZTS) Buy Recommendation
Validea Detailed Fundamental Analysis - ZTS
We Did The Math SUSA Can Go To $105
[Financials]
Basic EPS: $5.08
Normalized EBITDA: $3.701000e+09
Net Income: $2.344000e+09
Your answer should look like the following
<think>reasoning about why the stock would go down here.
</think><answer>sell</answer>
or
<think>reasoning about why the stock would go up here.
</think><answer>buy</answer>
Please reason about and provide several reasons for why you think the stock would go up or down in the <think></think> tags. Please provide your answer as a single rating, 'buy' or 'sell', in the <answer></answer> tags, with buy meaning that the stock price will go up,
and sell meaning that the stock price will go down.
|
ZTS | {
"company_info": {
"description": "Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.",
"name": "Zoetis Inc."
},
"current_date": "2023-11-01",
"financials": {
"financials": "{\"Tax Effect Of Unusual Items\": -7105000.0, \"Tax Rate For Calcs\": 0.203, \"Normalized EBITDA\": 3701000000.0, \"Total Unusual Items\": -35000000.0, \"Total Unusual Items Excluding Goodwill\": -35000000.0, \"Net Income From Continuing Operation Net Minority Interest\": 2344000000.0, \"Reconciled Depreciation\": 491000000.0, \"Reconciled Cost Of Revenue\": 2219000000.0, \"EBITDA\": 3666000000.0, \"EBIT\": 3175000000.0, \"Net Interest Income\": -134000000.0, \"Interest Expense\": 239000000.0, \"Interest Income\": 105000000.0, \"Normalized Income\": 2371895000.0, \"Net Income From Continuing And Discontinued Operation\": 2344000000.0, \"Total Expenses\": 5475000000.0, \"Diluted Average Shares\": 462269000.0, \"Basic Average Shares\": 461172000.0, \"Diluted EPS\": 5.07, \"Basic EPS\": 5.08, \"Diluted NI Availto Com Stockholders\": 2344000000.0, \"Net Income Common Stockholders\": 2344000000.0, \"Net Income\": 2344000000.0, \"Minority Interests\": 4000000.0, \"Net Income Including Noncontrolling Interests\": 2340000000.0, \"Net Income Continuous Operations\": 2340000000.0, \"Tax Provision\": 596000000.0, \"Pretax Income\": 2936000000.0, \"Other Income Expense\": 1000000.0, \"Other Non Operating Income Expenses\": 36000000.0, \"Special Income Charges\": 12000000.0, \"Gain On Sale Of Ppe\": 0.0, \"Gain On Sale Of Business\": 101000000.0, \"Write Off\": 2000000.0, \"Impairment Of Capital Assets\": 35000000.0, \"Restructuring And Mergern Acquisition\": 52000000.0, \"Gain On Sale Of Security\": -47000000.0, \"Net Non Operating Interest Income Expense\": -134000000.0, \"Interest Expense Non Operating\": 239000000.0, \"Interest Income Non Operating\": 105000000.0, \"Operating Income\": 3069000000.0, \"Operating Expense\": 2914000000.0, \"Depreciation Amortization Depletion Income Statement\": 149000000.0, \"Depreciation And Amortization In Income Statement\": 149000000.0, \"Amortization\": 149000000.0, \"Amortization Of Intangibles Income Statement\": 149000000.0, \"Research And Development\": 614000000.0, \"Selling General And Administration\": 2151000000.0, \"Gross Profit\": 5983000000.0, \"Cost Of Revenue\": 2561000000.0, \"Total Revenue\": 8544000000.0, \"Operating Revenue\": 8544000000.0}",
"year": "2023-12-31"
},
"news": {
"news_date": "2023-10-25",
"news_headlines": [
"JAZZ vs. ZTS: Which Stock Is the Better Value Option?",
"Zoetis (ZTS) Reports Next Week: Wall Street Expects Earnings Growth",
"Top Research Reports for Costco, Pfizer & IBM",
"Ex-Dividend Reminder: Zoetis, Synchrony Financial and Realty Income",
"Stifel Maintains Zoetis Inc - (ZTS) Buy Recommendation",
"Validea Detailed Fundamental Analysis - ZTS",
"We Did The Math SUSA Can Go To $105",
"Analysts Estimate Sage Therapeutics, Inc. (SAGE) to Report a Decline in Earnings: What to Look Out for"
]
},
"price": {
"close": 149.5028533935547,
"close_previous": 161.1904754638672,
"open": 154.41914736576896,
"open_previous": 163.05184226078853,
"previous_date": "2023-10-25",
"price_date": "2023-11-01"
},
"ticker": "ZTS"
} |
You are a seasoned stock market analyst who is trying to predict whether the prices will go down or up over the day, 2023-11-01, for a specific stock, by offering a buy or sell rating.
[Company Name]
Zoetis Inc.
[Company Description]
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
[Price Movement]
It was 149.5028533935547 on 2023-10-25.
The price of the stock on 2023-11-01 started at 154.41914736576896.
[News since 2023-10-25]
JAZZ vs. ZTS: Which Stock Is the Better Value Option?
Zoetis (ZTS) Reports Next Week: Wall Street Expects Earnings Growth
Top Research Reports for Costco, Pfizer & IBM
Ex-Dividend Reminder: Zoetis, Synchrony Financial and Realty Income
Stifel Maintains Zoetis Inc - (ZTS) Buy Recommendation
Validea Detailed Fundamental Analysis - ZTS
We Did The Math SUSA Can Go To $105
Analysts Estimate Sage Therapeutics, Inc. (SAGE) to Report a Decline in Earnings: What to Look Out for
[Financials]
Basic EPS: $5.08
Normalized EBITDA: $3.701000e+09
Net Income: $2.344000e+09
Your answer should look like the following
<think>reasoning about why the stock would go down here.
</think><answer>sell</answer>
or
<think>reasoning about why the stock would go up here.
</think><answer>buy</answer>
Please reason about and provide several reasons for why you think the stock would go up or down in the <think></think> tags. Please provide your answer as a single rating, 'buy' or 'sell', in the <answer></answer> tags, with buy meaning that the stock price will go up,
and sell meaning that the stock price will go down.
|
ZTS | {
"company_info": {
"description": "Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.",
"name": "Zoetis Inc."
},
"current_date": "2023-11-02",
"financials": {
"financials": "{\"Tax Effect Of Unusual Items\": -7105000.0, \"Tax Rate For Calcs\": 0.203, \"Normalized EBITDA\": 3701000000.0, \"Total Unusual Items\": -35000000.0, \"Total Unusual Items Excluding Goodwill\": -35000000.0, \"Net Income From Continuing Operation Net Minority Interest\": 2344000000.0, \"Reconciled Depreciation\": 491000000.0, \"Reconciled Cost Of Revenue\": 2219000000.0, \"EBITDA\": 3666000000.0, \"EBIT\": 3175000000.0, \"Net Interest Income\": -134000000.0, \"Interest Expense\": 239000000.0, \"Interest Income\": 105000000.0, \"Normalized Income\": 2371895000.0, \"Net Income From Continuing And Discontinued Operation\": 2344000000.0, \"Total Expenses\": 5475000000.0, \"Diluted Average Shares\": 462269000.0, \"Basic Average Shares\": 461172000.0, \"Diluted EPS\": 5.07, \"Basic EPS\": 5.08, \"Diluted NI Availto Com Stockholders\": 2344000000.0, \"Net Income Common Stockholders\": 2344000000.0, \"Net Income\": 2344000000.0, \"Minority Interests\": 4000000.0, \"Net Income Including Noncontrolling Interests\": 2340000000.0, \"Net Income Continuous Operations\": 2340000000.0, \"Tax Provision\": 596000000.0, \"Pretax Income\": 2936000000.0, \"Other Income Expense\": 1000000.0, \"Other Non Operating Income Expenses\": 36000000.0, \"Special Income Charges\": 12000000.0, \"Gain On Sale Of Ppe\": 0.0, \"Gain On Sale Of Business\": 101000000.0, \"Write Off\": 2000000.0, \"Impairment Of Capital Assets\": 35000000.0, \"Restructuring And Mergern Acquisition\": 52000000.0, \"Gain On Sale Of Security\": -47000000.0, \"Net Non Operating Interest Income Expense\": -134000000.0, \"Interest Expense Non Operating\": 239000000.0, \"Interest Income Non Operating\": 105000000.0, \"Operating Income\": 3069000000.0, \"Operating Expense\": 2914000000.0, \"Depreciation Amortization Depletion Income Statement\": 149000000.0, \"Depreciation And Amortization In Income Statement\": 149000000.0, \"Amortization\": 149000000.0, \"Amortization Of Intangibles Income Statement\": 149000000.0, \"Research And Development\": 614000000.0, \"Selling General And Administration\": 2151000000.0, \"Gross Profit\": 5983000000.0, \"Cost Of Revenue\": 2561000000.0, \"Total Revenue\": 8544000000.0, \"Operating Revenue\": 8544000000.0}",
"year": "2023-12-31"
},
"news": {
"news_date": "2023-10-26",
"news_headlines": [
"JAZZ vs. ZTS: Which Stock Is the Better Value Option?",
"Zoetis (ZTS) Reports Next Week: Wall Street Expects Earnings Growth",
"Top Research Reports for Costco, Pfizer & IBM",
"Ex-Dividend Reminder: Zoetis, Synchrony Financial and Realty Income",
"Stifel Maintains Zoetis Inc - (ZTS) Buy Recommendation",
"Validea Detailed Fundamental Analysis - ZTS",
"We Did The Math SUSA Can Go To $105",
"Analysts Estimate Sage Therapeutics, Inc. (SAGE) to Report a Decline in Earnings: What to Look Out for"
]
},
"price": {
"close": 158.8517303466797,
"close_previous": 155.6753387451172,
"open": 153.32335647774727,
"open_previous": 159.81170818492478,
"previous_date": "2023-10-26",
"price_date": "2023-11-02"
},
"ticker": "ZTS"
} |
You are a seasoned stock market analyst who is trying to predict whether the prices will go down or up over the day, 2023-11-02, for a specific stock, by offering a buy or sell rating.
[Company Name]
Zoetis Inc.
[Company Description]
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
[Price Movement]
It was 158.8517303466797 on 2023-10-26.
The price of the stock on 2023-11-02 started at 153.32335647774727.
[News since 2023-10-26]
JAZZ vs. ZTS: Which Stock Is the Better Value Option?
Zoetis (ZTS) Reports Next Week: Wall Street Expects Earnings Growth
Top Research Reports for Costco, Pfizer & IBM
Ex-Dividend Reminder: Zoetis, Synchrony Financial and Realty Income
Stifel Maintains Zoetis Inc - (ZTS) Buy Recommendation
Validea Detailed Fundamental Analysis - ZTS
We Did The Math SUSA Can Go To $105
Analysts Estimate Sage Therapeutics, Inc. (SAGE) to Report a Decline in Earnings: What to Look Out for
[Financials]
Basic EPS: $5.08
Normalized EBITDA: $3.701000e+09
Net Income: $2.344000e+09
Your answer should look like the following
<think>reasoning about why the stock would go down here.
</think><answer>sell</answer>
or
<think>reasoning about why the stock would go up here.
</think><answer>buy</answer>
Please reason about and provide several reasons for why you think the stock would go up or down in the <think></think> tags. Please provide your answer as a single rating, 'buy' or 'sell', in the <answer></answer> tags, with buy meaning that the stock price will go up,
and sell meaning that the stock price will go down.
|
ZTS | {
"company_info": {
"description": "Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.",
"name": "Zoetis Inc."
},
"current_date": "2023-11-03",
"financials": {
"financials": "{\"Tax Effect Of Unusual Items\": -7105000.0, \"Tax Rate For Calcs\": 0.203, \"Normalized EBITDA\": 3701000000.0, \"Total Unusual Items\": -35000000.0, \"Total Unusual Items Excluding Goodwill\": -35000000.0, \"Net Income From Continuing Operation Net Minority Interest\": 2344000000.0, \"Reconciled Depreciation\": 491000000.0, \"Reconciled Cost Of Revenue\": 2219000000.0, \"EBITDA\": 3666000000.0, \"EBIT\": 3175000000.0, \"Net Interest Income\": -134000000.0, \"Interest Expense\": 239000000.0, \"Interest Income\": 105000000.0, \"Normalized Income\": 2371895000.0, \"Net Income From Continuing And Discontinued Operation\": 2344000000.0, \"Total Expenses\": 5475000000.0, \"Diluted Average Shares\": 462269000.0, \"Basic Average Shares\": 461172000.0, \"Diluted EPS\": 5.07, \"Basic EPS\": 5.08, \"Diluted NI Availto Com Stockholders\": 2344000000.0, \"Net Income Common Stockholders\": 2344000000.0, \"Net Income\": 2344000000.0, \"Minority Interests\": 4000000.0, \"Net Income Including Noncontrolling Interests\": 2340000000.0, \"Net Income Continuous Operations\": 2340000000.0, \"Tax Provision\": 596000000.0, \"Pretax Income\": 2936000000.0, \"Other Income Expense\": 1000000.0, \"Other Non Operating Income Expenses\": 36000000.0, \"Special Income Charges\": 12000000.0, \"Gain On Sale Of Ppe\": 0.0, \"Gain On Sale Of Business\": 101000000.0, \"Write Off\": 2000000.0, \"Impairment Of Capital Assets\": 35000000.0, \"Restructuring And Mergern Acquisition\": 52000000.0, \"Gain On Sale Of Security\": -47000000.0, \"Net Non Operating Interest Income Expense\": -134000000.0, \"Interest Expense Non Operating\": 239000000.0, \"Interest Income Non Operating\": 105000000.0, \"Operating Income\": 3069000000.0, \"Operating Expense\": 2914000000.0, \"Depreciation Amortization Depletion Income Statement\": 149000000.0, \"Depreciation And Amortization In Income Statement\": 149000000.0, \"Amortization\": 149000000.0, \"Amortization Of Intangibles Income Statement\": 149000000.0, \"Research And Development\": 614000000.0, \"Selling General And Administration\": 2151000000.0, \"Gross Profit\": 5983000000.0, \"Cost Of Revenue\": 2561000000.0, \"Total Revenue\": 8544000000.0, \"Operating Revenue\": 8544000000.0}",
"year": "2023-12-31"
},
"news": {
"news_date": "2023-10-27",
"news_headlines": [
"Top Research Reports for Costco, Pfizer & IBM",
"Ex-Dividend Reminder: Zoetis, Synchrony Financial and Realty Income",
"Stifel Maintains Zoetis Inc - (ZTS) Buy Recommendation",
"Validea Detailed Fundamental Analysis - ZTS",
"We Did The Math SUSA Can Go To $105",
"Analysts Estimate Sage Therapeutics, Inc. (SAGE) to Report a Decline in Earnings: What to Look Out for",
"Here's What Key Metrics Tell Us About Zoetis (ZTS) Q3 Earnings",
"Zoetis (ZTS) Q3 2023 Earnings Call Transcript",
"Zoetis' (ZTS) Q3 Earnings Beat, Revenues Miss by a Whisker",
"See Which Of The Latest 13F Filers Holds Zoetis",
"Zoetis Q3 Profit Rises; Updates FY Outlook",
"Zoetis Q3 23 Earnings Conference Call At 8:30 AM ET"
]
},
"price": {
"close": 160.1548309326172,
"close_previous": 153.66622924804688,
"open": 162.14899632286028,
"open_previous": 155.53743927144782,
"previous_date": "2023-10-27",
"price_date": "2023-11-03"
},
"ticker": "ZTS"
} |
You are a seasoned stock market analyst who is trying to predict whether the prices will go down or up over the day, 2023-11-03, for a specific stock, by offering a buy or sell rating.
[Company Name]
Zoetis Inc.
[Company Description]
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
[Price Movement]
It was 160.1548309326172 on 2023-10-27.
The price of the stock on 2023-11-03 started at 162.14899632286028.
[News since 2023-10-27]
Top Research Reports for Costco, Pfizer & IBM
Ex-Dividend Reminder: Zoetis, Synchrony Financial and Realty Income
Stifel Maintains Zoetis Inc - (ZTS) Buy Recommendation
Validea Detailed Fundamental Analysis - ZTS
We Did The Math SUSA Can Go To $105
Analysts Estimate Sage Therapeutics, Inc. (SAGE) to Report a Decline in Earnings: What to Look Out for
Here's What Key Metrics Tell Us About Zoetis (ZTS) Q3 Earnings
Zoetis (ZTS) Q3 2023 Earnings Call Transcript
Zoetis' (ZTS) Q3 Earnings Beat, Revenues Miss by a Whisker
See Which Of The Latest 13F Filers Holds Zoetis
Zoetis Q3 Profit Rises; Updates FY Outlook
Zoetis Q3 23 Earnings Conference Call At 8:30 AM ET
[Financials]
Basic EPS: $5.08
Normalized EBITDA: $3.701000e+09
Net Income: $2.344000e+09
Your answer should look like the following
<think>reasoning about why the stock would go down here.
</think><answer>sell</answer>
or
<think>reasoning about why the stock would go up here.
</think><answer>buy</answer>
Please reason about and provide several reasons for why you think the stock would go up or down in the <think></think> tags. Please provide your answer as a single rating, 'buy' or 'sell', in the <answer></answer> tags, with buy meaning that the stock price will go up,
and sell meaning that the stock price will go down.
|
ZTS | {
"company_info": {
"description": "Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.",
"name": "Zoetis Inc."
},
"current_date": "2023-11-06",
"financials": {
"financials": "{\"Tax Effect Of Unusual Items\": -7105000.0, \"Tax Rate For Calcs\": 0.203, \"Normalized EBITDA\": 3701000000.0, \"Total Unusual Items\": -35000000.0, \"Total Unusual Items Excluding Goodwill\": -35000000.0, \"Net Income From Continuing Operation Net Minority Interest\": 2344000000.0, \"Reconciled Depreciation\": 491000000.0, \"Reconciled Cost Of Revenue\": 2219000000.0, \"EBITDA\": 3666000000.0, \"EBIT\": 3175000000.0, \"Net Interest Income\": -134000000.0, \"Interest Expense\": 239000000.0, \"Interest Income\": 105000000.0, \"Normalized Income\": 2371895000.0, \"Net Income From Continuing And Discontinued Operation\": 2344000000.0, \"Total Expenses\": 5475000000.0, \"Diluted Average Shares\": 462269000.0, \"Basic Average Shares\": 461172000.0, \"Diluted EPS\": 5.07, \"Basic EPS\": 5.08, \"Diluted NI Availto Com Stockholders\": 2344000000.0, \"Net Income Common Stockholders\": 2344000000.0, \"Net Income\": 2344000000.0, \"Minority Interests\": 4000000.0, \"Net Income Including Noncontrolling Interests\": 2340000000.0, \"Net Income Continuous Operations\": 2340000000.0, \"Tax Provision\": 596000000.0, \"Pretax Income\": 2936000000.0, \"Other Income Expense\": 1000000.0, \"Other Non Operating Income Expenses\": 36000000.0, \"Special Income Charges\": 12000000.0, \"Gain On Sale Of Ppe\": 0.0, \"Gain On Sale Of Business\": 101000000.0, \"Write Off\": 2000000.0, \"Impairment Of Capital Assets\": 35000000.0, \"Restructuring And Mergern Acquisition\": 52000000.0, \"Gain On Sale Of Security\": -47000000.0, \"Net Non Operating Interest Income Expense\": -134000000.0, \"Interest Expense Non Operating\": 239000000.0, \"Interest Income Non Operating\": 105000000.0, \"Operating Income\": 3069000000.0, \"Operating Expense\": 2914000000.0, \"Depreciation Amortization Depletion Income Statement\": 149000000.0, \"Depreciation And Amortization In Income Statement\": 149000000.0, \"Amortization\": 149000000.0, \"Amortization Of Intangibles Income Statement\": 149000000.0, \"Research And Development\": 614000000.0, \"Selling General And Administration\": 2151000000.0, \"Gross Profit\": 5983000000.0, \"Cost Of Revenue\": 2561000000.0, \"Total Revenue\": 8544000000.0, \"Operating Revenue\": 8544000000.0}",
"year": "2023-12-31"
},
"news": {
"news_date": "2023-10-30",
"news_headlines": [
"Stifel Maintains Zoetis Inc - (ZTS) Buy Recommendation",
"Validea Detailed Fundamental Analysis - ZTS",
"We Did The Math SUSA Can Go To $105",
"Analysts Estimate Sage Therapeutics, Inc. (SAGE) to Report a Decline in Earnings: What to Look Out for",
"Here's What Key Metrics Tell Us About Zoetis (ZTS) Q3 Earnings",
"Zoetis (ZTS) Q3 2023 Earnings Call Transcript",
"Zoetis' (ZTS) Q3 Earnings Beat, Revenues Miss by a Whisker",
"See Which Of The Latest 13F Filers Holds Zoetis",
"Zoetis Q3 Profit Rises; Updates FY Outlook",
"Zoetis Q3 23 Earnings Conference Call At 8:30 AM ET"
]
},
"price": {
"close": 161.08282470703125,
"close_previous": 154.6215362548828,
"open": 168.10187842301102,
"open_previous": 154.74957163514463,
"previous_date": "2023-10-30",
"price_date": "2023-11-06"
},
"ticker": "ZTS"
} |
You are a seasoned stock market analyst who is trying to predict whether the prices will go down or up over the day, 2023-11-06, for a specific stock, by offering a buy or sell rating.
[Company Name]
Zoetis Inc.
[Company Description]
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
[Price Movement]
It was 161.08282470703125 on 2023-10-30.
The price of the stock on 2023-11-06 started at 168.10187842301102.
[News since 2023-10-30]
Stifel Maintains Zoetis Inc - (ZTS) Buy Recommendation
Validea Detailed Fundamental Analysis - ZTS
We Did The Math SUSA Can Go To $105
Analysts Estimate Sage Therapeutics, Inc. (SAGE) to Report a Decline in Earnings: What to Look Out for
Here's What Key Metrics Tell Us About Zoetis (ZTS) Q3 Earnings
Zoetis (ZTS) Q3 2023 Earnings Call Transcript
Zoetis' (ZTS) Q3 Earnings Beat, Revenues Miss by a Whisker
See Which Of The Latest 13F Filers Holds Zoetis
Zoetis Q3 Profit Rises; Updates FY Outlook
Zoetis Q3 23 Earnings Conference Call At 8:30 AM ET
[Financials]
Basic EPS: $5.08
Normalized EBITDA: $3.701000e+09
Net Income: $2.344000e+09
Your answer should look like the following
<think>reasoning about why the stock would go down here.
</think><answer>sell</answer>
or
<think>reasoning about why the stock would go up here.
</think><answer>buy</answer>
Please reason about and provide several reasons for why you think the stock would go up or down in the <think></think> tags. Please provide your answer as a single rating, 'buy' or 'sell', in the <answer></answer> tags, with buy meaning that the stock price will go up,
and sell meaning that the stock price will go down.
|
ZTS | {
"company_info": {
"description": "Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.",
"name": "Zoetis Inc."
},
"current_date": "2023-11-07",
"financials": {
"financials": "{\"Tax Effect Of Unusual Items\": -7105000.0, \"Tax Rate For Calcs\": 0.203, \"Normalized EBITDA\": 3701000000.0, \"Total Unusual Items\": -35000000.0, \"Total Unusual Items Excluding Goodwill\": -35000000.0, \"Net Income From Continuing Operation Net Minority Interest\": 2344000000.0, \"Reconciled Depreciation\": 491000000.0, \"Reconciled Cost Of Revenue\": 2219000000.0, \"EBITDA\": 3666000000.0, \"EBIT\": 3175000000.0, \"Net Interest Income\": -134000000.0, \"Interest Expense\": 239000000.0, \"Interest Income\": 105000000.0, \"Normalized Income\": 2371895000.0, \"Net Income From Continuing And Discontinued Operation\": 2344000000.0, \"Total Expenses\": 5475000000.0, \"Diluted Average Shares\": 462269000.0, \"Basic Average Shares\": 461172000.0, \"Diluted EPS\": 5.07, \"Basic EPS\": 5.08, \"Diluted NI Availto Com Stockholders\": 2344000000.0, \"Net Income Common Stockholders\": 2344000000.0, \"Net Income\": 2344000000.0, \"Minority Interests\": 4000000.0, \"Net Income Including Noncontrolling Interests\": 2340000000.0, \"Net Income Continuous Operations\": 2340000000.0, \"Tax Provision\": 596000000.0, \"Pretax Income\": 2936000000.0, \"Other Income Expense\": 1000000.0, \"Other Non Operating Income Expenses\": 36000000.0, \"Special Income Charges\": 12000000.0, \"Gain On Sale Of Ppe\": 0.0, \"Gain On Sale Of Business\": 101000000.0, \"Write Off\": 2000000.0, \"Impairment Of Capital Assets\": 35000000.0, \"Restructuring And Mergern Acquisition\": 52000000.0, \"Gain On Sale Of Security\": -47000000.0, \"Net Non Operating Interest Income Expense\": -134000000.0, \"Interest Expense Non Operating\": 239000000.0, \"Interest Income Non Operating\": 105000000.0, \"Operating Income\": 3069000000.0, \"Operating Expense\": 2914000000.0, \"Depreciation Amortization Depletion Income Statement\": 149000000.0, \"Depreciation And Amortization In Income Statement\": 149000000.0, \"Amortization\": 149000000.0, \"Amortization Of Intangibles Income Statement\": 149000000.0, \"Research And Development\": 614000000.0, \"Selling General And Administration\": 2151000000.0, \"Gross Profit\": 5983000000.0, \"Cost Of Revenue\": 2561000000.0, \"Total Revenue\": 8544000000.0, \"Operating Revenue\": 8544000000.0}",
"year": "2023-12-31"
},
"news": {
"news_date": "2023-10-31",
"news_headlines": [
"Analysts Estimate Sage Therapeutics, Inc. (SAGE) to Report a Decline in Earnings: What to Look Out for",
"Here's What Key Metrics Tell Us About Zoetis (ZTS) Q3 Earnings",
"Zoetis (ZTS) Q3 2023 Earnings Call Transcript",
"Zoetis' (ZTS) Q3 Earnings Beat, Revenues Miss by a Whisker",
"See Which Of The Latest 13F Filers Holds Zoetis",
"Zoetis Q3 Profit Rises; Updates FY Outlook",
"Zoetis Q3 23 Earnings Conference Call At 8:30 AM ET"
]
},
"price": {
"close": 165.0217742919922,
"close_previous": 154.9917449951172,
"open": 161.00382851961945,
"open_previous": 155.495215941311,
"previous_date": "2023-10-31",
"price_date": "2023-11-07"
},
"ticker": "ZTS"
} |
You are a seasoned stock market analyst who is trying to predict whether the prices will go down or up over the day, 2023-11-07, for a specific stock, by offering a buy or sell rating.
[Company Name]
Zoetis Inc.
[Company Description]
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
[Price Movement]
It was 165.0217742919922 on 2023-10-31.
The price of the stock on 2023-11-07 started at 161.00382851961945.
[News since 2023-10-31]
Analysts Estimate Sage Therapeutics, Inc. (SAGE) to Report a Decline in Earnings: What to Look Out for
Here's What Key Metrics Tell Us About Zoetis (ZTS) Q3 Earnings
Zoetis (ZTS) Q3 2023 Earnings Call Transcript
Zoetis' (ZTS) Q3 Earnings Beat, Revenues Miss by a Whisker
See Which Of The Latest 13F Filers Holds Zoetis
Zoetis Q3 Profit Rises; Updates FY Outlook
Zoetis Q3 23 Earnings Conference Call At 8:30 AM ET
[Financials]
Basic EPS: $5.08
Normalized EBITDA: $3.701000e+09
Net Income: $2.344000e+09
Your answer should look like the following
<think>reasoning about why the stock would go down here.
</think><answer>sell</answer>
or
<think>reasoning about why the stock would go up here.
</think><answer>buy</answer>
Please reason about and provide several reasons for why you think the stock would go up or down in the <think></think> tags. Please provide your answer as a single rating, 'buy' or 'sell', in the <answer></answer> tags, with buy meaning that the stock price will go up,
and sell meaning that the stock price will go down.
|
ZTS | {
"company_info": {
"description": "Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.",
"name": "Zoetis Inc."
},
"current_date": "2023-11-08",
"financials": {
"financials": "{\"Tax Effect Of Unusual Items\": -7105000.0, \"Tax Rate For Calcs\": 0.203, \"Normalized EBITDA\": 3701000000.0, \"Total Unusual Items\": -35000000.0, \"Total Unusual Items Excluding Goodwill\": -35000000.0, \"Net Income From Continuing Operation Net Minority Interest\": 2344000000.0, \"Reconciled Depreciation\": 491000000.0, \"Reconciled Cost Of Revenue\": 2219000000.0, \"EBITDA\": 3666000000.0, \"EBIT\": 3175000000.0, \"Net Interest Income\": -134000000.0, \"Interest Expense\": 239000000.0, \"Interest Income\": 105000000.0, \"Normalized Income\": 2371895000.0, \"Net Income From Continuing And Discontinued Operation\": 2344000000.0, \"Total Expenses\": 5475000000.0, \"Diluted Average Shares\": 462269000.0, \"Basic Average Shares\": 461172000.0, \"Diluted EPS\": 5.07, \"Basic EPS\": 5.08, \"Diluted NI Availto Com Stockholders\": 2344000000.0, \"Net Income Common Stockholders\": 2344000000.0, \"Net Income\": 2344000000.0, \"Minority Interests\": 4000000.0, \"Net Income Including Noncontrolling Interests\": 2340000000.0, \"Net Income Continuous Operations\": 2340000000.0, \"Tax Provision\": 596000000.0, \"Pretax Income\": 2936000000.0, \"Other Income Expense\": 1000000.0, \"Other Non Operating Income Expenses\": 36000000.0, \"Special Income Charges\": 12000000.0, \"Gain On Sale Of Ppe\": 0.0, \"Gain On Sale Of Business\": 101000000.0, \"Write Off\": 2000000.0, \"Impairment Of Capital Assets\": 35000000.0, \"Restructuring And Mergern Acquisition\": 52000000.0, \"Gain On Sale Of Security\": -47000000.0, \"Net Non Operating Interest Income Expense\": -134000000.0, \"Interest Expense Non Operating\": 239000000.0, \"Interest Income Non Operating\": 105000000.0, \"Operating Income\": 3069000000.0, \"Operating Expense\": 2914000000.0, \"Depreciation Amortization Depletion Income Statement\": 149000000.0, \"Depreciation And Amortization In Income Statement\": 149000000.0, \"Amortization\": 149000000.0, \"Amortization Of Intangibles Income Statement\": 149000000.0, \"Research And Development\": 614000000.0, \"Selling General And Administration\": 2151000000.0, \"Gross Profit\": 5983000000.0, \"Cost Of Revenue\": 2561000000.0, \"Total Revenue\": 8544000000.0, \"Operating Revenue\": 8544000000.0}",
"year": "2023-12-31"
},
"news": {
"news_date": "2023-11-01",
"news_headlines": [
"Here's What Key Metrics Tell Us About Zoetis (ZTS) Q3 Earnings",
"Zoetis (ZTS) Q3 2023 Earnings Call Transcript",
"Zoetis' (ZTS) Q3 Earnings Beat, Revenues Miss by a Whisker",
"See Which Of The Latest 13F Filers Holds Zoetis",
"Zoetis Q3 Profit Rises; Updates FY Outlook",
"Zoetis Q3 23 Earnings Conference Call At 8:30 AM ET"
]
},
"price": {
"close": 168.68431091308594,
"close_previous": 149.5028533935547,
"open": 166.67041220897096,
"open_previous": 154.41914736576896,
"previous_date": "2023-11-01",
"price_date": "2023-11-08"
},
"ticker": "ZTS"
} |
You are a seasoned stock market analyst who is trying to predict whether the prices will go down or up over the day, 2023-11-08, for a specific stock, by offering a buy or sell rating.
[Company Name]
Zoetis Inc.
[Company Description]
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
[Price Movement]
It was 168.68431091308594 on 2023-11-01.
The price of the stock on 2023-11-08 started at 166.67041220897096.
[News since 2023-11-01]
Here's What Key Metrics Tell Us About Zoetis (ZTS) Q3 Earnings
Zoetis (ZTS) Q3 2023 Earnings Call Transcript
Zoetis' (ZTS) Q3 Earnings Beat, Revenues Miss by a Whisker
See Which Of The Latest 13F Filers Holds Zoetis
Zoetis Q3 Profit Rises; Updates FY Outlook
Zoetis Q3 23 Earnings Conference Call At 8:30 AM ET
[Financials]
Basic EPS: $5.08
Normalized EBITDA: $3.701000e+09
Net Income: $2.344000e+09
Your answer should look like the following
<think>reasoning about why the stock would go down here.
</think><answer>sell</answer>
or
<think>reasoning about why the stock would go up here.
</think><answer>buy</answer>
Please reason about and provide several reasons for why you think the stock would go up or down in the <think></think> tags. Please provide your answer as a single rating, 'buy' or 'sell', in the <answer></answer> tags, with buy meaning that the stock price will go up,
and sell meaning that the stock price will go down.
|
ZTS | {
"company_info": {
"description": "Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.",
"name": "Zoetis Inc."
},
"current_date": "2023-11-09",
"financials": {
"financials": "{\"Tax Effect Of Unusual Items\": -7105000.0, \"Tax Rate For Calcs\": 0.203, \"Normalized EBITDA\": 3701000000.0, \"Total Unusual Items\": -35000000.0, \"Total Unusual Items Excluding Goodwill\": -35000000.0, \"Net Income From Continuing Operation Net Minority Interest\": 2344000000.0, \"Reconciled Depreciation\": 491000000.0, \"Reconciled Cost Of Revenue\": 2219000000.0, \"EBITDA\": 3666000000.0, \"EBIT\": 3175000000.0, \"Net Interest Income\": -134000000.0, \"Interest Expense\": 239000000.0, \"Interest Income\": 105000000.0, \"Normalized Income\": 2371895000.0, \"Net Income From Continuing And Discontinued Operation\": 2344000000.0, \"Total Expenses\": 5475000000.0, \"Diluted Average Shares\": 462269000.0, \"Basic Average Shares\": 461172000.0, \"Diluted EPS\": 5.07, \"Basic EPS\": 5.08, \"Diluted NI Availto Com Stockholders\": 2344000000.0, \"Net Income Common Stockholders\": 2344000000.0, \"Net Income\": 2344000000.0, \"Minority Interests\": 4000000.0, \"Net Income Including Noncontrolling Interests\": 2340000000.0, \"Net Income Continuous Operations\": 2340000000.0, \"Tax Provision\": 596000000.0, \"Pretax Income\": 2936000000.0, \"Other Income Expense\": 1000000.0, \"Other Non Operating Income Expenses\": 36000000.0, \"Special Income Charges\": 12000000.0, \"Gain On Sale Of Ppe\": 0.0, \"Gain On Sale Of Business\": 101000000.0, \"Write Off\": 2000000.0, \"Impairment Of Capital Assets\": 35000000.0, \"Restructuring And Mergern Acquisition\": 52000000.0, \"Gain On Sale Of Security\": -47000000.0, \"Net Non Operating Interest Income Expense\": -134000000.0, \"Interest Expense Non Operating\": 239000000.0, \"Interest Income Non Operating\": 105000000.0, \"Operating Income\": 3069000000.0, \"Operating Expense\": 2914000000.0, \"Depreciation Amortization Depletion Income Statement\": 149000000.0, \"Depreciation And Amortization In Income Statement\": 149000000.0, \"Amortization\": 149000000.0, \"Amortization Of Intangibles Income Statement\": 149000000.0, \"Research And Development\": 614000000.0, \"Selling General And Administration\": 2151000000.0, \"Gross Profit\": 5983000000.0, \"Cost Of Revenue\": 2561000000.0, \"Total Revenue\": 8544000000.0, \"Operating Revenue\": 8544000000.0}",
"year": "2023-12-31"
},
"news": {
"news_date": "2023-11-02",
"news_headlines": [
"Here's What Key Metrics Tell Us About Zoetis (ZTS) Q3 Earnings",
"Zoetis (ZTS) Q3 2023 Earnings Call Transcript",
"Zoetis' (ZTS) Q3 Earnings Beat, Revenues Miss by a Whisker",
"See Which Of The Latest 13F Filers Holds Zoetis",
"Zoetis Q3 Profit Rises; Updates FY Outlook",
"Zoetis Q3 23 Earnings Conference Call At 8:30 AM ET",
"ZTS Factor-Based Stock Analysis"
]
},
"price": {
"close": 168.4473876953125,
"close_previous": 158.8517303466797,
"open": 168.78303496311267,
"open_previous": 153.32335647774727,
"previous_date": "2023-11-02",
"price_date": "2023-11-09"
},
"ticker": "ZTS"
} |
You are a seasoned stock market analyst who is trying to predict whether the prices will go down or up over the day, 2023-11-09, for a specific stock, by offering a buy or sell rating.
[Company Name]
Zoetis Inc.
[Company Description]
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
[Price Movement]
It was 168.4473876953125 on 2023-11-02.
The price of the stock on 2023-11-09 started at 168.78303496311267.
[News since 2023-11-02]
Here's What Key Metrics Tell Us About Zoetis (ZTS) Q3 Earnings
Zoetis (ZTS) Q3 2023 Earnings Call Transcript
Zoetis' (ZTS) Q3 Earnings Beat, Revenues Miss by a Whisker
See Which Of The Latest 13F Filers Holds Zoetis
Zoetis Q3 Profit Rises; Updates FY Outlook
Zoetis Q3 23 Earnings Conference Call At 8:30 AM ET
ZTS Factor-Based Stock Analysis
[Financials]
Basic EPS: $5.08
Normalized EBITDA: $3.701000e+09
Net Income: $2.344000e+09
Your answer should look like the following
<think>reasoning about why the stock would go down here.
</think><answer>sell</answer>
or
<think>reasoning about why the stock would go up here.
</think><answer>buy</answer>
Please reason about and provide several reasons for why you think the stock would go up or down in the <think></think> tags. Please provide your answer as a single rating, 'buy' or 'sell', in the <answer></answer> tags, with buy meaning that the stock price will go up,
and sell meaning that the stock price will go down.
|
ZTS | {
"company_info": {
"description": "Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.",
"name": "Zoetis Inc."
},
"current_date": "2023-11-10",
"financials": {
"financials": "{\"Tax Effect Of Unusual Items\": -7105000.0, \"Tax Rate For Calcs\": 0.203, \"Normalized EBITDA\": 3701000000.0, \"Total Unusual Items\": -35000000.0, \"Total Unusual Items Excluding Goodwill\": -35000000.0, \"Net Income From Continuing Operation Net Minority Interest\": 2344000000.0, \"Reconciled Depreciation\": 491000000.0, \"Reconciled Cost Of Revenue\": 2219000000.0, \"EBITDA\": 3666000000.0, \"EBIT\": 3175000000.0, \"Net Interest Income\": -134000000.0, \"Interest Expense\": 239000000.0, \"Interest Income\": 105000000.0, \"Normalized Income\": 2371895000.0, \"Net Income From Continuing And Discontinued Operation\": 2344000000.0, \"Total Expenses\": 5475000000.0, \"Diluted Average Shares\": 462269000.0, \"Basic Average Shares\": 461172000.0, \"Diluted EPS\": 5.07, \"Basic EPS\": 5.08, \"Diluted NI Availto Com Stockholders\": 2344000000.0, \"Net Income Common Stockholders\": 2344000000.0, \"Net Income\": 2344000000.0, \"Minority Interests\": 4000000.0, \"Net Income Including Noncontrolling Interests\": 2340000000.0, \"Net Income Continuous Operations\": 2340000000.0, \"Tax Provision\": 596000000.0, \"Pretax Income\": 2936000000.0, \"Other Income Expense\": 1000000.0, \"Other Non Operating Income Expenses\": 36000000.0, \"Special Income Charges\": 12000000.0, \"Gain On Sale Of Ppe\": 0.0, \"Gain On Sale Of Business\": 101000000.0, \"Write Off\": 2000000.0, \"Impairment Of Capital Assets\": 35000000.0, \"Restructuring And Mergern Acquisition\": 52000000.0, \"Gain On Sale Of Security\": -47000000.0, \"Net Non Operating Interest Income Expense\": -134000000.0, \"Interest Expense Non Operating\": 239000000.0, \"Interest Income Non Operating\": 105000000.0, \"Operating Income\": 3069000000.0, \"Operating Expense\": 2914000000.0, \"Depreciation Amortization Depletion Income Statement\": 149000000.0, \"Depreciation And Amortization In Income Statement\": 149000000.0, \"Amortization\": 149000000.0, \"Amortization Of Intangibles Income Statement\": 149000000.0, \"Research And Development\": 614000000.0, \"Selling General And Administration\": 2151000000.0, \"Gross Profit\": 5983000000.0, \"Cost Of Revenue\": 2561000000.0, \"Total Revenue\": 8544000000.0, \"Operating Revenue\": 8544000000.0}",
"year": "2023-12-31"
},
"news": {
"news_date": "2023-11-03",
"news_headlines": [
"ZTS Factor-Based Stock Analysis"
]
},
"price": {
"close": 167.15414428710938,
"close_previous": 160.1548309326172,
"open": 168.32890970536334,
"open_previous": 162.14899632286028,
"previous_date": "2023-11-03",
"price_date": "2023-11-10"
},
"ticker": "ZTS"
} |
You are a seasoned stock market analyst who is trying to predict whether the prices will go down or up over the day, 2023-11-10, for a specific stock, by offering a buy or sell rating.
[Company Name]
Zoetis Inc.
[Company Description]
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
[Price Movement]
It was 167.15414428710938 on 2023-11-03.
The price of the stock on 2023-11-10 started at 168.32890970536334.
[News since 2023-11-03]
ZTS Factor-Based Stock Analysis
[Financials]
Basic EPS: $5.08
Normalized EBITDA: $3.701000e+09
Net Income: $2.344000e+09
Your answer should look like the following
<think>reasoning about why the stock would go down here.
</think><answer>sell</answer>
or
<think>reasoning about why the stock would go up here.
</think><answer>buy</answer>
Please reason about and provide several reasons for why you think the stock would go up or down in the <think></think> tags. Please provide your answer as a single rating, 'buy' or 'sell', in the <answer></answer> tags, with buy meaning that the stock price will go up,
and sell meaning that the stock price will go down.
|
ZTS | {
"company_info": {
"description": "Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.",
"name": "Zoetis Inc."
},
"current_date": "2023-11-13",
"financials": {
"financials": "{\"Tax Effect Of Unusual Items\": -7105000.0, \"Tax Rate For Calcs\": 0.203, \"Normalized EBITDA\": 3701000000.0, \"Total Unusual Items\": -35000000.0, \"Total Unusual Items Excluding Goodwill\": -35000000.0, \"Net Income From Continuing Operation Net Minority Interest\": 2344000000.0, \"Reconciled Depreciation\": 491000000.0, \"Reconciled Cost Of Revenue\": 2219000000.0, \"EBITDA\": 3666000000.0, \"EBIT\": 3175000000.0, \"Net Interest Income\": -134000000.0, \"Interest Expense\": 239000000.0, \"Interest Income\": 105000000.0, \"Normalized Income\": 2371895000.0, \"Net Income From Continuing And Discontinued Operation\": 2344000000.0, \"Total Expenses\": 5475000000.0, \"Diluted Average Shares\": 462269000.0, \"Basic Average Shares\": 461172000.0, \"Diluted EPS\": 5.07, \"Basic EPS\": 5.08, \"Diluted NI Availto Com Stockholders\": 2344000000.0, \"Net Income Common Stockholders\": 2344000000.0, \"Net Income\": 2344000000.0, \"Minority Interests\": 4000000.0, \"Net Income Including Noncontrolling Interests\": 2340000000.0, \"Net Income Continuous Operations\": 2340000000.0, \"Tax Provision\": 596000000.0, \"Pretax Income\": 2936000000.0, \"Other Income Expense\": 1000000.0, \"Other Non Operating Income Expenses\": 36000000.0, \"Special Income Charges\": 12000000.0, \"Gain On Sale Of Ppe\": 0.0, \"Gain On Sale Of Business\": 101000000.0, \"Write Off\": 2000000.0, \"Impairment Of Capital Assets\": 35000000.0, \"Restructuring And Mergern Acquisition\": 52000000.0, \"Gain On Sale Of Security\": -47000000.0, \"Net Non Operating Interest Income Expense\": -134000000.0, \"Interest Expense Non Operating\": 239000000.0, \"Interest Income Non Operating\": 105000000.0, \"Operating Income\": 3069000000.0, \"Operating Expense\": 2914000000.0, \"Depreciation Amortization Depletion Income Statement\": 149000000.0, \"Depreciation And Amortization In Income Statement\": 149000000.0, \"Amortization\": 149000000.0, \"Amortization Of Intangibles Income Statement\": 149000000.0, \"Research And Development\": 614000000.0, \"Selling General And Administration\": 2151000000.0, \"Gross Profit\": 5983000000.0, \"Cost Of Revenue\": 2561000000.0, \"Total Revenue\": 8544000000.0, \"Operating Revenue\": 8544000000.0}",
"year": "2023-12-31"
},
"news": {
"news_date": "2023-11-06",
"news_headlines": [
"ZTS Factor-Based Stock Analysis"
]
},
"price": {
"close": 166.67041015625,
"close_previous": 161.08282470703125,
"open": 166.52231984549093,
"open_previous": 168.10187842301102,
"previous_date": "2023-11-06",
"price_date": "2023-11-13"
},
"ticker": "ZTS"
} |
You are a seasoned stock market analyst who is trying to predict whether the prices will go down or up over the day, 2023-11-13, for a specific stock, by offering a buy or sell rating.
[Company Name]
Zoetis Inc.
[Company Description]
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
[Price Movement]
It was 166.67041015625 on 2023-11-06.
The price of the stock on 2023-11-13 started at 166.52231984549093.
[News since 2023-11-06]
ZTS Factor-Based Stock Analysis
[Financials]
Basic EPS: $5.08
Normalized EBITDA: $3.701000e+09
Net Income: $2.344000e+09
Your answer should look like the following
<think>reasoning about why the stock would go down here.
</think><answer>sell</answer>
or
<think>reasoning about why the stock would go up here.
</think><answer>buy</answer>
Please reason about and provide several reasons for why you think the stock would go up or down in the <think></think> tags. Please provide your answer as a single rating, 'buy' or 'sell', in the <answer></answer> tags, with buy meaning that the stock price will go up,
and sell meaning that the stock price will go down.
|
ZTS | {
"company_info": {
"description": "Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.",
"name": "Zoetis Inc."
},
"current_date": "2023-11-14",
"financials": {
"financials": "{\"Tax Effect Of Unusual Items\": -7105000.0, \"Tax Rate For Calcs\": 0.203, \"Normalized EBITDA\": 3701000000.0, \"Total Unusual Items\": -35000000.0, \"Total Unusual Items Excluding Goodwill\": -35000000.0, \"Net Income From Continuing Operation Net Minority Interest\": 2344000000.0, \"Reconciled Depreciation\": 491000000.0, \"Reconciled Cost Of Revenue\": 2219000000.0, \"EBITDA\": 3666000000.0, \"EBIT\": 3175000000.0, \"Net Interest Income\": -134000000.0, \"Interest Expense\": 239000000.0, \"Interest Income\": 105000000.0, \"Normalized Income\": 2371895000.0, \"Net Income From Continuing And Discontinued Operation\": 2344000000.0, \"Total Expenses\": 5475000000.0, \"Diluted Average Shares\": 462269000.0, \"Basic Average Shares\": 461172000.0, \"Diluted EPS\": 5.07, \"Basic EPS\": 5.08, \"Diluted NI Availto Com Stockholders\": 2344000000.0, \"Net Income Common Stockholders\": 2344000000.0, \"Net Income\": 2344000000.0, \"Minority Interests\": 4000000.0, \"Net Income Including Noncontrolling Interests\": 2340000000.0, \"Net Income Continuous Operations\": 2340000000.0, \"Tax Provision\": 596000000.0, \"Pretax Income\": 2936000000.0, \"Other Income Expense\": 1000000.0, \"Other Non Operating Income Expenses\": 36000000.0, \"Special Income Charges\": 12000000.0, \"Gain On Sale Of Ppe\": 0.0, \"Gain On Sale Of Business\": 101000000.0, \"Write Off\": 2000000.0, \"Impairment Of Capital Assets\": 35000000.0, \"Restructuring And Mergern Acquisition\": 52000000.0, \"Gain On Sale Of Security\": -47000000.0, \"Net Non Operating Interest Income Expense\": -134000000.0, \"Interest Expense Non Operating\": 239000000.0, \"Interest Income Non Operating\": 105000000.0, \"Operating Income\": 3069000000.0, \"Operating Expense\": 2914000000.0, \"Depreciation Amortization Depletion Income Statement\": 149000000.0, \"Depreciation And Amortization In Income Statement\": 149000000.0, \"Amortization\": 149000000.0, \"Amortization Of Intangibles Income Statement\": 149000000.0, \"Research And Development\": 614000000.0, \"Selling General And Administration\": 2151000000.0, \"Gross Profit\": 5983000000.0, \"Cost Of Revenue\": 2561000000.0, \"Total Revenue\": 8544000000.0, \"Operating Revenue\": 8544000000.0}",
"year": "2023-12-31"
},
"news": {
"news_date": "2023-11-07",
"news_headlines": [
"ZTS Factor-Based Stock Analysis"
]
},
"price": {
"close": 170.44154357910156,
"close_previous": 165.0217742919922,
"open": 169.21741466487407,
"open_previous": 161.00382851961945,
"previous_date": "2023-11-07",
"price_date": "2023-11-14"
},
"ticker": "ZTS"
} |
You are a seasoned stock market analyst who is trying to predict whether the prices will go down or up over the day, 2023-11-14, for a specific stock, by offering a buy or sell rating.
[Company Name]
Zoetis Inc.
[Company Description]
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
[Price Movement]
It was 170.44154357910156 on 2023-11-07.
The price of the stock on 2023-11-14 started at 169.21741466487407.
[News since 2023-11-07]
ZTS Factor-Based Stock Analysis
[Financials]
Basic EPS: $5.08
Normalized EBITDA: $3.701000e+09
Net Income: $2.344000e+09
Your answer should look like the following
<think>reasoning about why the stock would go down here.
</think><answer>sell</answer>
or
<think>reasoning about why the stock would go up here.
</think><answer>buy</answer>
Please reason about and provide several reasons for why you think the stock would go up or down in the <think></think> tags. Please provide your answer as a single rating, 'buy' or 'sell', in the <answer></answer> tags, with buy meaning that the stock price will go up,
and sell meaning that the stock price will go down.
|
ZTS | {
"company_info": {
"description": "Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.",
"name": "Zoetis Inc."
},
"current_date": "2023-11-15",
"financials": {
"financials": "{\"Tax Effect Of Unusual Items\": -7105000.0, \"Tax Rate For Calcs\": 0.203, \"Normalized EBITDA\": 3701000000.0, \"Total Unusual Items\": -35000000.0, \"Total Unusual Items Excluding Goodwill\": -35000000.0, \"Net Income From Continuing Operation Net Minority Interest\": 2344000000.0, \"Reconciled Depreciation\": 491000000.0, \"Reconciled Cost Of Revenue\": 2219000000.0, \"EBITDA\": 3666000000.0, \"EBIT\": 3175000000.0, \"Net Interest Income\": -134000000.0, \"Interest Expense\": 239000000.0, \"Interest Income\": 105000000.0, \"Normalized Income\": 2371895000.0, \"Net Income From Continuing And Discontinued Operation\": 2344000000.0, \"Total Expenses\": 5475000000.0, \"Diluted Average Shares\": 462269000.0, \"Basic Average Shares\": 461172000.0, \"Diluted EPS\": 5.07, \"Basic EPS\": 5.08, \"Diluted NI Availto Com Stockholders\": 2344000000.0, \"Net Income Common Stockholders\": 2344000000.0, \"Net Income\": 2344000000.0, \"Minority Interests\": 4000000.0, \"Net Income Including Noncontrolling Interests\": 2340000000.0, \"Net Income Continuous Operations\": 2340000000.0, \"Tax Provision\": 596000000.0, \"Pretax Income\": 2936000000.0, \"Other Income Expense\": 1000000.0, \"Other Non Operating Income Expenses\": 36000000.0, \"Special Income Charges\": 12000000.0, \"Gain On Sale Of Ppe\": 0.0, \"Gain On Sale Of Business\": 101000000.0, \"Write Off\": 2000000.0, \"Impairment Of Capital Assets\": 35000000.0, \"Restructuring And Mergern Acquisition\": 52000000.0, \"Gain On Sale Of Security\": -47000000.0, \"Net Non Operating Interest Income Expense\": -134000000.0, \"Interest Expense Non Operating\": 239000000.0, \"Interest Income Non Operating\": 105000000.0, \"Operating Income\": 3069000000.0, \"Operating Expense\": 2914000000.0, \"Depreciation Amortization Depletion Income Statement\": 149000000.0, \"Depreciation And Amortization In Income Statement\": 149000000.0, \"Amortization\": 149000000.0, \"Amortization Of Intangibles Income Statement\": 149000000.0, \"Research And Development\": 614000000.0, \"Selling General And Administration\": 2151000000.0, \"Gross Profit\": 5983000000.0, \"Cost Of Revenue\": 2561000000.0, \"Total Revenue\": 8544000000.0, \"Operating Revenue\": 8544000000.0}",
"year": "2023-12-31"
},
"news": {
"news_date": "2023-11-08",
"news_headlines": [
"ZTS Factor-Based Stock Analysis"
]
},
"price": {
"close": 172.38633728027344,
"close_previous": 168.68431091308594,
"open": 170.28359349377882,
"open_previous": 166.67041220897096,
"previous_date": "2023-11-08",
"price_date": "2023-11-15"
},
"ticker": "ZTS"
} |
You are a seasoned stock market analyst who is trying to predict whether the prices will go down or up over the day, 2023-11-15, for a specific stock, by offering a buy or sell rating.
[Company Name]
Zoetis Inc.
[Company Description]
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
[Price Movement]
It was 172.38633728027344 on 2023-11-08.
The price of the stock on 2023-11-15 started at 170.28359349377882.
[News since 2023-11-08]
ZTS Factor-Based Stock Analysis
[Financials]
Basic EPS: $5.08
Normalized EBITDA: $3.701000e+09
Net Income: $2.344000e+09
Your answer should look like the following
<think>reasoning about why the stock would go down here.
</think><answer>sell</answer>
or
<think>reasoning about why the stock would go up here.
</think><answer>buy</answer>
Please reason about and provide several reasons for why you think the stock would go up or down in the <think></think> tags. Please provide your answer as a single rating, 'buy' or 'sell', in the <answer></answer> tags, with buy meaning that the stock price will go up,
and sell meaning that the stock price will go down.
|
ZTS | {
"company_info": {
"description": "Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.",
"name": "Zoetis Inc."
},
"current_date": "2023-11-16",
"financials": {
"financials": "{\"Tax Effect Of Unusual Items\": -7105000.0, \"Tax Rate For Calcs\": 0.203, \"Normalized EBITDA\": 3701000000.0, \"Total Unusual Items\": -35000000.0, \"Total Unusual Items Excluding Goodwill\": -35000000.0, \"Net Income From Continuing Operation Net Minority Interest\": 2344000000.0, \"Reconciled Depreciation\": 491000000.0, \"Reconciled Cost Of Revenue\": 2219000000.0, \"EBITDA\": 3666000000.0, \"EBIT\": 3175000000.0, \"Net Interest Income\": -134000000.0, \"Interest Expense\": 239000000.0, \"Interest Income\": 105000000.0, \"Normalized Income\": 2371895000.0, \"Net Income From Continuing And Discontinued Operation\": 2344000000.0, \"Total Expenses\": 5475000000.0, \"Diluted Average Shares\": 462269000.0, \"Basic Average Shares\": 461172000.0, \"Diluted EPS\": 5.07, \"Basic EPS\": 5.08, \"Diluted NI Availto Com Stockholders\": 2344000000.0, \"Net Income Common Stockholders\": 2344000000.0, \"Net Income\": 2344000000.0, \"Minority Interests\": 4000000.0, \"Net Income Including Noncontrolling Interests\": 2340000000.0, \"Net Income Continuous Operations\": 2340000000.0, \"Tax Provision\": 596000000.0, \"Pretax Income\": 2936000000.0, \"Other Income Expense\": 1000000.0, \"Other Non Operating Income Expenses\": 36000000.0, \"Special Income Charges\": 12000000.0, \"Gain On Sale Of Ppe\": 0.0, \"Gain On Sale Of Business\": 101000000.0, \"Write Off\": 2000000.0, \"Impairment Of Capital Assets\": 35000000.0, \"Restructuring And Mergern Acquisition\": 52000000.0, \"Gain On Sale Of Security\": -47000000.0, \"Net Non Operating Interest Income Expense\": -134000000.0, \"Interest Expense Non Operating\": 239000000.0, \"Interest Income Non Operating\": 105000000.0, \"Operating Income\": 3069000000.0, \"Operating Expense\": 2914000000.0, \"Depreciation Amortization Depletion Income Statement\": 149000000.0, \"Depreciation And Amortization In Income Statement\": 149000000.0, \"Amortization\": 149000000.0, \"Amortization Of Intangibles Income Statement\": 149000000.0, \"Research And Development\": 614000000.0, \"Selling General And Administration\": 2151000000.0, \"Gross Profit\": 5983000000.0, \"Cost Of Revenue\": 2561000000.0, \"Total Revenue\": 8544000000.0, \"Operating Revenue\": 8544000000.0}",
"year": "2023-12-31"
},
"news": {
"news_date": "2023-11-09",
"news_headlines": []
},
"price": {
"close": 174.2817840576172,
"close_previous": 168.4473876953125,
"open": 172.79110462759118,
"open_previous": 168.78303496311267,
"previous_date": "2023-11-09",
"price_date": "2023-11-16"
},
"ticker": "ZTS"
} |
You are a seasoned stock market analyst who is trying to predict whether the prices will go down or up over the day, 2023-11-16, for a specific stock, by offering a buy or sell rating.
[Company Name]
Zoetis Inc.
[Company Description]
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
[Price Movement]
It was 174.2817840576172 on 2023-11-09.
The price of the stock on 2023-11-16 started at 172.79110462759118.
[News since 2023-11-09]
[Financials]
Basic EPS: $5.08
Normalized EBITDA: $3.701000e+09
Net Income: $2.344000e+09
Your answer should look like the following
<think>reasoning about why the stock would go down here.
</think><answer>sell</answer>
or
<think>reasoning about why the stock would go up here.
</think><answer>buy</answer>
Please reason about and provide several reasons for why you think the stock would go up or down in the <think></think> tags. Please provide your answer as a single rating, 'buy' or 'sell', in the <answer></answer> tags, with buy meaning that the stock price will go up,
and sell meaning that the stock price will go down.
|
ZTS | {
"company_info": {
"description": "Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.",
"name": "Zoetis Inc."
},
"current_date": "2023-11-17",
"financials": {
"financials": "{\"Tax Effect Of Unusual Items\": -7105000.0, \"Tax Rate For Calcs\": 0.203, \"Normalized EBITDA\": 3701000000.0, \"Total Unusual Items\": -35000000.0, \"Total Unusual Items Excluding Goodwill\": -35000000.0, \"Net Income From Continuing Operation Net Minority Interest\": 2344000000.0, \"Reconciled Depreciation\": 491000000.0, \"Reconciled Cost Of Revenue\": 2219000000.0, \"EBITDA\": 3666000000.0, \"EBIT\": 3175000000.0, \"Net Interest Income\": -134000000.0, \"Interest Expense\": 239000000.0, \"Interest Income\": 105000000.0, \"Normalized Income\": 2371895000.0, \"Net Income From Continuing And Discontinued Operation\": 2344000000.0, \"Total Expenses\": 5475000000.0, \"Diluted Average Shares\": 462269000.0, \"Basic Average Shares\": 461172000.0, \"Diluted EPS\": 5.07, \"Basic EPS\": 5.08, \"Diluted NI Availto Com Stockholders\": 2344000000.0, \"Net Income Common Stockholders\": 2344000000.0, \"Net Income\": 2344000000.0, \"Minority Interests\": 4000000.0, \"Net Income Including Noncontrolling Interests\": 2340000000.0, \"Net Income Continuous Operations\": 2340000000.0, \"Tax Provision\": 596000000.0, \"Pretax Income\": 2936000000.0, \"Other Income Expense\": 1000000.0, \"Other Non Operating Income Expenses\": 36000000.0, \"Special Income Charges\": 12000000.0, \"Gain On Sale Of Ppe\": 0.0, \"Gain On Sale Of Business\": 101000000.0, \"Write Off\": 2000000.0, \"Impairment Of Capital Assets\": 35000000.0, \"Restructuring And Mergern Acquisition\": 52000000.0, \"Gain On Sale Of Security\": -47000000.0, \"Net Non Operating Interest Income Expense\": -134000000.0, \"Interest Expense Non Operating\": 239000000.0, \"Interest Income Non Operating\": 105000000.0, \"Operating Income\": 3069000000.0, \"Operating Expense\": 2914000000.0, \"Depreciation Amortization Depletion Income Statement\": 149000000.0, \"Depreciation And Amortization In Income Statement\": 149000000.0, \"Amortization\": 149000000.0, \"Amortization Of Intangibles Income Statement\": 149000000.0, \"Research And Development\": 614000000.0, \"Selling General And Administration\": 2151000000.0, \"Gross Profit\": 5983000000.0, \"Cost Of Revenue\": 2561000000.0, \"Total Revenue\": 8544000000.0, \"Operating Revenue\": 8544000000.0}",
"year": "2023-12-31"
},
"news": {
"news_date": "2023-11-10",
"news_headlines": []
},
"price": {
"close": 172.56405639648438,
"close_previous": 167.15414428710938,
"open": 175.14067129726448,
"open_previous": 168.32890970536334,
"previous_date": "2023-11-10",
"price_date": "2023-11-17"
},
"ticker": "ZTS"
} |
You are a seasoned stock market analyst who is trying to predict whether the prices will go down or up over the day, 2023-11-17, for a specific stock, by offering a buy or sell rating.
[Company Name]
Zoetis Inc.
[Company Description]
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
[Price Movement]
It was 172.56405639648438 on 2023-11-10.
The price of the stock on 2023-11-17 started at 175.14067129726448.
[News since 2023-11-10]
[Financials]
Basic EPS: $5.08
Normalized EBITDA: $3.701000e+09
Net Income: $2.344000e+09
Your answer should look like the following
<think>reasoning about why the stock would go down here.
</think><answer>sell</answer>
or
<think>reasoning about why the stock would go up here.
</think><answer>buy</answer>
Please reason about and provide several reasons for why you think the stock would go up or down in the <think></think> tags. Please provide your answer as a single rating, 'buy' or 'sell', in the <answer></answer> tags, with buy meaning that the stock price will go up,
and sell meaning that the stock price will go down.
|
ZTS | {
"company_info": {
"description": "Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.",
"name": "Zoetis Inc."
},
"current_date": "2023-11-20",
"financials": {
"financials": "{\"Tax Effect Of Unusual Items\": -7105000.0, \"Tax Rate For Calcs\": 0.203, \"Normalized EBITDA\": 3701000000.0, \"Total Unusual Items\": -35000000.0, \"Total Unusual Items Excluding Goodwill\": -35000000.0, \"Net Income From Continuing Operation Net Minority Interest\": 2344000000.0, \"Reconciled Depreciation\": 491000000.0, \"Reconciled Cost Of Revenue\": 2219000000.0, \"EBITDA\": 3666000000.0, \"EBIT\": 3175000000.0, \"Net Interest Income\": -134000000.0, \"Interest Expense\": 239000000.0, \"Interest Income\": 105000000.0, \"Normalized Income\": 2371895000.0, \"Net Income From Continuing And Discontinued Operation\": 2344000000.0, \"Total Expenses\": 5475000000.0, \"Diluted Average Shares\": 462269000.0, \"Basic Average Shares\": 461172000.0, \"Diluted EPS\": 5.07, \"Basic EPS\": 5.08, \"Diluted NI Availto Com Stockholders\": 2344000000.0, \"Net Income Common Stockholders\": 2344000000.0, \"Net Income\": 2344000000.0, \"Minority Interests\": 4000000.0, \"Net Income Including Noncontrolling Interests\": 2340000000.0, \"Net Income Continuous Operations\": 2340000000.0, \"Tax Provision\": 596000000.0, \"Pretax Income\": 2936000000.0, \"Other Income Expense\": 1000000.0, \"Other Non Operating Income Expenses\": 36000000.0, \"Special Income Charges\": 12000000.0, \"Gain On Sale Of Ppe\": 0.0, \"Gain On Sale Of Business\": 101000000.0, \"Write Off\": 2000000.0, \"Impairment Of Capital Assets\": 35000000.0, \"Restructuring And Mergern Acquisition\": 52000000.0, \"Gain On Sale Of Security\": -47000000.0, \"Net Non Operating Interest Income Expense\": -134000000.0, \"Interest Expense Non Operating\": 239000000.0, \"Interest Income Non Operating\": 105000000.0, \"Operating Income\": 3069000000.0, \"Operating Expense\": 2914000000.0, \"Depreciation Amortization Depletion Income Statement\": 149000000.0, \"Depreciation And Amortization In Income Statement\": 149000000.0, \"Amortization\": 149000000.0, \"Amortization Of Intangibles Income Statement\": 149000000.0, \"Research And Development\": 614000000.0, \"Selling General And Administration\": 2151000000.0, \"Gross Profit\": 5983000000.0, \"Cost Of Revenue\": 2561000000.0, \"Total Revenue\": 8544000000.0, \"Operating Revenue\": 8544000000.0}",
"year": "2023-12-31"
},
"news": {
"news_date": "2023-11-13",
"news_headlines": []
},
"price": {
"close": 173.80792236328125,
"close_previous": 166.67041015625,
"open": 172.09018925091726,
"open_previous": 166.52231984549093,
"previous_date": "2023-11-13",
"price_date": "2023-11-20"
},
"ticker": "ZTS"
} |
You are a seasoned stock market analyst who is trying to predict whether the prices will go down or up over the day, 2023-11-20, for a specific stock, by offering a buy or sell rating.
[Company Name]
Zoetis Inc.
[Company Description]
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
[Price Movement]
It was 173.80792236328125 on 2023-11-13.
The price of the stock on 2023-11-20 started at 172.09018925091726.
[News since 2023-11-13]
[Financials]
Basic EPS: $5.08
Normalized EBITDA: $3.701000e+09
Net Income: $2.344000e+09
Your answer should look like the following
<think>reasoning about why the stock would go down here.
</think><answer>sell</answer>
or
<think>reasoning about why the stock would go up here.
</think><answer>buy</answer>
Please reason about and provide several reasons for why you think the stock would go up or down in the <think></think> tags. Please provide your answer as a single rating, 'buy' or 'sell', in the <answer></answer> tags, with buy meaning that the stock price will go up,
and sell meaning that the stock price will go down.
|
ZTS | {
"company_info": {
"description": "Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.",
"name": "Zoetis Inc."
},
"current_date": "2023-11-21",
"financials": {
"financials": "{\"Tax Effect Of Unusual Items\": -7105000.0, \"Tax Rate For Calcs\": 0.203, \"Normalized EBITDA\": 3701000000.0, \"Total Unusual Items\": -35000000.0, \"Total Unusual Items Excluding Goodwill\": -35000000.0, \"Net Income From Continuing Operation Net Minority Interest\": 2344000000.0, \"Reconciled Depreciation\": 491000000.0, \"Reconciled Cost Of Revenue\": 2219000000.0, \"EBITDA\": 3666000000.0, \"EBIT\": 3175000000.0, \"Net Interest Income\": -134000000.0, \"Interest Expense\": 239000000.0, \"Interest Income\": 105000000.0, \"Normalized Income\": 2371895000.0, \"Net Income From Continuing And Discontinued Operation\": 2344000000.0, \"Total Expenses\": 5475000000.0, \"Diluted Average Shares\": 462269000.0, \"Basic Average Shares\": 461172000.0, \"Diluted EPS\": 5.07, \"Basic EPS\": 5.08, \"Diluted NI Availto Com Stockholders\": 2344000000.0, \"Net Income Common Stockholders\": 2344000000.0, \"Net Income\": 2344000000.0, \"Minority Interests\": 4000000.0, \"Net Income Including Noncontrolling Interests\": 2340000000.0, \"Net Income Continuous Operations\": 2340000000.0, \"Tax Provision\": 596000000.0, \"Pretax Income\": 2936000000.0, \"Other Income Expense\": 1000000.0, \"Other Non Operating Income Expenses\": 36000000.0, \"Special Income Charges\": 12000000.0, \"Gain On Sale Of Ppe\": 0.0, \"Gain On Sale Of Business\": 101000000.0, \"Write Off\": 2000000.0, \"Impairment Of Capital Assets\": 35000000.0, \"Restructuring And Mergern Acquisition\": 52000000.0, \"Gain On Sale Of Security\": -47000000.0, \"Net Non Operating Interest Income Expense\": -134000000.0, \"Interest Expense Non Operating\": 239000000.0, \"Interest Income Non Operating\": 105000000.0, \"Operating Income\": 3069000000.0, \"Operating Expense\": 2914000000.0, \"Depreciation Amortization Depletion Income Statement\": 149000000.0, \"Depreciation And Amortization In Income Statement\": 149000000.0, \"Amortization\": 149000000.0, \"Amortization Of Intangibles Income Statement\": 149000000.0, \"Research And Development\": 614000000.0, \"Selling General And Administration\": 2151000000.0, \"Gross Profit\": 5983000000.0, \"Cost Of Revenue\": 2561000000.0, \"Total Revenue\": 8544000000.0, \"Operating Revenue\": 8544000000.0}",
"year": "2023-12-31"
},
"news": {
"news_date": "2023-11-14",
"news_headlines": [
"Validea Detailed Fundamental Analysis - ZTS"
]
},
"price": {
"close": 176.44375610351562,
"close_previous": 170.44154357910156,
"open": 174.3804941278248,
"open_previous": 169.21741466487407,
"previous_date": "2023-11-14",
"price_date": "2023-11-21"
},
"ticker": "ZTS"
} |
You are a seasoned stock market analyst who is trying to predict whether the prices will go down or up over the day, 2023-11-21, for a specific stock, by offering a buy or sell rating.
[Company Name]
Zoetis Inc.
[Company Description]
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
[Price Movement]
It was 176.44375610351562 on 2023-11-14.
The price of the stock on 2023-11-21 started at 174.3804941278248.
[News since 2023-11-14]
Validea Detailed Fundamental Analysis - ZTS
[Financials]
Basic EPS: $5.08
Normalized EBITDA: $3.701000e+09
Net Income: $2.344000e+09
Your answer should look like the following
<think>reasoning about why the stock would go down here.
</think><answer>sell</answer>
or
<think>reasoning about why the stock would go up here.
</think><answer>buy</answer>
Please reason about and provide several reasons for why you think the stock would go up or down in the <think></think> tags. Please provide your answer as a single rating, 'buy' or 'sell', in the <answer></answer> tags, with buy meaning that the stock price will go up,
and sell meaning that the stock price will go down.
|
ZTS | {
"company_info": {
"description": "Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.",
"name": "Zoetis Inc."
},
"current_date": "2023-11-22",
"financials": {
"financials": "{\"Tax Effect Of Unusual Items\": -7105000.0, \"Tax Rate For Calcs\": 0.203, \"Normalized EBITDA\": 3701000000.0, \"Total Unusual Items\": -35000000.0, \"Total Unusual Items Excluding Goodwill\": -35000000.0, \"Net Income From Continuing Operation Net Minority Interest\": 2344000000.0, \"Reconciled Depreciation\": 491000000.0, \"Reconciled Cost Of Revenue\": 2219000000.0, \"EBITDA\": 3666000000.0, \"EBIT\": 3175000000.0, \"Net Interest Income\": -134000000.0, \"Interest Expense\": 239000000.0, \"Interest Income\": 105000000.0, \"Normalized Income\": 2371895000.0, \"Net Income From Continuing And Discontinued Operation\": 2344000000.0, \"Total Expenses\": 5475000000.0, \"Diluted Average Shares\": 462269000.0, \"Basic Average Shares\": 461172000.0, \"Diluted EPS\": 5.07, \"Basic EPS\": 5.08, \"Diluted NI Availto Com Stockholders\": 2344000000.0, \"Net Income Common Stockholders\": 2344000000.0, \"Net Income\": 2344000000.0, \"Minority Interests\": 4000000.0, \"Net Income Including Noncontrolling Interests\": 2340000000.0, \"Net Income Continuous Operations\": 2340000000.0, \"Tax Provision\": 596000000.0, \"Pretax Income\": 2936000000.0, \"Other Income Expense\": 1000000.0, \"Other Non Operating Income Expenses\": 36000000.0, \"Special Income Charges\": 12000000.0, \"Gain On Sale Of Ppe\": 0.0, \"Gain On Sale Of Business\": 101000000.0, \"Write Off\": 2000000.0, \"Impairment Of Capital Assets\": 35000000.0, \"Restructuring And Mergern Acquisition\": 52000000.0, \"Gain On Sale Of Security\": -47000000.0, \"Net Non Operating Interest Income Expense\": -134000000.0, \"Interest Expense Non Operating\": 239000000.0, \"Interest Income Non Operating\": 105000000.0, \"Operating Income\": 3069000000.0, \"Operating Expense\": 2914000000.0, \"Depreciation Amortization Depletion Income Statement\": 149000000.0, \"Depreciation And Amortization In Income Statement\": 149000000.0, \"Amortization\": 149000000.0, \"Amortization Of Intangibles Income Statement\": 149000000.0, \"Research And Development\": 614000000.0, \"Selling General And Administration\": 2151000000.0, \"Gross Profit\": 5983000000.0, \"Cost Of Revenue\": 2561000000.0, \"Total Revenue\": 8544000000.0, \"Operating Revenue\": 8544000000.0}",
"year": "2023-12-31"
},
"news": {
"news_date": "2023-11-15",
"news_headlines": [
"Validea Detailed Fundamental Analysis - ZTS"
]
},
"price": {
"close": 177.05584716796875,
"close_previous": 172.38633728027344,
"open": 177.69752665544883,
"open_previous": 170.28359349377882,
"previous_date": "2023-11-15",
"price_date": "2023-11-22"
},
"ticker": "ZTS"
} |
You are a seasoned stock market analyst who is trying to predict whether the prices will go down or up over the day, 2023-11-22, for a specific stock, by offering a buy or sell rating.
[Company Name]
Zoetis Inc.
[Company Description]
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
[Price Movement]
It was 177.05584716796875 on 2023-11-15.
The price of the stock on 2023-11-22 started at 177.69752665544883.
[News since 2023-11-15]
Validea Detailed Fundamental Analysis - ZTS
[Financials]
Basic EPS: $5.08
Normalized EBITDA: $3.701000e+09
Net Income: $2.344000e+09
Your answer should look like the following
<think>reasoning about why the stock would go down here.
</think><answer>sell</answer>
or
<think>reasoning about why the stock would go up here.
</think><answer>buy</answer>
Please reason about and provide several reasons for why you think the stock would go up or down in the <think></think> tags. Please provide your answer as a single rating, 'buy' or 'sell', in the <answer></answer> tags, with buy meaning that the stock price will go up,
and sell meaning that the stock price will go down.
|
ZTS | {
"company_info": {
"description": "Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.",
"name": "Zoetis Inc."
},
"current_date": "2023-11-24",
"financials": {
"financials": "{\"Tax Effect Of Unusual Items\": -7105000.0, \"Tax Rate For Calcs\": 0.203, \"Normalized EBITDA\": 3701000000.0, \"Total Unusual Items\": -35000000.0, \"Total Unusual Items Excluding Goodwill\": -35000000.0, \"Net Income From Continuing Operation Net Minority Interest\": 2344000000.0, \"Reconciled Depreciation\": 491000000.0, \"Reconciled Cost Of Revenue\": 2219000000.0, \"EBITDA\": 3666000000.0, \"EBIT\": 3175000000.0, \"Net Interest Income\": -134000000.0, \"Interest Expense\": 239000000.0, \"Interest Income\": 105000000.0, \"Normalized Income\": 2371895000.0, \"Net Income From Continuing And Discontinued Operation\": 2344000000.0, \"Total Expenses\": 5475000000.0, \"Diluted Average Shares\": 462269000.0, \"Basic Average Shares\": 461172000.0, \"Diluted EPS\": 5.07, \"Basic EPS\": 5.08, \"Diluted NI Availto Com Stockholders\": 2344000000.0, \"Net Income Common Stockholders\": 2344000000.0, \"Net Income\": 2344000000.0, \"Minority Interests\": 4000000.0, \"Net Income Including Noncontrolling Interests\": 2340000000.0, \"Net Income Continuous Operations\": 2340000000.0, \"Tax Provision\": 596000000.0, \"Pretax Income\": 2936000000.0, \"Other Income Expense\": 1000000.0, \"Other Non Operating Income Expenses\": 36000000.0, \"Special Income Charges\": 12000000.0, \"Gain On Sale Of Ppe\": 0.0, \"Gain On Sale Of Business\": 101000000.0, \"Write Off\": 2000000.0, \"Impairment Of Capital Assets\": 35000000.0, \"Restructuring And Mergern Acquisition\": 52000000.0, \"Gain On Sale Of Security\": -47000000.0, \"Net Non Operating Interest Income Expense\": -134000000.0, \"Interest Expense Non Operating\": 239000000.0, \"Interest Income Non Operating\": 105000000.0, \"Operating Income\": 3069000000.0, \"Operating Expense\": 2914000000.0, \"Depreciation Amortization Depletion Income Statement\": 149000000.0, \"Depreciation And Amortization In Income Statement\": 149000000.0, \"Amortization\": 149000000.0, \"Amortization Of Intangibles Income Statement\": 149000000.0, \"Research And Development\": 614000000.0, \"Selling General And Administration\": 2151000000.0, \"Gross Profit\": 5983000000.0, \"Cost Of Revenue\": 2561000000.0, \"Total Revenue\": 8544000000.0, \"Operating Revenue\": 8544000000.0}",
"year": "2023-12-31"
},
"news": {
"news_date": "2023-11-17",
"news_headlines": [
"Validea Detailed Fundamental Analysis - ZTS"
]
},
"price": {
"close": 177.90484619140625,
"close_previous": 172.56405639648438,
"open": 177.86534941672397,
"open_previous": 175.14067129726448,
"previous_date": "2023-11-17",
"price_date": "2023-11-24"
},
"ticker": "ZTS"
} |
You are a seasoned stock market analyst who is trying to predict whether the prices will go down or up over the day, 2023-11-24, for a specific stock, by offering a buy or sell rating.
[Company Name]
Zoetis Inc.
[Company Description]
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
[Price Movement]
It was 177.90484619140625 on 2023-11-17.
The price of the stock on 2023-11-24 started at 177.86534941672397.
[News since 2023-11-17]
Validea Detailed Fundamental Analysis - ZTS
[Financials]
Basic EPS: $5.08
Normalized EBITDA: $3.701000e+09
Net Income: $2.344000e+09
Your answer should look like the following
<think>reasoning about why the stock would go down here.
</think><answer>sell</answer>
or
<think>reasoning about why the stock would go up here.
</think><answer>buy</answer>
Please reason about and provide several reasons for why you think the stock would go up or down in the <think></think> tags. Please provide your answer as a single rating, 'buy' or 'sell', in the <answer></answer> tags, with buy meaning that the stock price will go up,
and sell meaning that the stock price will go down.
|
ZTS | {
"company_info": {
"description": "Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.",
"name": "Zoetis Inc."
},
"current_date": "2023-11-27",
"financials": {
"financials": "{\"Tax Effect Of Unusual Items\": -7105000.0, \"Tax Rate For Calcs\": 0.203, \"Normalized EBITDA\": 3701000000.0, \"Total Unusual Items\": -35000000.0, \"Total Unusual Items Excluding Goodwill\": -35000000.0, \"Net Income From Continuing Operation Net Minority Interest\": 2344000000.0, \"Reconciled Depreciation\": 491000000.0, \"Reconciled Cost Of Revenue\": 2219000000.0, \"EBITDA\": 3666000000.0, \"EBIT\": 3175000000.0, \"Net Interest Income\": -134000000.0, \"Interest Expense\": 239000000.0, \"Interest Income\": 105000000.0, \"Normalized Income\": 2371895000.0, \"Net Income From Continuing And Discontinued Operation\": 2344000000.0, \"Total Expenses\": 5475000000.0, \"Diluted Average Shares\": 462269000.0, \"Basic Average Shares\": 461172000.0, \"Diluted EPS\": 5.07, \"Basic EPS\": 5.08, \"Diluted NI Availto Com Stockholders\": 2344000000.0, \"Net Income Common Stockholders\": 2344000000.0, \"Net Income\": 2344000000.0, \"Minority Interests\": 4000000.0, \"Net Income Including Noncontrolling Interests\": 2340000000.0, \"Net Income Continuous Operations\": 2340000000.0, \"Tax Provision\": 596000000.0, \"Pretax Income\": 2936000000.0, \"Other Income Expense\": 1000000.0, \"Other Non Operating Income Expenses\": 36000000.0, \"Special Income Charges\": 12000000.0, \"Gain On Sale Of Ppe\": 0.0, \"Gain On Sale Of Business\": 101000000.0, \"Write Off\": 2000000.0, \"Impairment Of Capital Assets\": 35000000.0, \"Restructuring And Mergern Acquisition\": 52000000.0, \"Gain On Sale Of Security\": -47000000.0, \"Net Non Operating Interest Income Expense\": -134000000.0, \"Interest Expense Non Operating\": 239000000.0, \"Interest Income Non Operating\": 105000000.0, \"Operating Income\": 3069000000.0, \"Operating Expense\": 2914000000.0, \"Depreciation Amortization Depletion Income Statement\": 149000000.0, \"Depreciation And Amortization In Income Statement\": 149000000.0, \"Amortization\": 149000000.0, \"Amortization Of Intangibles Income Statement\": 149000000.0, \"Research And Development\": 614000000.0, \"Selling General And Administration\": 2151000000.0, \"Gross Profit\": 5983000000.0, \"Cost Of Revenue\": 2561000000.0, \"Total Revenue\": 8544000000.0, \"Operating Revenue\": 8544000000.0}",
"year": "2023-12-31"
},
"news": {
"news_date": "2023-11-20",
"news_headlines": [
"Validea Detailed Fundamental Analysis - ZTS"
]
},
"price": {
"close": 176.5030059814453,
"close_previous": 173.80792236328125,
"open": 177.7271499782891,
"open_previous": 172.09018925091726,
"previous_date": "2023-11-20",
"price_date": "2023-11-27"
},
"ticker": "ZTS"
} |
You are a seasoned stock market analyst who is trying to predict whether the prices will go down or up over the day, 2023-11-27, for a specific stock, by offering a buy or sell rating.
[Company Name]
Zoetis Inc.
[Company Description]
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
[Price Movement]
It was 176.5030059814453 on 2023-11-20.
The price of the stock on 2023-11-27 started at 177.7271499782891.
[News since 2023-11-20]
Validea Detailed Fundamental Analysis - ZTS
[Financials]
Basic EPS: $5.08
Normalized EBITDA: $3.701000e+09
Net Income: $2.344000e+09
Your answer should look like the following
<think>reasoning about why the stock would go down here.
</think><answer>sell</answer>
or
<think>reasoning about why the stock would go up here.
</think><answer>buy</answer>
Please reason about and provide several reasons for why you think the stock would go up or down in the <think></think> tags. Please provide your answer as a single rating, 'buy' or 'sell', in the <answer></answer> tags, with buy meaning that the stock price will go up,
and sell meaning that the stock price will go down.
|
ZTS | {
"company_info": {
"description": "Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.",
"name": "Zoetis Inc."
},
"current_date": "2023-11-28",
"financials": {
"financials": "{\"Tax Effect Of Unusual Items\": -7105000.0, \"Tax Rate For Calcs\": 0.203, \"Normalized EBITDA\": 3701000000.0, \"Total Unusual Items\": -35000000.0, \"Total Unusual Items Excluding Goodwill\": -35000000.0, \"Net Income From Continuing Operation Net Minority Interest\": 2344000000.0, \"Reconciled Depreciation\": 491000000.0, \"Reconciled Cost Of Revenue\": 2219000000.0, \"EBITDA\": 3666000000.0, \"EBIT\": 3175000000.0, \"Net Interest Income\": -134000000.0, \"Interest Expense\": 239000000.0, \"Interest Income\": 105000000.0, \"Normalized Income\": 2371895000.0, \"Net Income From Continuing And Discontinued Operation\": 2344000000.0, \"Total Expenses\": 5475000000.0, \"Diluted Average Shares\": 462269000.0, \"Basic Average Shares\": 461172000.0, \"Diluted EPS\": 5.07, \"Basic EPS\": 5.08, \"Diluted NI Availto Com Stockholders\": 2344000000.0, \"Net Income Common Stockholders\": 2344000000.0, \"Net Income\": 2344000000.0, \"Minority Interests\": 4000000.0, \"Net Income Including Noncontrolling Interests\": 2340000000.0, \"Net Income Continuous Operations\": 2340000000.0, \"Tax Provision\": 596000000.0, \"Pretax Income\": 2936000000.0, \"Other Income Expense\": 1000000.0, \"Other Non Operating Income Expenses\": 36000000.0, \"Special Income Charges\": 12000000.0, \"Gain On Sale Of Ppe\": 0.0, \"Gain On Sale Of Business\": 101000000.0, \"Write Off\": 2000000.0, \"Impairment Of Capital Assets\": 35000000.0, \"Restructuring And Mergern Acquisition\": 52000000.0, \"Gain On Sale Of Security\": -47000000.0, \"Net Non Operating Interest Income Expense\": -134000000.0, \"Interest Expense Non Operating\": 239000000.0, \"Interest Income Non Operating\": 105000000.0, \"Operating Income\": 3069000000.0, \"Operating Expense\": 2914000000.0, \"Depreciation Amortization Depletion Income Statement\": 149000000.0, \"Depreciation And Amortization In Income Statement\": 149000000.0, \"Amortization\": 149000000.0, \"Amortization Of Intangibles Income Statement\": 149000000.0, \"Research And Development\": 614000000.0, \"Selling General And Administration\": 2151000000.0, \"Gross Profit\": 5983000000.0, \"Cost Of Revenue\": 2561000000.0, \"Total Revenue\": 8544000000.0, \"Operating Revenue\": 8544000000.0}",
"year": "2023-12-31"
},
"news": {
"news_date": "2023-11-21",
"news_headlines": [
"3 Pet Care Stocks to Capitalize on the Animal Economy",
"Validea Detailed Fundamental Analysis - ZTS"
]
},
"price": {
"close": 174.70631408691406,
"close_previous": 176.44375610351562,
"open": 175.8317313330745,
"open_previous": 174.3804941278248,
"previous_date": "2023-11-21",
"price_date": "2023-11-28"
},
"ticker": "ZTS"
} |
You are a seasoned stock market analyst who is trying to predict whether the prices will go down or up over the day, 2023-11-28, for a specific stock, by offering a buy or sell rating.
[Company Name]
Zoetis Inc.
[Company Description]
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
[Price Movement]
It was 174.70631408691406 on 2023-11-21.
The price of the stock on 2023-11-28 started at 175.8317313330745.
[News since 2023-11-21]
3 Pet Care Stocks to Capitalize on the Animal Economy
Validea Detailed Fundamental Analysis - ZTS
[Financials]
Basic EPS: $5.08
Normalized EBITDA: $3.701000e+09
Net Income: $2.344000e+09
Your answer should look like the following
<think>reasoning about why the stock would go down here.
</think><answer>sell</answer>
or
<think>reasoning about why the stock would go up here.
</think><answer>buy</answer>
Please reason about and provide several reasons for why you think the stock would go up or down in the <think></think> tags. Please provide your answer as a single rating, 'buy' or 'sell', in the <answer></answer> tags, with buy meaning that the stock price will go up,
and sell meaning that the stock price will go down.
|
ZTS | {
"company_info": {
"description": "Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.",
"name": "Zoetis Inc."
},
"current_date": "2023-11-29",
"financials": {
"financials": "{\"Tax Effect Of Unusual Items\": -7105000.0, \"Tax Rate For Calcs\": 0.203, \"Normalized EBITDA\": 3701000000.0, \"Total Unusual Items\": -35000000.0, \"Total Unusual Items Excluding Goodwill\": -35000000.0, \"Net Income From Continuing Operation Net Minority Interest\": 2344000000.0, \"Reconciled Depreciation\": 491000000.0, \"Reconciled Cost Of Revenue\": 2219000000.0, \"EBITDA\": 3666000000.0, \"EBIT\": 3175000000.0, \"Net Interest Income\": -134000000.0, \"Interest Expense\": 239000000.0, \"Interest Income\": 105000000.0, \"Normalized Income\": 2371895000.0, \"Net Income From Continuing And Discontinued Operation\": 2344000000.0, \"Total Expenses\": 5475000000.0, \"Diluted Average Shares\": 462269000.0, \"Basic Average Shares\": 461172000.0, \"Diluted EPS\": 5.07, \"Basic EPS\": 5.08, \"Diluted NI Availto Com Stockholders\": 2344000000.0, \"Net Income Common Stockholders\": 2344000000.0, \"Net Income\": 2344000000.0, \"Minority Interests\": 4000000.0, \"Net Income Including Noncontrolling Interests\": 2340000000.0, \"Net Income Continuous Operations\": 2340000000.0, \"Tax Provision\": 596000000.0, \"Pretax Income\": 2936000000.0, \"Other Income Expense\": 1000000.0, \"Other Non Operating Income Expenses\": 36000000.0, \"Special Income Charges\": 12000000.0, \"Gain On Sale Of Ppe\": 0.0, \"Gain On Sale Of Business\": 101000000.0, \"Write Off\": 2000000.0, \"Impairment Of Capital Assets\": 35000000.0, \"Restructuring And Mergern Acquisition\": 52000000.0, \"Gain On Sale Of Security\": -47000000.0, \"Net Non Operating Interest Income Expense\": -134000000.0, \"Interest Expense Non Operating\": 239000000.0, \"Interest Income Non Operating\": 105000000.0, \"Operating Income\": 3069000000.0, \"Operating Expense\": 2914000000.0, \"Depreciation Amortization Depletion Income Statement\": 149000000.0, \"Depreciation And Amortization In Income Statement\": 149000000.0, \"Amortization\": 149000000.0, \"Amortization Of Intangibles Income Statement\": 149000000.0, \"Research And Development\": 614000000.0, \"Selling General And Administration\": 2151000000.0, \"Gross Profit\": 5983000000.0, \"Cost Of Revenue\": 2561000000.0, \"Total Revenue\": 8544000000.0, \"Operating Revenue\": 8544000000.0}",
"year": "2023-12-31"
},
"news": {
"news_date": "2023-11-22",
"news_headlines": [
"3 Pet Care Stocks to Capitalize on the Animal Economy",
"Validea Detailed Fundamental Analysis - ZTS",
"S&P 500 Analyst Moves: ZTS"
]
},
"price": {
"close": 173.54136657714844,
"close_previous": 177.05584716796875,
"open": 175.59476195817368,
"open_previous": 177.69752665544883,
"previous_date": "2023-11-22",
"price_date": "2023-11-29"
},
"ticker": "ZTS"
} |
You are a seasoned stock market analyst who is trying to predict whether the prices will go down or up over the day, 2023-11-29, for a specific stock, by offering a buy or sell rating.
[Company Name]
Zoetis Inc.
[Company Description]
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
[Price Movement]
It was 173.54136657714844 on 2023-11-22.
The price of the stock on 2023-11-29 started at 175.59476195817368.
[News since 2023-11-22]
3 Pet Care Stocks to Capitalize on the Animal Economy
Validea Detailed Fundamental Analysis - ZTS
S&P 500 Analyst Moves: ZTS
[Financials]
Basic EPS: $5.08
Normalized EBITDA: $3.701000e+09
Net Income: $2.344000e+09
Your answer should look like the following
<think>reasoning about why the stock would go down here.
</think><answer>sell</answer>
or
<think>reasoning about why the stock would go up here.
</think><answer>buy</answer>
Please reason about and provide several reasons for why you think the stock would go up or down in the <think></think> tags. Please provide your answer as a single rating, 'buy' or 'sell', in the <answer></answer> tags, with buy meaning that the stock price will go up,
and sell meaning that the stock price will go down.
|
ZTS | {
"company_info": {
"description": "Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.",
"name": "Zoetis Inc."
},
"current_date": "2023-11-30",
"financials": {
"financials": "{\"Tax Effect Of Unusual Items\": -7105000.0, \"Tax Rate For Calcs\": 0.203, \"Normalized EBITDA\": 3701000000.0, \"Total Unusual Items\": -35000000.0, \"Total Unusual Items Excluding Goodwill\": -35000000.0, \"Net Income From Continuing Operation Net Minority Interest\": 2344000000.0, \"Reconciled Depreciation\": 491000000.0, \"Reconciled Cost Of Revenue\": 2219000000.0, \"EBITDA\": 3666000000.0, \"EBIT\": 3175000000.0, \"Net Interest Income\": -134000000.0, \"Interest Expense\": 239000000.0, \"Interest Income\": 105000000.0, \"Normalized Income\": 2371895000.0, \"Net Income From Continuing And Discontinued Operation\": 2344000000.0, \"Total Expenses\": 5475000000.0, \"Diluted Average Shares\": 462269000.0, \"Basic Average Shares\": 461172000.0, \"Diluted EPS\": 5.07, \"Basic EPS\": 5.08, \"Diluted NI Availto Com Stockholders\": 2344000000.0, \"Net Income Common Stockholders\": 2344000000.0, \"Net Income\": 2344000000.0, \"Minority Interests\": 4000000.0, \"Net Income Including Noncontrolling Interests\": 2340000000.0, \"Net Income Continuous Operations\": 2340000000.0, \"Tax Provision\": 596000000.0, \"Pretax Income\": 2936000000.0, \"Other Income Expense\": 1000000.0, \"Other Non Operating Income Expenses\": 36000000.0, \"Special Income Charges\": 12000000.0, \"Gain On Sale Of Ppe\": 0.0, \"Gain On Sale Of Business\": 101000000.0, \"Write Off\": 2000000.0, \"Impairment Of Capital Assets\": 35000000.0, \"Restructuring And Mergern Acquisition\": 52000000.0, \"Gain On Sale Of Security\": -47000000.0, \"Net Non Operating Interest Income Expense\": -134000000.0, \"Interest Expense Non Operating\": 239000000.0, \"Interest Income Non Operating\": 105000000.0, \"Operating Income\": 3069000000.0, \"Operating Expense\": 2914000000.0, \"Depreciation Amortization Depletion Income Statement\": 149000000.0, \"Depreciation And Amortization In Income Statement\": 149000000.0, \"Amortization\": 149000000.0, \"Amortization Of Intangibles Income Statement\": 149000000.0, \"Research And Development\": 614000000.0, \"Selling General And Administration\": 2151000000.0, \"Gross Profit\": 5983000000.0, \"Cost Of Revenue\": 2561000000.0, \"Total Revenue\": 8544000000.0, \"Operating Revenue\": 8544000000.0}",
"year": "2023-12-31"
},
"news": {
"news_date": "2023-11-23",
"news_headlines": [
"3 Pet Care Stocks to Capitalize on the Animal Economy",
"Validea Detailed Fundamental Analysis - ZTS",
"S&P 500 Analyst Moves: ZTS",
"The Math Shows VOOV Can Go To $176"
]
},
"price": {
"close": 174.41014099121094,
"close_previous": 177.05584716796875,
"open": 172.80098615805227,
"open_previous": 177.69752665544883,
"previous_date": "2023-11-22",
"price_date": "2023-11-30"
},
"ticker": "ZTS"
} |
You are a seasoned stock market analyst who is trying to predict whether the prices will go down or up over the day, 2023-11-30, for a specific stock, by offering a buy or sell rating.
[Company Name]
Zoetis Inc.
[Company Description]
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
[Price Movement]
It was 174.41014099121094 on 2023-11-22.
The price of the stock on 2023-11-30 started at 172.80098615805227.
[News since 2023-11-23]
3 Pet Care Stocks to Capitalize on the Animal Economy
Validea Detailed Fundamental Analysis - ZTS
S&P 500 Analyst Moves: ZTS
The Math Shows VOOV Can Go To $176
[Financials]
Basic EPS: $5.08
Normalized EBITDA: $3.701000e+09
Net Income: $2.344000e+09
Your answer should look like the following
<think>reasoning about why the stock would go down here.
</think><answer>sell</answer>
or
<think>reasoning about why the stock would go up here.
</think><answer>buy</answer>
Please reason about and provide several reasons for why you think the stock would go up or down in the <think></think> tags. Please provide your answer as a single rating, 'buy' or 'sell', in the <answer></answer> tags, with buy meaning that the stock price will go up,
and sell meaning that the stock price will go down.
|
ZTS | {
"company_info": {
"description": "Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.",
"name": "Zoetis Inc."
},
"current_date": "2023-12-01",
"financials": {
"financials": "{\"Tax Effect Of Unusual Items\": -7105000.0, \"Tax Rate For Calcs\": 0.203, \"Normalized EBITDA\": 3701000000.0, \"Total Unusual Items\": -35000000.0, \"Total Unusual Items Excluding Goodwill\": -35000000.0, \"Net Income From Continuing Operation Net Minority Interest\": 2344000000.0, \"Reconciled Depreciation\": 491000000.0, \"Reconciled Cost Of Revenue\": 2219000000.0, \"EBITDA\": 3666000000.0, \"EBIT\": 3175000000.0, \"Net Interest Income\": -134000000.0, \"Interest Expense\": 239000000.0, \"Interest Income\": 105000000.0, \"Normalized Income\": 2371895000.0, \"Net Income From Continuing And Discontinued Operation\": 2344000000.0, \"Total Expenses\": 5475000000.0, \"Diluted Average Shares\": 462269000.0, \"Basic Average Shares\": 461172000.0, \"Diluted EPS\": 5.07, \"Basic EPS\": 5.08, \"Diluted NI Availto Com Stockholders\": 2344000000.0, \"Net Income Common Stockholders\": 2344000000.0, \"Net Income\": 2344000000.0, \"Minority Interests\": 4000000.0, \"Net Income Including Noncontrolling Interests\": 2340000000.0, \"Net Income Continuous Operations\": 2340000000.0, \"Tax Provision\": 596000000.0, \"Pretax Income\": 2936000000.0, \"Other Income Expense\": 1000000.0, \"Other Non Operating Income Expenses\": 36000000.0, \"Special Income Charges\": 12000000.0, \"Gain On Sale Of Ppe\": 0.0, \"Gain On Sale Of Business\": 101000000.0, \"Write Off\": 2000000.0, \"Impairment Of Capital Assets\": 35000000.0, \"Restructuring And Mergern Acquisition\": 52000000.0, \"Gain On Sale Of Security\": -47000000.0, \"Net Non Operating Interest Income Expense\": -134000000.0, \"Interest Expense Non Operating\": 239000000.0, \"Interest Income Non Operating\": 105000000.0, \"Operating Income\": 3069000000.0, \"Operating Expense\": 2914000000.0, \"Depreciation Amortization Depletion Income Statement\": 149000000.0, \"Depreciation And Amortization In Income Statement\": 149000000.0, \"Amortization\": 149000000.0, \"Amortization Of Intangibles Income Statement\": 149000000.0, \"Research And Development\": 614000000.0, \"Selling General And Administration\": 2151000000.0, \"Gross Profit\": 5983000000.0, \"Cost Of Revenue\": 2561000000.0, \"Total Revenue\": 8544000000.0, \"Operating Revenue\": 8544000000.0}",
"year": "2023-12-31"
},
"news": {
"news_date": "2023-11-24",
"news_headlines": [
"3 Pet Care Stocks to Capitalize on the Animal Economy",
"Validea Detailed Fundamental Analysis - ZTS",
"S&P 500 Analyst Moves: ZTS",
"The Math Shows VOOV Can Go To $176"
]
},
"price": {
"close": 176.83865356445312,
"close_previous": 177.90484619140625,
"open": 173.99548842264008,
"open_previous": 177.86534941672397,
"previous_date": "2023-11-24",
"price_date": "2023-12-01"
},
"ticker": "ZTS"
} |
You are a seasoned stock market analyst who is trying to predict whether the prices will go down or up over the day, 2023-12-01, for a specific stock, by offering a buy or sell rating.
[Company Name]
Zoetis Inc.
[Company Description]
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
[Price Movement]
It was 176.83865356445312 on 2023-11-24.
The price of the stock on 2023-12-01 started at 173.99548842264008.
[News since 2023-11-24]
3 Pet Care Stocks to Capitalize on the Animal Economy
Validea Detailed Fundamental Analysis - ZTS
S&P 500 Analyst Moves: ZTS
The Math Shows VOOV Can Go To $176
[Financials]
Basic EPS: $5.08
Normalized EBITDA: $3.701000e+09
Net Income: $2.344000e+09
Your answer should look like the following
<think>reasoning about why the stock would go down here.
</think><answer>sell</answer>
or
<think>reasoning about why the stock would go up here.
</think><answer>buy</answer>
Please reason about and provide several reasons for why you think the stock would go up or down in the <think></think> tags. Please provide your answer as a single rating, 'buy' or 'sell', in the <answer></answer> tags, with buy meaning that the stock price will go up,
and sell meaning that the stock price will go down.
|
ZTS | {
"company_info": {
"description": "Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.",
"name": "Zoetis Inc."
},
"current_date": "2023-12-04",
"financials": {
"financials": "{\"Tax Effect Of Unusual Items\": -7105000.0, \"Tax Rate For Calcs\": 0.203, \"Normalized EBITDA\": 3701000000.0, \"Total Unusual Items\": -35000000.0, \"Total Unusual Items Excluding Goodwill\": -35000000.0, \"Net Income From Continuing Operation Net Minority Interest\": 2344000000.0, \"Reconciled Depreciation\": 491000000.0, \"Reconciled Cost Of Revenue\": 2219000000.0, \"EBITDA\": 3666000000.0, \"EBIT\": 3175000000.0, \"Net Interest Income\": -134000000.0, \"Interest Expense\": 239000000.0, \"Interest Income\": 105000000.0, \"Normalized Income\": 2371895000.0, \"Net Income From Continuing And Discontinued Operation\": 2344000000.0, \"Total Expenses\": 5475000000.0, \"Diluted Average Shares\": 462269000.0, \"Basic Average Shares\": 461172000.0, \"Diluted EPS\": 5.07, \"Basic EPS\": 5.08, \"Diluted NI Availto Com Stockholders\": 2344000000.0, \"Net Income Common Stockholders\": 2344000000.0, \"Net Income\": 2344000000.0, \"Minority Interests\": 4000000.0, \"Net Income Including Noncontrolling Interests\": 2340000000.0, \"Net Income Continuous Operations\": 2340000000.0, \"Tax Provision\": 596000000.0, \"Pretax Income\": 2936000000.0, \"Other Income Expense\": 1000000.0, \"Other Non Operating Income Expenses\": 36000000.0, \"Special Income Charges\": 12000000.0, \"Gain On Sale Of Ppe\": 0.0, \"Gain On Sale Of Business\": 101000000.0, \"Write Off\": 2000000.0, \"Impairment Of Capital Assets\": 35000000.0, \"Restructuring And Mergern Acquisition\": 52000000.0, \"Gain On Sale Of Security\": -47000000.0, \"Net Non Operating Interest Income Expense\": -134000000.0, \"Interest Expense Non Operating\": 239000000.0, \"Interest Income Non Operating\": 105000000.0, \"Operating Income\": 3069000000.0, \"Operating Expense\": 2914000000.0, \"Depreciation Amortization Depletion Income Statement\": 149000000.0, \"Depreciation And Amortization In Income Statement\": 149000000.0, \"Amortization\": 149000000.0, \"Amortization Of Intangibles Income Statement\": 149000000.0, \"Research And Development\": 614000000.0, \"Selling General And Administration\": 2151000000.0, \"Gross Profit\": 5983000000.0, \"Cost Of Revenue\": 2561000000.0, \"Total Revenue\": 8544000000.0, \"Operating Revenue\": 8544000000.0}",
"year": "2023-12-31"
},
"news": {
"news_date": "2023-11-27",
"news_headlines": [
"3 Pet Care Stocks to Capitalize on the Animal Economy",
"Validea Detailed Fundamental Analysis - ZTS",
"S&P 500 Analyst Moves: ZTS",
"The Math Shows VOOV Can Go To $176"
]
},
"price": {
"close": 179.79042053222656,
"close_previous": 176.5030059814453,
"open": 176.52276256508634,
"open_previous": 177.7271499782891,
"previous_date": "2023-11-27",
"price_date": "2023-12-04"
},
"ticker": "ZTS"
} |
You are a seasoned stock market analyst who is trying to predict whether the prices will go down or up over the day, 2023-12-04, for a specific stock, by offering a buy or sell rating.
[Company Name]
Zoetis Inc.
[Company Description]
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
[Price Movement]
It was 179.79042053222656 on 2023-11-27.
The price of the stock on 2023-12-04 started at 176.52276256508634.
[News since 2023-11-27]
3 Pet Care Stocks to Capitalize on the Animal Economy
Validea Detailed Fundamental Analysis - ZTS
S&P 500 Analyst Moves: ZTS
The Math Shows VOOV Can Go To $176
[Financials]
Basic EPS: $5.08
Normalized EBITDA: $3.701000e+09
Net Income: $2.344000e+09
Your answer should look like the following
<think>reasoning about why the stock would go down here.
</think><answer>sell</answer>
or
<think>reasoning about why the stock would go up here.
</think><answer>buy</answer>
Please reason about and provide several reasons for why you think the stock would go up or down in the <think></think> tags. Please provide your answer as a single rating, 'buy' or 'sell', in the <answer></answer> tags, with buy meaning that the stock price will go up,
and sell meaning that the stock price will go down.
|
ZTS | {
"company_info": {
"description": "Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.",
"name": "Zoetis Inc."
},
"current_date": "2023-12-05",
"financials": {
"financials": "{\"Tax Effect Of Unusual Items\": -7105000.0, \"Tax Rate For Calcs\": 0.203, \"Normalized EBITDA\": 3701000000.0, \"Total Unusual Items\": -35000000.0, \"Total Unusual Items Excluding Goodwill\": -35000000.0, \"Net Income From Continuing Operation Net Minority Interest\": 2344000000.0, \"Reconciled Depreciation\": 491000000.0, \"Reconciled Cost Of Revenue\": 2219000000.0, \"EBITDA\": 3666000000.0, \"EBIT\": 3175000000.0, \"Net Interest Income\": -134000000.0, \"Interest Expense\": 239000000.0, \"Interest Income\": 105000000.0, \"Normalized Income\": 2371895000.0, \"Net Income From Continuing And Discontinued Operation\": 2344000000.0, \"Total Expenses\": 5475000000.0, \"Diluted Average Shares\": 462269000.0, \"Basic Average Shares\": 461172000.0, \"Diluted EPS\": 5.07, \"Basic EPS\": 5.08, \"Diluted NI Availto Com Stockholders\": 2344000000.0, \"Net Income Common Stockholders\": 2344000000.0, \"Net Income\": 2344000000.0, \"Minority Interests\": 4000000.0, \"Net Income Including Noncontrolling Interests\": 2340000000.0, \"Net Income Continuous Operations\": 2340000000.0, \"Tax Provision\": 596000000.0, \"Pretax Income\": 2936000000.0, \"Other Income Expense\": 1000000.0, \"Other Non Operating Income Expenses\": 36000000.0, \"Special Income Charges\": 12000000.0, \"Gain On Sale Of Ppe\": 0.0, \"Gain On Sale Of Business\": 101000000.0, \"Write Off\": 2000000.0, \"Impairment Of Capital Assets\": 35000000.0, \"Restructuring And Mergern Acquisition\": 52000000.0, \"Gain On Sale Of Security\": -47000000.0, \"Net Non Operating Interest Income Expense\": -134000000.0, \"Interest Expense Non Operating\": 239000000.0, \"Interest Income Non Operating\": 105000000.0, \"Operating Income\": 3069000000.0, \"Operating Expense\": 2914000000.0, \"Depreciation Amortization Depletion Income Statement\": 149000000.0, \"Depreciation And Amortization In Income Statement\": 149000000.0, \"Amortization\": 149000000.0, \"Amortization Of Intangibles Income Statement\": 149000000.0, \"Research And Development\": 614000000.0, \"Selling General And Administration\": 2151000000.0, \"Gross Profit\": 5983000000.0, \"Cost Of Revenue\": 2561000000.0, \"Total Revenue\": 8544000000.0, \"Operating Revenue\": 8544000000.0}",
"year": "2023-12-31"
},
"news": {
"news_date": "2023-11-28",
"news_headlines": [
"S&P 500 Analyst Moves: ZTS",
"The Math Shows VOOV Can Go To $176",
"Validea Detailed Fundamental Analysis - ZTS"
]
},
"price": {
"close": 177.3520050048828,
"close_previous": 174.70631408691406,
"open": 178.97102637890262,
"open_previous": 175.8317313330745,
"previous_date": "2023-11-28",
"price_date": "2023-12-05"
},
"ticker": "ZTS"
} |
You are a seasoned stock market analyst who is trying to predict whether the prices will go down or up over the day, 2023-12-05, for a specific stock, by offering a buy or sell rating.
[Company Name]
Zoetis Inc.
[Company Description]
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
[Price Movement]
It was 177.3520050048828 on 2023-11-28.
The price of the stock on 2023-12-05 started at 178.97102637890262.
[News since 2023-11-28]
S&P 500 Analyst Moves: ZTS
The Math Shows VOOV Can Go To $176
Validea Detailed Fundamental Analysis - ZTS
[Financials]
Basic EPS: $5.08
Normalized EBITDA: $3.701000e+09
Net Income: $2.344000e+09
Your answer should look like the following
<think>reasoning about why the stock would go down here.
</think><answer>sell</answer>
or
<think>reasoning about why the stock would go up here.
</think><answer>buy</answer>
Please reason about and provide several reasons for why you think the stock would go up or down in the <think></think> tags. Please provide your answer as a single rating, 'buy' or 'sell', in the <answer></answer> tags, with buy meaning that the stock price will go up,
and sell meaning that the stock price will go down.
|
ZTS | {
"company_info": {
"description": "Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.",
"name": "Zoetis Inc."
},
"current_date": "2023-12-06",
"financials": {
"financials": "{\"Tax Effect Of Unusual Items\": -7105000.0, \"Tax Rate For Calcs\": 0.203, \"Normalized EBITDA\": 3701000000.0, \"Total Unusual Items\": -35000000.0, \"Total Unusual Items Excluding Goodwill\": -35000000.0, \"Net Income From Continuing Operation Net Minority Interest\": 2344000000.0, \"Reconciled Depreciation\": 491000000.0, \"Reconciled Cost Of Revenue\": 2219000000.0, \"EBITDA\": 3666000000.0, \"EBIT\": 3175000000.0, \"Net Interest Income\": -134000000.0, \"Interest Expense\": 239000000.0, \"Interest Income\": 105000000.0, \"Normalized Income\": 2371895000.0, \"Net Income From Continuing And Discontinued Operation\": 2344000000.0, \"Total Expenses\": 5475000000.0, \"Diluted Average Shares\": 462269000.0, \"Basic Average Shares\": 461172000.0, \"Diluted EPS\": 5.07, \"Basic EPS\": 5.08, \"Diluted NI Availto Com Stockholders\": 2344000000.0, \"Net Income Common Stockholders\": 2344000000.0, \"Net Income\": 2344000000.0, \"Minority Interests\": 4000000.0, \"Net Income Including Noncontrolling Interests\": 2340000000.0, \"Net Income Continuous Operations\": 2340000000.0, \"Tax Provision\": 596000000.0, \"Pretax Income\": 2936000000.0, \"Other Income Expense\": 1000000.0, \"Other Non Operating Income Expenses\": 36000000.0, \"Special Income Charges\": 12000000.0, \"Gain On Sale Of Ppe\": 0.0, \"Gain On Sale Of Business\": 101000000.0, \"Write Off\": 2000000.0, \"Impairment Of Capital Assets\": 35000000.0, \"Restructuring And Mergern Acquisition\": 52000000.0, \"Gain On Sale Of Security\": -47000000.0, \"Net Non Operating Interest Income Expense\": -134000000.0, \"Interest Expense Non Operating\": 239000000.0, \"Interest Income Non Operating\": 105000000.0, \"Operating Income\": 3069000000.0, \"Operating Expense\": 2914000000.0, \"Depreciation Amortization Depletion Income Statement\": 149000000.0, \"Depreciation And Amortization In Income Statement\": 149000000.0, \"Amortization\": 149000000.0, \"Amortization Of Intangibles Income Statement\": 149000000.0, \"Research And Development\": 614000000.0, \"Selling General And Administration\": 2151000000.0, \"Gross Profit\": 5983000000.0, \"Cost Of Revenue\": 2561000000.0, \"Total Revenue\": 8544000000.0, \"Operating Revenue\": 8544000000.0}",
"year": "2023-12-31"
},
"news": {
"news_date": "2023-11-29",
"news_headlines": [
"The Math Shows VOOV Can Go To $176",
"Validea Detailed Fundamental Analysis - ZTS"
]
},
"price": {
"close": 179.6719512939453,
"close_previous": 173.54136657714844,
"open": 178.43794063945393,
"open_previous": 175.59476195817368,
"previous_date": "2023-11-29",
"price_date": "2023-12-06"
},
"ticker": "ZTS"
} |
You are a seasoned stock market analyst who is trying to predict whether the prices will go down or up over the day, 2023-12-06, for a specific stock, by offering a buy or sell rating.
[Company Name]
Zoetis Inc.
[Company Description]
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
[Price Movement]
It was 179.6719512939453 on 2023-11-29.
The price of the stock on 2023-12-06 started at 178.43794063945393.
[News since 2023-11-29]
The Math Shows VOOV Can Go To $176
Validea Detailed Fundamental Analysis - ZTS
[Financials]
Basic EPS: $5.08
Normalized EBITDA: $3.701000e+09
Net Income: $2.344000e+09
Your answer should look like the following
<think>reasoning about why the stock would go down here.
</think><answer>sell</answer>
or
<think>reasoning about why the stock would go up here.
</think><answer>buy</answer>
Please reason about and provide several reasons for why you think the stock would go up or down in the <think></think> tags. Please provide your answer as a single rating, 'buy' or 'sell', in the <answer></answer> tags, with buy meaning that the stock price will go up,
and sell meaning that the stock price will go down.
|
ZTS | {
"company_info": {
"description": "Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.",
"name": "Zoetis Inc."
},
"current_date": "2023-12-07",
"financials": {
"financials": "{\"Tax Effect Of Unusual Items\": -7105000.0, \"Tax Rate For Calcs\": 0.203, \"Normalized EBITDA\": 3701000000.0, \"Total Unusual Items\": -35000000.0, \"Total Unusual Items Excluding Goodwill\": -35000000.0, \"Net Income From Continuing Operation Net Minority Interest\": 2344000000.0, \"Reconciled Depreciation\": 491000000.0, \"Reconciled Cost Of Revenue\": 2219000000.0, \"EBITDA\": 3666000000.0, \"EBIT\": 3175000000.0, \"Net Interest Income\": -134000000.0, \"Interest Expense\": 239000000.0, \"Interest Income\": 105000000.0, \"Normalized Income\": 2371895000.0, \"Net Income From Continuing And Discontinued Operation\": 2344000000.0, \"Total Expenses\": 5475000000.0, \"Diluted Average Shares\": 462269000.0, \"Basic Average Shares\": 461172000.0, \"Diluted EPS\": 5.07, \"Basic EPS\": 5.08, \"Diluted NI Availto Com Stockholders\": 2344000000.0, \"Net Income Common Stockholders\": 2344000000.0, \"Net Income\": 2344000000.0, \"Minority Interests\": 4000000.0, \"Net Income Including Noncontrolling Interests\": 2340000000.0, \"Net Income Continuous Operations\": 2340000000.0, \"Tax Provision\": 596000000.0, \"Pretax Income\": 2936000000.0, \"Other Income Expense\": 1000000.0, \"Other Non Operating Income Expenses\": 36000000.0, \"Special Income Charges\": 12000000.0, \"Gain On Sale Of Ppe\": 0.0, \"Gain On Sale Of Business\": 101000000.0, \"Write Off\": 2000000.0, \"Impairment Of Capital Assets\": 35000000.0, \"Restructuring And Mergern Acquisition\": 52000000.0, \"Gain On Sale Of Security\": -47000000.0, \"Net Non Operating Interest Income Expense\": -134000000.0, \"Interest Expense Non Operating\": 239000000.0, \"Interest Income Non Operating\": 105000000.0, \"Operating Income\": 3069000000.0, \"Operating Expense\": 2914000000.0, \"Depreciation Amortization Depletion Income Statement\": 149000000.0, \"Depreciation And Amortization In Income Statement\": 149000000.0, \"Amortization\": 149000000.0, \"Amortization Of Intangibles Income Statement\": 149000000.0, \"Research And Development\": 614000000.0, \"Selling General And Administration\": 2151000000.0, \"Gross Profit\": 5983000000.0, \"Cost Of Revenue\": 2561000000.0, \"Total Revenue\": 8544000000.0, \"Operating Revenue\": 8544000000.0}",
"year": "2023-12-31"
},
"news": {
"news_date": "2023-11-30",
"news_headlines": [
"Validea Detailed Fundamental Analysis - ZTS"
]
},
"price": {
"close": 179.50411987304688,
"close_previous": 174.41014099121094,
"open": 180.12606603631016,
"open_previous": 172.80098615805227,
"previous_date": "2023-11-30",
"price_date": "2023-12-07"
},
"ticker": "ZTS"
} |
You are a seasoned stock market analyst who is trying to predict whether the prices will go down or up over the day, 2023-12-07, for a specific stock, by offering a buy or sell rating.
[Company Name]
Zoetis Inc.
[Company Description]
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
[Price Movement]
It was 179.50411987304688 on 2023-11-30.
The price of the stock on 2023-12-07 started at 180.12606603631016.
[News since 2023-11-30]
Validea Detailed Fundamental Analysis - ZTS
[Financials]
Basic EPS: $5.08
Normalized EBITDA: $3.701000e+09
Net Income: $2.344000e+09
Your answer should look like the following
<think>reasoning about why the stock would go down here.
</think><answer>sell</answer>
or
<think>reasoning about why the stock would go up here.
</think><answer>buy</answer>
Please reason about and provide several reasons for why you think the stock would go up or down in the <think></think> tags. Please provide your answer as a single rating, 'buy' or 'sell', in the <answer></answer> tags, with buy meaning that the stock price will go up,
and sell meaning that the stock price will go down.
|
ZTS | {
"company_info": {
"description": "Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.",
"name": "Zoetis Inc."
},
"current_date": "2023-12-08",
"financials": {
"financials": "{\"Tax Effect Of Unusual Items\": -7105000.0, \"Tax Rate For Calcs\": 0.203, \"Normalized EBITDA\": 3701000000.0, \"Total Unusual Items\": -35000000.0, \"Total Unusual Items Excluding Goodwill\": -35000000.0, \"Net Income From Continuing Operation Net Minority Interest\": 2344000000.0, \"Reconciled Depreciation\": 491000000.0, \"Reconciled Cost Of Revenue\": 2219000000.0, \"EBITDA\": 3666000000.0, \"EBIT\": 3175000000.0, \"Net Interest Income\": -134000000.0, \"Interest Expense\": 239000000.0, \"Interest Income\": 105000000.0, \"Normalized Income\": 2371895000.0, \"Net Income From Continuing And Discontinued Operation\": 2344000000.0, \"Total Expenses\": 5475000000.0, \"Diluted Average Shares\": 462269000.0, \"Basic Average Shares\": 461172000.0, \"Diluted EPS\": 5.07, \"Basic EPS\": 5.08, \"Diluted NI Availto Com Stockholders\": 2344000000.0, \"Net Income Common Stockholders\": 2344000000.0, \"Net Income\": 2344000000.0, \"Minority Interests\": 4000000.0, \"Net Income Including Noncontrolling Interests\": 2340000000.0, \"Net Income Continuous Operations\": 2340000000.0, \"Tax Provision\": 596000000.0, \"Pretax Income\": 2936000000.0, \"Other Income Expense\": 1000000.0, \"Other Non Operating Income Expenses\": 36000000.0, \"Special Income Charges\": 12000000.0, \"Gain On Sale Of Ppe\": 0.0, \"Gain On Sale Of Business\": 101000000.0, \"Write Off\": 2000000.0, \"Impairment Of Capital Assets\": 35000000.0, \"Restructuring And Mergern Acquisition\": 52000000.0, \"Gain On Sale Of Security\": -47000000.0, \"Net Non Operating Interest Income Expense\": -134000000.0, \"Interest Expense Non Operating\": 239000000.0, \"Interest Income Non Operating\": 105000000.0, \"Operating Income\": 3069000000.0, \"Operating Expense\": 2914000000.0, \"Depreciation Amortization Depletion Income Statement\": 149000000.0, \"Depreciation And Amortization In Income Statement\": 149000000.0, \"Amortization\": 149000000.0, \"Amortization Of Intangibles Income Statement\": 149000000.0, \"Research And Development\": 614000000.0, \"Selling General And Administration\": 2151000000.0, \"Gross Profit\": 5983000000.0, \"Cost Of Revenue\": 2561000000.0, \"Total Revenue\": 8544000000.0, \"Operating Revenue\": 8544000000.0}",
"year": "2023-12-31"
},
"news": {
"news_date": "2023-12-01",
"news_headlines": [
"Validea Detailed Fundamental Analysis - ZTS",
"GRFS vs. ZTS: Which Stock Is the Better Value Option?"
]
},
"price": {
"close": 182.2386932373047,
"close_previous": 176.83865356445312,
"open": 179.75092362527022,
"open_previous": 173.99548842264008,
"previous_date": "2023-12-01",
"price_date": "2023-12-08"
},
"ticker": "ZTS"
} |
You are a seasoned stock market analyst who is trying to predict whether the prices will go down or up over the day, 2023-12-08, for a specific stock, by offering a buy or sell rating.
[Company Name]
Zoetis Inc.
[Company Description]
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
[Price Movement]
It was 182.2386932373047 on 2023-12-01.
The price of the stock on 2023-12-08 started at 179.75092362527022.
[News since 2023-12-01]
Validea Detailed Fundamental Analysis - ZTS
GRFS vs. ZTS: Which Stock Is the Better Value Option?
[Financials]
Basic EPS: $5.08
Normalized EBITDA: $3.701000e+09
Net Income: $2.344000e+09
Your answer should look like the following
<think>reasoning about why the stock would go down here.
</think><answer>sell</answer>
or
<think>reasoning about why the stock would go up here.
</think><answer>buy</answer>
Please reason about and provide several reasons for why you think the stock would go up or down in the <think></think> tags. Please provide your answer as a single rating, 'buy' or 'sell', in the <answer></answer> tags, with buy meaning that the stock price will go up,
and sell meaning that the stock price will go down.
|
ZTS | {
"company_info": {
"description": "Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.",
"name": "Zoetis Inc."
},
"current_date": "2023-12-11",
"financials": {
"financials": "{\"Tax Effect Of Unusual Items\": -7105000.0, \"Tax Rate For Calcs\": 0.203, \"Normalized EBITDA\": 3701000000.0, \"Total Unusual Items\": -35000000.0, \"Total Unusual Items Excluding Goodwill\": -35000000.0, \"Net Income From Continuing Operation Net Minority Interest\": 2344000000.0, \"Reconciled Depreciation\": 491000000.0, \"Reconciled Cost Of Revenue\": 2219000000.0, \"EBITDA\": 3666000000.0, \"EBIT\": 3175000000.0, \"Net Interest Income\": -134000000.0, \"Interest Expense\": 239000000.0, \"Interest Income\": 105000000.0, \"Normalized Income\": 2371895000.0, \"Net Income From Continuing And Discontinued Operation\": 2344000000.0, \"Total Expenses\": 5475000000.0, \"Diluted Average Shares\": 462269000.0, \"Basic Average Shares\": 461172000.0, \"Diluted EPS\": 5.07, \"Basic EPS\": 5.08, \"Diluted NI Availto Com Stockholders\": 2344000000.0, \"Net Income Common Stockholders\": 2344000000.0, \"Net Income\": 2344000000.0, \"Minority Interests\": 4000000.0, \"Net Income Including Noncontrolling Interests\": 2340000000.0, \"Net Income Continuous Operations\": 2340000000.0, \"Tax Provision\": 596000000.0, \"Pretax Income\": 2936000000.0, \"Other Income Expense\": 1000000.0, \"Other Non Operating Income Expenses\": 36000000.0, \"Special Income Charges\": 12000000.0, \"Gain On Sale Of Ppe\": 0.0, \"Gain On Sale Of Business\": 101000000.0, \"Write Off\": 2000000.0, \"Impairment Of Capital Assets\": 35000000.0, \"Restructuring And Mergern Acquisition\": 52000000.0, \"Gain On Sale Of Security\": -47000000.0, \"Net Non Operating Interest Income Expense\": -134000000.0, \"Interest Expense Non Operating\": 239000000.0, \"Interest Income Non Operating\": 105000000.0, \"Operating Income\": 3069000000.0, \"Operating Expense\": 2914000000.0, \"Depreciation Amortization Depletion Income Statement\": 149000000.0, \"Depreciation And Amortization In Income Statement\": 149000000.0, \"Amortization\": 149000000.0, \"Amortization Of Intangibles Income Statement\": 149000000.0, \"Research And Development\": 614000000.0, \"Selling General And Administration\": 2151000000.0, \"Gross Profit\": 5983000000.0, \"Cost Of Revenue\": 2561000000.0, \"Total Revenue\": 8544000000.0, \"Operating Revenue\": 8544000000.0}",
"year": "2023-12-31"
},
"news": {
"news_date": "2023-12-04",
"news_headlines": [
"Validea Detailed Fundamental Analysis - ZTS",
"GRFS vs. ZTS: Which Stock Is the Better Value Option?",
"Daily Dividend Report: ECL,KDP,LLY,ZTS,MDLZ,VZ",
"Validea's Top Health Care Stocks Based On John Neff - 12/10/2023"
]
},
"price": {
"close": 187.0365447998047,
"close_previous": 179.79042053222656,
"open": 182.80141154228488,
"open_previous": 176.52276256508634,
"previous_date": "2023-12-04",
"price_date": "2023-12-11"
},
"ticker": "ZTS"
} |
You are a seasoned stock market analyst who is trying to predict whether the prices will go down or up over the day, 2023-12-11, for a specific stock, by offering a buy or sell rating.
[Company Name]
Zoetis Inc.
[Company Description]
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
[Price Movement]
It was 187.0365447998047 on 2023-12-04.
The price of the stock on 2023-12-11 started at 182.80141154228488.
[News since 2023-12-04]
Validea Detailed Fundamental Analysis - ZTS
GRFS vs. ZTS: Which Stock Is the Better Value Option?
Daily Dividend Report: ECL,KDP,LLY,ZTS,MDLZ,VZ
Validea's Top Health Care Stocks Based On John Neff - 12/10/2023
[Financials]
Basic EPS: $5.08
Normalized EBITDA: $3.701000e+09
Net Income: $2.344000e+09
Your answer should look like the following
<think>reasoning about why the stock would go down here.
</think><answer>sell</answer>
or
<think>reasoning about why the stock would go up here.
</think><answer>buy</answer>
Please reason about and provide several reasons for why you think the stock would go up or down in the <think></think> tags. Please provide your answer as a single rating, 'buy' or 'sell', in the <answer></answer> tags, with buy meaning that the stock price will go up,
and sell meaning that the stock price will go down.
|
ZTS | {
"company_info": {
"description": "Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.",
"name": "Zoetis Inc."
},
"current_date": "2023-12-12",
"financials": {
"financials": "{\"Tax Effect Of Unusual Items\": -7105000.0, \"Tax Rate For Calcs\": 0.203, \"Normalized EBITDA\": 3701000000.0, \"Total Unusual Items\": -35000000.0, \"Total Unusual Items Excluding Goodwill\": -35000000.0, \"Net Income From Continuing Operation Net Minority Interest\": 2344000000.0, \"Reconciled Depreciation\": 491000000.0, \"Reconciled Cost Of Revenue\": 2219000000.0, \"EBITDA\": 3666000000.0, \"EBIT\": 3175000000.0, \"Net Interest Income\": -134000000.0, \"Interest Expense\": 239000000.0, \"Interest Income\": 105000000.0, \"Normalized Income\": 2371895000.0, \"Net Income From Continuing And Discontinued Operation\": 2344000000.0, \"Total Expenses\": 5475000000.0, \"Diluted Average Shares\": 462269000.0, \"Basic Average Shares\": 461172000.0, \"Diluted EPS\": 5.07, \"Basic EPS\": 5.08, \"Diluted NI Availto Com Stockholders\": 2344000000.0, \"Net Income Common Stockholders\": 2344000000.0, \"Net Income\": 2344000000.0, \"Minority Interests\": 4000000.0, \"Net Income Including Noncontrolling Interests\": 2340000000.0, \"Net Income Continuous Operations\": 2340000000.0, \"Tax Provision\": 596000000.0, \"Pretax Income\": 2936000000.0, \"Other Income Expense\": 1000000.0, \"Other Non Operating Income Expenses\": 36000000.0, \"Special Income Charges\": 12000000.0, \"Gain On Sale Of Ppe\": 0.0, \"Gain On Sale Of Business\": 101000000.0, \"Write Off\": 2000000.0, \"Impairment Of Capital Assets\": 35000000.0, \"Restructuring And Mergern Acquisition\": 52000000.0, \"Gain On Sale Of Security\": -47000000.0, \"Net Non Operating Interest Income Expense\": -134000000.0, \"Interest Expense Non Operating\": 239000000.0, \"Interest Income Non Operating\": 105000000.0, \"Operating Income\": 3069000000.0, \"Operating Expense\": 2914000000.0, \"Depreciation Amortization Depletion Income Statement\": 149000000.0, \"Depreciation And Amortization In Income Statement\": 149000000.0, \"Amortization\": 149000000.0, \"Amortization Of Intangibles Income Statement\": 149000000.0, \"Research And Development\": 614000000.0, \"Selling General And Administration\": 2151000000.0, \"Gross Profit\": 5983000000.0, \"Cost Of Revenue\": 2561000000.0, \"Total Revenue\": 8544000000.0, \"Operating Revenue\": 8544000000.0}",
"year": "2023-12-31"
},
"news": {
"news_date": "2023-12-05",
"news_headlines": [
"GRFS vs. ZTS: Which Stock Is the Better Value Option?",
"Daily Dividend Report: ECL,KDP,LLY,ZTS,MDLZ,VZ",
"Validea's Top Health Care Stocks Based On John Neff - 12/10/2023",
"Zoetis Inc - Class A Shares Close in on 52-Week High - Market Mover",
"4 Stocks to Watch That Recently Declared Dividend Hikes",
"Analysts and Technical Indicators Agree: These 3 Stocks Are “Strong Buys,” Week of 12/11/2023 "
]
},
"price": {
"close": 189.0208282470703,
"close_previous": 177.3520050048828,
"open": 187.64860892174937,
"open_previous": 178.97102637890262,
"previous_date": "2023-12-05",
"price_date": "2023-12-12"
},
"ticker": "ZTS"
} |
You are a seasoned stock market analyst who is trying to predict whether the prices will go down or up over the day, 2023-12-12, for a specific stock, by offering a buy or sell rating.
[Company Name]
Zoetis Inc.
[Company Description]
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
[Price Movement]
It was 189.0208282470703 on 2023-12-05.
The price of the stock on 2023-12-12 started at 187.64860892174937.
[News since 2023-12-05]
GRFS vs. ZTS: Which Stock Is the Better Value Option?
Daily Dividend Report: ECL,KDP,LLY,ZTS,MDLZ,VZ
Validea's Top Health Care Stocks Based On John Neff - 12/10/2023
Zoetis Inc - Class A Shares Close in on 52-Week High - Market Mover
4 Stocks to Watch That Recently Declared Dividend Hikes
Analysts and Technical Indicators Agree: These 3 Stocks Are “Strong Buys,” Week of 12/11/2023
[Financials]
Basic EPS: $5.08
Normalized EBITDA: $3.701000e+09
Net Income: $2.344000e+09
Your answer should look like the following
<think>reasoning about why the stock would go down here.
</think><answer>sell</answer>
or
<think>reasoning about why the stock would go up here.
</think><answer>buy</answer>
Please reason about and provide several reasons for why you think the stock would go up or down in the <think></think> tags. Please provide your answer as a single rating, 'buy' or 'sell', in the <answer></answer> tags, with buy meaning that the stock price will go up,
and sell meaning that the stock price will go down.
|
ZTS | {
"company_info": {
"description": "Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.",
"name": "Zoetis Inc."
},
"current_date": "2023-12-13",
"financials": {
"financials": "{\"Tax Effect Of Unusual Items\": -7105000.0, \"Tax Rate For Calcs\": 0.203, \"Normalized EBITDA\": 3701000000.0, \"Total Unusual Items\": -35000000.0, \"Total Unusual Items Excluding Goodwill\": -35000000.0, \"Net Income From Continuing Operation Net Minority Interest\": 2344000000.0, \"Reconciled Depreciation\": 491000000.0, \"Reconciled Cost Of Revenue\": 2219000000.0, \"EBITDA\": 3666000000.0, \"EBIT\": 3175000000.0, \"Net Interest Income\": -134000000.0, \"Interest Expense\": 239000000.0, \"Interest Income\": 105000000.0, \"Normalized Income\": 2371895000.0, \"Net Income From Continuing And Discontinued Operation\": 2344000000.0, \"Total Expenses\": 5475000000.0, \"Diluted Average Shares\": 462269000.0, \"Basic Average Shares\": 461172000.0, \"Diluted EPS\": 5.07, \"Basic EPS\": 5.08, \"Diluted NI Availto Com Stockholders\": 2344000000.0, \"Net Income Common Stockholders\": 2344000000.0, \"Net Income\": 2344000000.0, \"Minority Interests\": 4000000.0, \"Net Income Including Noncontrolling Interests\": 2340000000.0, \"Net Income Continuous Operations\": 2340000000.0, \"Tax Provision\": 596000000.0, \"Pretax Income\": 2936000000.0, \"Other Income Expense\": 1000000.0, \"Other Non Operating Income Expenses\": 36000000.0, \"Special Income Charges\": 12000000.0, \"Gain On Sale Of Ppe\": 0.0, \"Gain On Sale Of Business\": 101000000.0, \"Write Off\": 2000000.0, \"Impairment Of Capital Assets\": 35000000.0, \"Restructuring And Mergern Acquisition\": 52000000.0, \"Gain On Sale Of Security\": -47000000.0, \"Net Non Operating Interest Income Expense\": -134000000.0, \"Interest Expense Non Operating\": 239000000.0, \"Interest Income Non Operating\": 105000000.0, \"Operating Income\": 3069000000.0, \"Operating Expense\": 2914000000.0, \"Depreciation Amortization Depletion Income Statement\": 149000000.0, \"Depreciation And Amortization In Income Statement\": 149000000.0, \"Amortization\": 149000000.0, \"Amortization Of Intangibles Income Statement\": 149000000.0, \"Research And Development\": 614000000.0, \"Selling General And Administration\": 2151000000.0, \"Gross Profit\": 5983000000.0, \"Cost Of Revenue\": 2561000000.0, \"Total Revenue\": 8544000000.0, \"Operating Revenue\": 8544000000.0}",
"year": "2023-12-31"
},
"news": {
"news_date": "2023-12-06",
"news_headlines": [
"GRFS vs. ZTS: Which Stock Is the Better Value Option?",
"Daily Dividend Report: ECL,KDP,LLY,ZTS,MDLZ,VZ",
"Validea's Top Health Care Stocks Based On John Neff - 12/10/2023",
"Zoetis Inc - Class A Shares Close in on 52-Week High - Market Mover",
"4 Stocks to Watch That Recently Declared Dividend Hikes",
"Analysts and Technical Indicators Agree: These 3 Stocks Are “Strong Buys,” Week of 12/11/2023 ",
"Agree To Buy Zoetis At $140, Earn 4.1% Using Options",
"The Zacks Analyst Blog Highlights Invitation Homes, Choice Hotels International, Zoetis and Owens Corning"
]
},
"price": {
"close": 194.88482666015625,
"close_previous": 179.6719512939453,
"open": 189.32683818272963,
"open_previous": 178.43794063945393,
"previous_date": "2023-12-06",
"price_date": "2023-12-13"
},
"ticker": "ZTS"
} |
You are a seasoned stock market analyst who is trying to predict whether the prices will go down or up over the day, 2023-12-13, for a specific stock, by offering a buy or sell rating.
[Company Name]
Zoetis Inc.
[Company Description]
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
[Price Movement]
It was 194.88482666015625 on 2023-12-06.
The price of the stock on 2023-12-13 started at 189.32683818272963.
[News since 2023-12-06]
GRFS vs. ZTS: Which Stock Is the Better Value Option?
Daily Dividend Report: ECL,KDP,LLY,ZTS,MDLZ,VZ
Validea's Top Health Care Stocks Based On John Neff - 12/10/2023
Zoetis Inc - Class A Shares Close in on 52-Week High - Market Mover
4 Stocks to Watch That Recently Declared Dividend Hikes
Analysts and Technical Indicators Agree: These 3 Stocks Are “Strong Buys,” Week of 12/11/2023
Agree To Buy Zoetis At $140, Earn 4.1% Using Options
The Zacks Analyst Blog Highlights Invitation Homes, Choice Hotels International, Zoetis and Owens Corning
[Financials]
Basic EPS: $5.08
Normalized EBITDA: $3.701000e+09
Net Income: $2.344000e+09
Your answer should look like the following
<think>reasoning about why the stock would go down here.
</think><answer>sell</answer>
or
<think>reasoning about why the stock would go up here.
</think><answer>buy</answer>
Please reason about and provide several reasons for why you think the stock would go up or down in the <think></think> tags. Please provide your answer as a single rating, 'buy' or 'sell', in the <answer></answer> tags, with buy meaning that the stock price will go up,
and sell meaning that the stock price will go down.
|
ZTS | {
"company_info": {
"description": "Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.",
"name": "Zoetis Inc."
},
"current_date": "2023-12-14",
"financials": {
"financials": "{\"Tax Effect Of Unusual Items\": -7105000.0, \"Tax Rate For Calcs\": 0.203, \"Normalized EBITDA\": 3701000000.0, \"Total Unusual Items\": -35000000.0, \"Total Unusual Items Excluding Goodwill\": -35000000.0, \"Net Income From Continuing Operation Net Minority Interest\": 2344000000.0, \"Reconciled Depreciation\": 491000000.0, \"Reconciled Cost Of Revenue\": 2219000000.0, \"EBITDA\": 3666000000.0, \"EBIT\": 3175000000.0, \"Net Interest Income\": -134000000.0, \"Interest Expense\": 239000000.0, \"Interest Income\": 105000000.0, \"Normalized Income\": 2371895000.0, \"Net Income From Continuing And Discontinued Operation\": 2344000000.0, \"Total Expenses\": 5475000000.0, \"Diluted Average Shares\": 462269000.0, \"Basic Average Shares\": 461172000.0, \"Diluted EPS\": 5.07, \"Basic EPS\": 5.08, \"Diluted NI Availto Com Stockholders\": 2344000000.0, \"Net Income Common Stockholders\": 2344000000.0, \"Net Income\": 2344000000.0, \"Minority Interests\": 4000000.0, \"Net Income Including Noncontrolling Interests\": 2340000000.0, \"Net Income Continuous Operations\": 2340000000.0, \"Tax Provision\": 596000000.0, \"Pretax Income\": 2936000000.0, \"Other Income Expense\": 1000000.0, \"Other Non Operating Income Expenses\": 36000000.0, \"Special Income Charges\": 12000000.0, \"Gain On Sale Of Ppe\": 0.0, \"Gain On Sale Of Business\": 101000000.0, \"Write Off\": 2000000.0, \"Impairment Of Capital Assets\": 35000000.0, \"Restructuring And Mergern Acquisition\": 52000000.0, \"Gain On Sale Of Security\": -47000000.0, \"Net Non Operating Interest Income Expense\": -134000000.0, \"Interest Expense Non Operating\": 239000000.0, \"Interest Income Non Operating\": 105000000.0, \"Operating Income\": 3069000000.0, \"Operating Expense\": 2914000000.0, \"Depreciation Amortization Depletion Income Statement\": 149000000.0, \"Depreciation And Amortization In Income Statement\": 149000000.0, \"Amortization\": 149000000.0, \"Amortization Of Intangibles Income Statement\": 149000000.0, \"Research And Development\": 614000000.0, \"Selling General And Administration\": 2151000000.0, \"Gross Profit\": 5983000000.0, \"Cost Of Revenue\": 2561000000.0, \"Total Revenue\": 8544000000.0, \"Operating Revenue\": 8544000000.0}",
"year": "2023-12-31"
},
"news": {
"news_date": "2023-12-07",
"news_headlines": [
"GRFS vs. ZTS: Which Stock Is the Better Value Option?",
"Daily Dividend Report: ECL,KDP,LLY,ZTS,MDLZ,VZ",
"Validea's Top Health Care Stocks Based On John Neff - 12/10/2023",
"Zoetis Inc - Class A Shares Close in on 52-Week High - Market Mover",
"4 Stocks to Watch That Recently Declared Dividend Hikes",
"Analysts and Technical Indicators Agree: These 3 Stocks Are “Strong Buys,” Week of 12/11/2023 ",
"Agree To Buy Zoetis At $140, Earn 4.1% Using Options",
"The Zacks Analyst Blog Highlights Invitation Homes, Choice Hotels International, Zoetis and Owens Corning"
]
},
"price": {
"close": 197.5305633544922,
"close_previous": 179.50411987304688,
"open": 195.46730101460386,
"open_previous": 180.12606603631016,
"previous_date": "2023-12-07",
"price_date": "2023-12-14"
},
"ticker": "ZTS"
} |
You are a seasoned stock market analyst who is trying to predict whether the prices will go down or up over the day, 2023-12-14, for a specific stock, by offering a buy or sell rating.
[Company Name]
Zoetis Inc.
[Company Description]
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
[Price Movement]
It was 197.5305633544922 on 2023-12-07.
The price of the stock on 2023-12-14 started at 195.46730101460386.
[News since 2023-12-07]
GRFS vs. ZTS: Which Stock Is the Better Value Option?
Daily Dividend Report: ECL,KDP,LLY,ZTS,MDLZ,VZ
Validea's Top Health Care Stocks Based On John Neff - 12/10/2023
Zoetis Inc - Class A Shares Close in on 52-Week High - Market Mover
4 Stocks to Watch That Recently Declared Dividend Hikes
Analysts and Technical Indicators Agree: These 3 Stocks Are “Strong Buys,” Week of 12/11/2023
Agree To Buy Zoetis At $140, Earn 4.1% Using Options
The Zacks Analyst Blog Highlights Invitation Homes, Choice Hotels International, Zoetis and Owens Corning
[Financials]
Basic EPS: $5.08
Normalized EBITDA: $3.701000e+09
Net Income: $2.344000e+09
Your answer should look like the following
<think>reasoning about why the stock would go down here.
</think><answer>sell</answer>
or
<think>reasoning about why the stock would go up here.
</think><answer>buy</answer>
Please reason about and provide several reasons for why you think the stock would go up or down in the <think></think> tags. Please provide your answer as a single rating, 'buy' or 'sell', in the <answer></answer> tags, with buy meaning that the stock price will go up,
and sell meaning that the stock price will go down.
|
ZTS | {
"company_info": {
"description": "Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.",
"name": "Zoetis Inc."
},
"current_date": "2023-12-15",
"financials": {
"financials": "{\"Tax Effect Of Unusual Items\": -7105000.0, \"Tax Rate For Calcs\": 0.203, \"Normalized EBITDA\": 3701000000.0, \"Total Unusual Items\": -35000000.0, \"Total Unusual Items Excluding Goodwill\": -35000000.0, \"Net Income From Continuing Operation Net Minority Interest\": 2344000000.0, \"Reconciled Depreciation\": 491000000.0, \"Reconciled Cost Of Revenue\": 2219000000.0, \"EBITDA\": 3666000000.0, \"EBIT\": 3175000000.0, \"Net Interest Income\": -134000000.0, \"Interest Expense\": 239000000.0, \"Interest Income\": 105000000.0, \"Normalized Income\": 2371895000.0, \"Net Income From Continuing And Discontinued Operation\": 2344000000.0, \"Total Expenses\": 5475000000.0, \"Diluted Average Shares\": 462269000.0, \"Basic Average Shares\": 461172000.0, \"Diluted EPS\": 5.07, \"Basic EPS\": 5.08, \"Diluted NI Availto Com Stockholders\": 2344000000.0, \"Net Income Common Stockholders\": 2344000000.0, \"Net Income\": 2344000000.0, \"Minority Interests\": 4000000.0, \"Net Income Including Noncontrolling Interests\": 2340000000.0, \"Net Income Continuous Operations\": 2340000000.0, \"Tax Provision\": 596000000.0, \"Pretax Income\": 2936000000.0, \"Other Income Expense\": 1000000.0, \"Other Non Operating Income Expenses\": 36000000.0, \"Special Income Charges\": 12000000.0, \"Gain On Sale Of Ppe\": 0.0, \"Gain On Sale Of Business\": 101000000.0, \"Write Off\": 2000000.0, \"Impairment Of Capital Assets\": 35000000.0, \"Restructuring And Mergern Acquisition\": 52000000.0, \"Gain On Sale Of Security\": -47000000.0, \"Net Non Operating Interest Income Expense\": -134000000.0, \"Interest Expense Non Operating\": 239000000.0, \"Interest Income Non Operating\": 105000000.0, \"Operating Income\": 3069000000.0, \"Operating Expense\": 2914000000.0, \"Depreciation Amortization Depletion Income Statement\": 149000000.0, \"Depreciation And Amortization In Income Statement\": 149000000.0, \"Amortization\": 149000000.0, \"Amortization Of Intangibles Income Statement\": 149000000.0, \"Research And Development\": 614000000.0, \"Selling General And Administration\": 2151000000.0, \"Gross Profit\": 5983000000.0, \"Cost Of Revenue\": 2561000000.0, \"Total Revenue\": 8544000000.0, \"Operating Revenue\": 8544000000.0}",
"year": "2023-12-31"
},
"news": {
"news_date": "2023-12-08",
"news_headlines": [
"Daily Dividend Report: ECL,KDP,LLY,ZTS,MDLZ,VZ",
"Validea's Top Health Care Stocks Based On John Neff - 12/10/2023",
"Zoetis Inc - Class A Shares Close in on 52-Week High - Market Mover",
"4 Stocks to Watch That Recently Declared Dividend Hikes",
"Analysts and Technical Indicators Agree: These 3 Stocks Are “Strong Buys,” Week of 12/11/2023 ",
"Agree To Buy Zoetis At $140, Earn 4.1% Using Options",
"The Zacks Analyst Blog Highlights Invitation Homes, Choice Hotels International, Zoetis and Owens Corning"
]
},
"price": {
"close": 193.77915954589844,
"close_previous": 182.2386932373047,
"open": 196.85926046347248,
"open_previous": 179.75092362527022,
"previous_date": "2023-12-08",
"price_date": "2023-12-15"
},
"ticker": "ZTS"
} |
You are a seasoned stock market analyst who is trying to predict whether the prices will go down or up over the day, 2023-12-15, for a specific stock, by offering a buy or sell rating.
[Company Name]
Zoetis Inc.
[Company Description]
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
[Price Movement]
It was 193.77915954589844 on 2023-12-08.
The price of the stock on 2023-12-15 started at 196.85926046347248.
[News since 2023-12-08]
Daily Dividend Report: ECL,KDP,LLY,ZTS,MDLZ,VZ
Validea's Top Health Care Stocks Based On John Neff - 12/10/2023
Zoetis Inc - Class A Shares Close in on 52-Week High - Market Mover
4 Stocks to Watch That Recently Declared Dividend Hikes
Analysts and Technical Indicators Agree: These 3 Stocks Are “Strong Buys,” Week of 12/11/2023
Agree To Buy Zoetis At $140, Earn 4.1% Using Options
The Zacks Analyst Blog Highlights Invitation Homes, Choice Hotels International, Zoetis and Owens Corning
[Financials]
Basic EPS: $5.08
Normalized EBITDA: $3.701000e+09
Net Income: $2.344000e+09
Your answer should look like the following
<think>reasoning about why the stock would go down here.
</think><answer>sell</answer>
or
<think>reasoning about why the stock would go up here.
</think><answer>buy</answer>
Please reason about and provide several reasons for why you think the stock would go up or down in the <think></think> tags. Please provide your answer as a single rating, 'buy' or 'sell', in the <answer></answer> tags, with buy meaning that the stock price will go up,
and sell meaning that the stock price will go down.
|
ZTS | {
"company_info": {
"description": "Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.",
"name": "Zoetis Inc."
},
"current_date": "2023-12-18",
"financials": {
"financials": "{\"Tax Effect Of Unusual Items\": -7105000.0, \"Tax Rate For Calcs\": 0.203, \"Normalized EBITDA\": 3701000000.0, \"Total Unusual Items\": -35000000.0, \"Total Unusual Items Excluding Goodwill\": -35000000.0, \"Net Income From Continuing Operation Net Minority Interest\": 2344000000.0, \"Reconciled Depreciation\": 491000000.0, \"Reconciled Cost Of Revenue\": 2219000000.0, \"EBITDA\": 3666000000.0, \"EBIT\": 3175000000.0, \"Net Interest Income\": -134000000.0, \"Interest Expense\": 239000000.0, \"Interest Income\": 105000000.0, \"Normalized Income\": 2371895000.0, \"Net Income From Continuing And Discontinued Operation\": 2344000000.0, \"Total Expenses\": 5475000000.0, \"Diluted Average Shares\": 462269000.0, \"Basic Average Shares\": 461172000.0, \"Diluted EPS\": 5.07, \"Basic EPS\": 5.08, \"Diluted NI Availto Com Stockholders\": 2344000000.0, \"Net Income Common Stockholders\": 2344000000.0, \"Net Income\": 2344000000.0, \"Minority Interests\": 4000000.0, \"Net Income Including Noncontrolling Interests\": 2340000000.0, \"Net Income Continuous Operations\": 2340000000.0, \"Tax Provision\": 596000000.0, \"Pretax Income\": 2936000000.0, \"Other Income Expense\": 1000000.0, \"Other Non Operating Income Expenses\": 36000000.0, \"Special Income Charges\": 12000000.0, \"Gain On Sale Of Ppe\": 0.0, \"Gain On Sale Of Business\": 101000000.0, \"Write Off\": 2000000.0, \"Impairment Of Capital Assets\": 35000000.0, \"Restructuring And Mergern Acquisition\": 52000000.0, \"Gain On Sale Of Security\": -47000000.0, \"Net Non Operating Interest Income Expense\": -134000000.0, \"Interest Expense Non Operating\": 239000000.0, \"Interest Income Non Operating\": 105000000.0, \"Operating Income\": 3069000000.0, \"Operating Expense\": 2914000000.0, \"Depreciation Amortization Depletion Income Statement\": 149000000.0, \"Depreciation And Amortization In Income Statement\": 149000000.0, \"Amortization\": 149000000.0, \"Amortization Of Intangibles Income Statement\": 149000000.0, \"Research And Development\": 614000000.0, \"Selling General And Administration\": 2151000000.0, \"Gross Profit\": 5983000000.0, \"Cost Of Revenue\": 2561000000.0, \"Total Revenue\": 8544000000.0, \"Operating Revenue\": 8544000000.0}",
"year": "2023-12-31"
},
"news": {
"news_date": "2023-12-11",
"news_headlines": [
"Zoetis Inc - Class A Shares Close in on 52-Week High - Market Mover",
"4 Stocks to Watch That Recently Declared Dividend Hikes",
"Analysts and Technical Indicators Agree: These 3 Stocks Are “Strong Buys,” Week of 12/11/2023 ",
"Agree To Buy Zoetis At $140, Earn 4.1% Using Options",
"The Zacks Analyst Blog Highlights Invitation Homes, Choice Hotels International, Zoetis and Owens Corning"
]
},
"price": {
"close": 194.20364379882812,
"close_previous": 187.0365447998047,
"open": 195.27969737361562,
"open_previous": 182.80141154228488,
"previous_date": "2023-12-11",
"price_date": "2023-12-18"
},
"ticker": "ZTS"
} |
You are a seasoned stock market analyst who is trying to predict whether the prices will go down or up over the day, 2023-12-18, for a specific stock, by offering a buy or sell rating.
[Company Name]
Zoetis Inc.
[Company Description]
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
[Price Movement]
It was 194.20364379882812 on 2023-12-11.
The price of the stock on 2023-12-18 started at 195.27969737361562.
[News since 2023-12-11]
Zoetis Inc - Class A Shares Close in on 52-Week High - Market Mover
4 Stocks to Watch That Recently Declared Dividend Hikes
Analysts and Technical Indicators Agree: These 3 Stocks Are “Strong Buys,” Week of 12/11/2023
Agree To Buy Zoetis At $140, Earn 4.1% Using Options
The Zacks Analyst Blog Highlights Invitation Homes, Choice Hotels International, Zoetis and Owens Corning
[Financials]
Basic EPS: $5.08
Normalized EBITDA: $3.701000e+09
Net Income: $2.344000e+09
Your answer should look like the following
<think>reasoning about why the stock would go down here.
</think><answer>sell</answer>
or
<think>reasoning about why the stock would go up here.
</think><answer>buy</answer>
Please reason about and provide several reasons for why you think the stock would go up or down in the <think></think> tags. Please provide your answer as a single rating, 'buy' or 'sell', in the <answer></answer> tags, with buy meaning that the stock price will go up,
and sell meaning that the stock price will go down.
|
ZTS | {
"company_info": {
"description": "Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.",
"name": "Zoetis Inc."
},
"current_date": "2023-12-19",
"financials": {
"financials": "{\"Tax Effect Of Unusual Items\": -7105000.0, \"Tax Rate For Calcs\": 0.203, \"Normalized EBITDA\": 3701000000.0, \"Total Unusual Items\": -35000000.0, \"Total Unusual Items Excluding Goodwill\": -35000000.0, \"Net Income From Continuing Operation Net Minority Interest\": 2344000000.0, \"Reconciled Depreciation\": 491000000.0, \"Reconciled Cost Of Revenue\": 2219000000.0, \"EBITDA\": 3666000000.0, \"EBIT\": 3175000000.0, \"Net Interest Income\": -134000000.0, \"Interest Expense\": 239000000.0, \"Interest Income\": 105000000.0, \"Normalized Income\": 2371895000.0, \"Net Income From Continuing And Discontinued Operation\": 2344000000.0, \"Total Expenses\": 5475000000.0, \"Diluted Average Shares\": 462269000.0, \"Basic Average Shares\": 461172000.0, \"Diluted EPS\": 5.07, \"Basic EPS\": 5.08, \"Diluted NI Availto Com Stockholders\": 2344000000.0, \"Net Income Common Stockholders\": 2344000000.0, \"Net Income\": 2344000000.0, \"Minority Interests\": 4000000.0, \"Net Income Including Noncontrolling Interests\": 2340000000.0, \"Net Income Continuous Operations\": 2340000000.0, \"Tax Provision\": 596000000.0, \"Pretax Income\": 2936000000.0, \"Other Income Expense\": 1000000.0, \"Other Non Operating Income Expenses\": 36000000.0, \"Special Income Charges\": 12000000.0, \"Gain On Sale Of Ppe\": 0.0, \"Gain On Sale Of Business\": 101000000.0, \"Write Off\": 2000000.0, \"Impairment Of Capital Assets\": 35000000.0, \"Restructuring And Mergern Acquisition\": 52000000.0, \"Gain On Sale Of Security\": -47000000.0, \"Net Non Operating Interest Income Expense\": -134000000.0, \"Interest Expense Non Operating\": 239000000.0, \"Interest Income Non Operating\": 105000000.0, \"Operating Income\": 3069000000.0, \"Operating Expense\": 2914000000.0, \"Depreciation Amortization Depletion Income Statement\": 149000000.0, \"Depreciation And Amortization In Income Statement\": 149000000.0, \"Amortization\": 149000000.0, \"Amortization Of Intangibles Income Statement\": 149000000.0, \"Research And Development\": 614000000.0, \"Selling General And Administration\": 2151000000.0, \"Gross Profit\": 5983000000.0, \"Cost Of Revenue\": 2561000000.0, \"Total Revenue\": 8544000000.0, \"Operating Revenue\": 8544000000.0}",
"year": "2023-12-31"
},
"news": {
"news_date": "2023-12-12",
"news_headlines": [
"Agree To Buy Zoetis At $140, Earn 4.1% Using Options",
"The Zacks Analyst Blog Highlights Invitation Homes, Choice Hotels International, Zoetis and Owens Corning"
]
},
"price": {
"close": 195.54627990722656,
"close_previous": 189.0208282470703,
"open": 195.25011431660784,
"open_previous": 187.64860892174937,
"previous_date": "2023-12-12",
"price_date": "2023-12-19"
},
"ticker": "ZTS"
} |
You are a seasoned stock market analyst who is trying to predict whether the prices will go down or up over the day, 2023-12-19, for a specific stock, by offering a buy or sell rating.
[Company Name]
Zoetis Inc.
[Company Description]
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
[Price Movement]
It was 195.54627990722656 on 2023-12-12.
The price of the stock on 2023-12-19 started at 195.25011431660784.
[News since 2023-12-12]
Agree To Buy Zoetis At $140, Earn 4.1% Using Options
The Zacks Analyst Blog Highlights Invitation Homes, Choice Hotels International, Zoetis and Owens Corning
[Financials]
Basic EPS: $5.08
Normalized EBITDA: $3.701000e+09
Net Income: $2.344000e+09
Your answer should look like the following
<think>reasoning about why the stock would go down here.
</think><answer>sell</answer>
or
<think>reasoning about why the stock would go up here.
</think><answer>buy</answer>
Please reason about and provide several reasons for why you think the stock would go up or down in the <think></think> tags. Please provide your answer as a single rating, 'buy' or 'sell', in the <answer></answer> tags, with buy meaning that the stock price will go up,
and sell meaning that the stock price will go down.
|
ZTS | {
"company_info": {
"description": "Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.",
"name": "Zoetis Inc."
},
"current_date": "2023-12-20",
"financials": {
"financials": "{\"Tax Effect Of Unusual Items\": -7105000.0, \"Tax Rate For Calcs\": 0.203, \"Normalized EBITDA\": 3701000000.0, \"Total Unusual Items\": -35000000.0, \"Total Unusual Items Excluding Goodwill\": -35000000.0, \"Net Income From Continuing Operation Net Minority Interest\": 2344000000.0, \"Reconciled Depreciation\": 491000000.0, \"Reconciled Cost Of Revenue\": 2219000000.0, \"EBITDA\": 3666000000.0, \"EBIT\": 3175000000.0, \"Net Interest Income\": -134000000.0, \"Interest Expense\": 239000000.0, \"Interest Income\": 105000000.0, \"Normalized Income\": 2371895000.0, \"Net Income From Continuing And Discontinued Operation\": 2344000000.0, \"Total Expenses\": 5475000000.0, \"Diluted Average Shares\": 462269000.0, \"Basic Average Shares\": 461172000.0, \"Diluted EPS\": 5.07, \"Basic EPS\": 5.08, \"Diluted NI Availto Com Stockholders\": 2344000000.0, \"Net Income Common Stockholders\": 2344000000.0, \"Net Income\": 2344000000.0, \"Minority Interests\": 4000000.0, \"Net Income Including Noncontrolling Interests\": 2340000000.0, \"Net Income Continuous Operations\": 2340000000.0, \"Tax Provision\": 596000000.0, \"Pretax Income\": 2936000000.0, \"Other Income Expense\": 1000000.0, \"Other Non Operating Income Expenses\": 36000000.0, \"Special Income Charges\": 12000000.0, \"Gain On Sale Of Ppe\": 0.0, \"Gain On Sale Of Business\": 101000000.0, \"Write Off\": 2000000.0, \"Impairment Of Capital Assets\": 35000000.0, \"Restructuring And Mergern Acquisition\": 52000000.0, \"Gain On Sale Of Security\": -47000000.0, \"Net Non Operating Interest Income Expense\": -134000000.0, \"Interest Expense Non Operating\": 239000000.0, \"Interest Income Non Operating\": 105000000.0, \"Operating Income\": 3069000000.0, \"Operating Expense\": 2914000000.0, \"Depreciation Amortization Depletion Income Statement\": 149000000.0, \"Depreciation And Amortization In Income Statement\": 149000000.0, \"Amortization\": 149000000.0, \"Amortization Of Intangibles Income Statement\": 149000000.0, \"Research And Development\": 614000000.0, \"Selling General And Administration\": 2151000000.0, \"Gross Profit\": 5983000000.0, \"Cost Of Revenue\": 2561000000.0, \"Total Revenue\": 8544000000.0, \"Operating Revenue\": 8544000000.0}",
"year": "2023-12-31"
},
"news": {
"news_date": "2023-12-13",
"news_headlines": []
},
"price": {
"close": 192.14041137695312,
"close_previous": 194.88482666015625,
"open": 195.46729948212786,
"open_previous": 189.32683818272963,
"previous_date": "2023-12-13",
"price_date": "2023-12-20"
},
"ticker": "ZTS"
} |
You are a seasoned stock market analyst who is trying to predict whether the prices will go down or up over the day, 2023-12-20, for a specific stock, by offering a buy or sell rating.
[Company Name]
Zoetis Inc.
[Company Description]
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
[Price Movement]
It was 192.14041137695312 on 2023-12-13.
The price of the stock on 2023-12-20 started at 195.46729948212786.
[News since 2023-12-13]
[Financials]
Basic EPS: $5.08
Normalized EBITDA: $3.701000e+09
Net Income: $2.344000e+09
Your answer should look like the following
<think>reasoning about why the stock would go down here.
</think><answer>sell</answer>
or
<think>reasoning about why the stock would go up here.
</think><answer>buy</answer>
Please reason about and provide several reasons for why you think the stock would go up or down in the <think></think> tags. Please provide your answer as a single rating, 'buy' or 'sell', in the <answer></answer> tags, with buy meaning that the stock price will go up,
and sell meaning that the stock price will go down.
|
ZTS | {
"company_info": {
"description": "Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.",
"name": "Zoetis Inc."
},
"current_date": "2023-12-21",
"financials": {
"financials": "{\"Tax Effect Of Unusual Items\": -7105000.0, \"Tax Rate For Calcs\": 0.203, \"Normalized EBITDA\": 3701000000.0, \"Total Unusual Items\": -35000000.0, \"Total Unusual Items Excluding Goodwill\": -35000000.0, \"Net Income From Continuing Operation Net Minority Interest\": 2344000000.0, \"Reconciled Depreciation\": 491000000.0, \"Reconciled Cost Of Revenue\": 2219000000.0, \"EBITDA\": 3666000000.0, \"EBIT\": 3175000000.0, \"Net Interest Income\": -134000000.0, \"Interest Expense\": 239000000.0, \"Interest Income\": 105000000.0, \"Normalized Income\": 2371895000.0, \"Net Income From Continuing And Discontinued Operation\": 2344000000.0, \"Total Expenses\": 5475000000.0, \"Diluted Average Shares\": 462269000.0, \"Basic Average Shares\": 461172000.0, \"Diluted EPS\": 5.07, \"Basic EPS\": 5.08, \"Diluted NI Availto Com Stockholders\": 2344000000.0, \"Net Income Common Stockholders\": 2344000000.0, \"Net Income\": 2344000000.0, \"Minority Interests\": 4000000.0, \"Net Income Including Noncontrolling Interests\": 2340000000.0, \"Net Income Continuous Operations\": 2340000000.0, \"Tax Provision\": 596000000.0, \"Pretax Income\": 2936000000.0, \"Other Income Expense\": 1000000.0, \"Other Non Operating Income Expenses\": 36000000.0, \"Special Income Charges\": 12000000.0, \"Gain On Sale Of Ppe\": 0.0, \"Gain On Sale Of Business\": 101000000.0, \"Write Off\": 2000000.0, \"Impairment Of Capital Assets\": 35000000.0, \"Restructuring And Mergern Acquisition\": 52000000.0, \"Gain On Sale Of Security\": -47000000.0, \"Net Non Operating Interest Income Expense\": -134000000.0, \"Interest Expense Non Operating\": 239000000.0, \"Interest Income Non Operating\": 105000000.0, \"Operating Income\": 3069000000.0, \"Operating Expense\": 2914000000.0, \"Depreciation Amortization Depletion Income Statement\": 149000000.0, \"Depreciation And Amortization In Income Statement\": 149000000.0, \"Amortization\": 149000000.0, \"Amortization Of Intangibles Income Statement\": 149000000.0, \"Research And Development\": 614000000.0, \"Selling General And Administration\": 2151000000.0, \"Gross Profit\": 5983000000.0, \"Cost Of Revenue\": 2561000000.0, \"Total Revenue\": 8544000000.0, \"Operating Revenue\": 8544000000.0}",
"year": "2023-12-31"
},
"news": {
"news_date": "2023-12-14",
"news_headlines": []
},
"price": {
"close": 192.1699981689453,
"close_previous": 197.5305633544922,
"open": 193.49285386068678,
"open_previous": 195.46730101460386,
"previous_date": "2023-12-14",
"price_date": "2023-12-21"
},
"ticker": "ZTS"
} |
You are a seasoned stock market analyst who is trying to predict whether the prices will go down or up over the day, 2023-12-21, for a specific stock, by offering a buy or sell rating.
[Company Name]
Zoetis Inc.
[Company Description]
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
[Price Movement]
It was 192.1699981689453 on 2023-12-14.
The price of the stock on 2023-12-21 started at 193.49285386068678.
[News since 2023-12-14]
[Financials]
Basic EPS: $5.08
Normalized EBITDA: $3.701000e+09
Net Income: $2.344000e+09
Your answer should look like the following
<think>reasoning about why the stock would go down here.
</think><answer>sell</answer>
or
<think>reasoning about why the stock would go up here.
</think><answer>buy</answer>
Please reason about and provide several reasons for why you think the stock would go up or down in the <think></think> tags. Please provide your answer as a single rating, 'buy' or 'sell', in the <answer></answer> tags, with buy meaning that the stock price will go up,
and sell meaning that the stock price will go down.
|
ZTS | {
"company_info": {
"description": "Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.",
"name": "Zoetis Inc."
},
"current_date": "2023-12-22",
"financials": {
"financials": "{\"Tax Effect Of Unusual Items\": -7105000.0, \"Tax Rate For Calcs\": 0.203, \"Normalized EBITDA\": 3701000000.0, \"Total Unusual Items\": -35000000.0, \"Total Unusual Items Excluding Goodwill\": -35000000.0, \"Net Income From Continuing Operation Net Minority Interest\": 2344000000.0, \"Reconciled Depreciation\": 491000000.0, \"Reconciled Cost Of Revenue\": 2219000000.0, \"EBITDA\": 3666000000.0, \"EBIT\": 3175000000.0, \"Net Interest Income\": -134000000.0, \"Interest Expense\": 239000000.0, \"Interest Income\": 105000000.0, \"Normalized Income\": 2371895000.0, \"Net Income From Continuing And Discontinued Operation\": 2344000000.0, \"Total Expenses\": 5475000000.0, \"Diluted Average Shares\": 462269000.0, \"Basic Average Shares\": 461172000.0, \"Diluted EPS\": 5.07, \"Basic EPS\": 5.08, \"Diluted NI Availto Com Stockholders\": 2344000000.0, \"Net Income Common Stockholders\": 2344000000.0, \"Net Income\": 2344000000.0, \"Minority Interests\": 4000000.0, \"Net Income Including Noncontrolling Interests\": 2340000000.0, \"Net Income Continuous Operations\": 2340000000.0, \"Tax Provision\": 596000000.0, \"Pretax Income\": 2936000000.0, \"Other Income Expense\": 1000000.0, \"Other Non Operating Income Expenses\": 36000000.0, \"Special Income Charges\": 12000000.0, \"Gain On Sale Of Ppe\": 0.0, \"Gain On Sale Of Business\": 101000000.0, \"Write Off\": 2000000.0, \"Impairment Of Capital Assets\": 35000000.0, \"Restructuring And Mergern Acquisition\": 52000000.0, \"Gain On Sale Of Security\": -47000000.0, \"Net Non Operating Interest Income Expense\": -134000000.0, \"Interest Expense Non Operating\": 239000000.0, \"Interest Income Non Operating\": 105000000.0, \"Operating Income\": 3069000000.0, \"Operating Expense\": 2914000000.0, \"Depreciation Amortization Depletion Income Statement\": 149000000.0, \"Depreciation And Amortization In Income Statement\": 149000000.0, \"Amortization\": 149000000.0, \"Amortization Of Intangibles Income Statement\": 149000000.0, \"Research And Development\": 614000000.0, \"Selling General And Administration\": 2151000000.0, \"Gross Profit\": 5983000000.0, \"Cost Of Revenue\": 2561000000.0, \"Total Revenue\": 8544000000.0, \"Operating Revenue\": 8544000000.0}",
"year": "2023-12-31"
},
"news": {
"news_date": "2023-12-15",
"news_headlines": []
},
"price": {
"close": 192.4859161376953,
"close_previous": 193.77915954589844,
"open": 192.82157848828734,
"open_previous": 196.85926046347248,
"previous_date": "2023-12-15",
"price_date": "2023-12-22"
},
"ticker": "ZTS"
} |
You are a seasoned stock market analyst who is trying to predict whether the prices will go down or up over the day, 2023-12-22, for a specific stock, by offering a buy or sell rating.
[Company Name]
Zoetis Inc.
[Company Description]
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
[Price Movement]
It was 192.4859161376953 on 2023-12-15.
The price of the stock on 2023-12-22 started at 192.82157848828734.
[News since 2023-12-15]
[Financials]
Basic EPS: $5.08
Normalized EBITDA: $3.701000e+09
Net Income: $2.344000e+09
Your answer should look like the following
<think>reasoning about why the stock would go down here.
</think><answer>sell</answer>
or
<think>reasoning about why the stock would go up here.
</think><answer>buy</answer>
Please reason about and provide several reasons for why you think the stock would go up or down in the <think></think> tags. Please provide your answer as a single rating, 'buy' or 'sell', in the <answer></answer> tags, with buy meaning that the stock price will go up,
and sell meaning that the stock price will go down.
|
ZTS | {
"company_info": {
"description": "Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.",
"name": "Zoetis Inc."
},
"current_date": "2023-12-26",
"financials": {
"financials": "{\"Tax Effect Of Unusual Items\": -7105000.0, \"Tax Rate For Calcs\": 0.203, \"Normalized EBITDA\": 3701000000.0, \"Total Unusual Items\": -35000000.0, \"Total Unusual Items Excluding Goodwill\": -35000000.0, \"Net Income From Continuing Operation Net Minority Interest\": 2344000000.0, \"Reconciled Depreciation\": 491000000.0, \"Reconciled Cost Of Revenue\": 2219000000.0, \"EBITDA\": 3666000000.0, \"EBIT\": 3175000000.0, \"Net Interest Income\": -134000000.0, \"Interest Expense\": 239000000.0, \"Interest Income\": 105000000.0, \"Normalized Income\": 2371895000.0, \"Net Income From Continuing And Discontinued Operation\": 2344000000.0, \"Total Expenses\": 5475000000.0, \"Diluted Average Shares\": 462269000.0, \"Basic Average Shares\": 461172000.0, \"Diluted EPS\": 5.07, \"Basic EPS\": 5.08, \"Diluted NI Availto Com Stockholders\": 2344000000.0, \"Net Income Common Stockholders\": 2344000000.0, \"Net Income\": 2344000000.0, \"Minority Interests\": 4000000.0, \"Net Income Including Noncontrolling Interests\": 2340000000.0, \"Net Income Continuous Operations\": 2340000000.0, \"Tax Provision\": 596000000.0, \"Pretax Income\": 2936000000.0, \"Other Income Expense\": 1000000.0, \"Other Non Operating Income Expenses\": 36000000.0, \"Special Income Charges\": 12000000.0, \"Gain On Sale Of Ppe\": 0.0, \"Gain On Sale Of Business\": 101000000.0, \"Write Off\": 2000000.0, \"Impairment Of Capital Assets\": 35000000.0, \"Restructuring And Mergern Acquisition\": 52000000.0, \"Gain On Sale Of Security\": -47000000.0, \"Net Non Operating Interest Income Expense\": -134000000.0, \"Interest Expense Non Operating\": 239000000.0, \"Interest Income Non Operating\": 105000000.0, \"Operating Income\": 3069000000.0, \"Operating Expense\": 2914000000.0, \"Depreciation Amortization Depletion Income Statement\": 149000000.0, \"Depreciation And Amortization In Income Statement\": 149000000.0, \"Amortization\": 149000000.0, \"Amortization Of Intangibles Income Statement\": 149000000.0, \"Research And Development\": 614000000.0, \"Selling General And Administration\": 2151000000.0, \"Gross Profit\": 5983000000.0, \"Cost Of Revenue\": 2561000000.0, \"Total Revenue\": 8544000000.0, \"Operating Revenue\": 8544000000.0}",
"year": "2023-12-31"
},
"news": {
"news_date": "2023-12-19",
"news_headlines": []
},
"price": {
"close": 192.999267578125,
"close_previous": 195.54627990722656,
"open": 192.38720310999608,
"open_previous": 195.25011431660784,
"previous_date": "2023-12-19",
"price_date": "2023-12-26"
},
"ticker": "ZTS"
} |
You are a seasoned stock market analyst who is trying to predict whether the prices will go down or up over the day, 2023-12-26, for a specific stock, by offering a buy or sell rating.
[Company Name]
Zoetis Inc.
[Company Description]
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
[Price Movement]
It was 192.999267578125 on 2023-12-19.
The price of the stock on 2023-12-26 started at 192.38720310999608.
[News since 2023-12-19]
[Financials]
Basic EPS: $5.08
Normalized EBITDA: $3.701000e+09
Net Income: $2.344000e+09
Your answer should look like the following
<think>reasoning about why the stock would go down here.
</think><answer>sell</answer>
or
<think>reasoning about why the stock would go up here.
</think><answer>buy</answer>
Please reason about and provide several reasons for why you think the stock would go up or down in the <think></think> tags. Please provide your answer as a single rating, 'buy' or 'sell', in the <answer></answer> tags, with buy meaning that the stock price will go up,
and sell meaning that the stock price will go down.
|
ZTS | {
"company_info": {
"description": "Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.",
"name": "Zoetis Inc."
},
"current_date": "2023-12-27",
"financials": {
"financials": "{\"Tax Effect Of Unusual Items\": -7105000.0, \"Tax Rate For Calcs\": 0.203, \"Normalized EBITDA\": 3701000000.0, \"Total Unusual Items\": -35000000.0, \"Total Unusual Items Excluding Goodwill\": -35000000.0, \"Net Income From Continuing Operation Net Minority Interest\": 2344000000.0, \"Reconciled Depreciation\": 491000000.0, \"Reconciled Cost Of Revenue\": 2219000000.0, \"EBITDA\": 3666000000.0, \"EBIT\": 3175000000.0, \"Net Interest Income\": -134000000.0, \"Interest Expense\": 239000000.0, \"Interest Income\": 105000000.0, \"Normalized Income\": 2371895000.0, \"Net Income From Continuing And Discontinued Operation\": 2344000000.0, \"Total Expenses\": 5475000000.0, \"Diluted Average Shares\": 462269000.0, \"Basic Average Shares\": 461172000.0, \"Diluted EPS\": 5.07, \"Basic EPS\": 5.08, \"Diluted NI Availto Com Stockholders\": 2344000000.0, \"Net Income Common Stockholders\": 2344000000.0, \"Net Income\": 2344000000.0, \"Minority Interests\": 4000000.0, \"Net Income Including Noncontrolling Interests\": 2340000000.0, \"Net Income Continuous Operations\": 2340000000.0, \"Tax Provision\": 596000000.0, \"Pretax Income\": 2936000000.0, \"Other Income Expense\": 1000000.0, \"Other Non Operating Income Expenses\": 36000000.0, \"Special Income Charges\": 12000000.0, \"Gain On Sale Of Ppe\": 0.0, \"Gain On Sale Of Business\": 101000000.0, \"Write Off\": 2000000.0, \"Impairment Of Capital Assets\": 35000000.0, \"Restructuring And Mergern Acquisition\": 52000000.0, \"Gain On Sale Of Security\": -47000000.0, \"Net Non Operating Interest Income Expense\": -134000000.0, \"Interest Expense Non Operating\": 239000000.0, \"Interest Income Non Operating\": 105000000.0, \"Operating Income\": 3069000000.0, \"Operating Expense\": 2914000000.0, \"Depreciation Amortization Depletion Income Statement\": 149000000.0, \"Depreciation And Amortization In Income Statement\": 149000000.0, \"Amortization\": 149000000.0, \"Amortization Of Intangibles Income Statement\": 149000000.0, \"Research And Development\": 614000000.0, \"Selling General And Administration\": 2151000000.0, \"Gross Profit\": 5983000000.0, \"Cost Of Revenue\": 2561000000.0, \"Total Revenue\": 8544000000.0, \"Operating Revenue\": 8544000000.0}",
"year": "2023-12-31"
},
"news": {
"news_date": "2023-12-20",
"news_headlines": []
},
"price": {
"close": 194.38133239746094,
"close_previous": 192.14041137695312,
"open": 192.9104014883961,
"open_previous": 195.46729948212786,
"previous_date": "2023-12-20",
"price_date": "2023-12-27"
},
"ticker": "ZTS"
} |
You are a seasoned stock market analyst who is trying to predict whether the prices will go down or up over the day, 2023-12-27, for a specific stock, by offering a buy or sell rating.
[Company Name]
Zoetis Inc.
[Company Description]
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
[Price Movement]
It was 194.38133239746094 on 2023-12-20.
The price of the stock on 2023-12-27 started at 192.9104014883961.
[News since 2023-12-20]
[Financials]
Basic EPS: $5.08
Normalized EBITDA: $3.701000e+09
Net Income: $2.344000e+09
Your answer should look like the following
<think>reasoning about why the stock would go down here.
</think><answer>sell</answer>
or
<think>reasoning about why the stock would go up here.
</think><answer>buy</answer>
Please reason about and provide several reasons for why you think the stock would go up or down in the <think></think> tags. Please provide your answer as a single rating, 'buy' or 'sell', in the <answer></answer> tags, with buy meaning that the stock price will go up,
and sell meaning that the stock price will go down.
|
ZTS | {
"company_info": {
"description": "Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.",
"name": "Zoetis Inc."
},
"current_date": "2023-12-28",
"financials": {
"financials": "{\"Tax Effect Of Unusual Items\": -7105000.0, \"Tax Rate For Calcs\": 0.203, \"Normalized EBITDA\": 3701000000.0, \"Total Unusual Items\": -35000000.0, \"Total Unusual Items Excluding Goodwill\": -35000000.0, \"Net Income From Continuing Operation Net Minority Interest\": 2344000000.0, \"Reconciled Depreciation\": 491000000.0, \"Reconciled Cost Of Revenue\": 2219000000.0, \"EBITDA\": 3666000000.0, \"EBIT\": 3175000000.0, \"Net Interest Income\": -134000000.0, \"Interest Expense\": 239000000.0, \"Interest Income\": 105000000.0, \"Normalized Income\": 2371895000.0, \"Net Income From Continuing And Discontinued Operation\": 2344000000.0, \"Total Expenses\": 5475000000.0, \"Diluted Average Shares\": 462269000.0, \"Basic Average Shares\": 461172000.0, \"Diluted EPS\": 5.07, \"Basic EPS\": 5.08, \"Diluted NI Availto Com Stockholders\": 2344000000.0, \"Net Income Common Stockholders\": 2344000000.0, \"Net Income\": 2344000000.0, \"Minority Interests\": 4000000.0, \"Net Income Including Noncontrolling Interests\": 2340000000.0, \"Net Income Continuous Operations\": 2340000000.0, \"Tax Provision\": 596000000.0, \"Pretax Income\": 2936000000.0, \"Other Income Expense\": 1000000.0, \"Other Non Operating Income Expenses\": 36000000.0, \"Special Income Charges\": 12000000.0, \"Gain On Sale Of Ppe\": 0.0, \"Gain On Sale Of Business\": 101000000.0, \"Write Off\": 2000000.0, \"Impairment Of Capital Assets\": 35000000.0, \"Restructuring And Mergern Acquisition\": 52000000.0, \"Gain On Sale Of Security\": -47000000.0, \"Net Non Operating Interest Income Expense\": -134000000.0, \"Interest Expense Non Operating\": 239000000.0, \"Interest Income Non Operating\": 105000000.0, \"Operating Income\": 3069000000.0, \"Operating Expense\": 2914000000.0, \"Depreciation Amortization Depletion Income Statement\": 149000000.0, \"Depreciation And Amortization In Income Statement\": 149000000.0, \"Amortization\": 149000000.0, \"Amortization Of Intangibles Income Statement\": 149000000.0, \"Research And Development\": 614000000.0, \"Selling General And Administration\": 2151000000.0, \"Gross Profit\": 5983000000.0, \"Cost Of Revenue\": 2561000000.0, \"Total Revenue\": 8544000000.0, \"Operating Revenue\": 8544000000.0}",
"year": "2023-12-31"
},
"news": {
"news_date": "2023-12-21",
"news_headlines": []
},
"price": {
"close": 194.6380157470703,
"close_previous": 192.1699981689453,
"open": 195.09212318475556,
"open_previous": 193.49285386068678,
"previous_date": "2023-12-21",
"price_date": "2023-12-28"
},
"ticker": "ZTS"
} |
You are a seasoned stock market analyst who is trying to predict whether the prices will go down or up over the day, 2023-12-28, for a specific stock, by offering a buy or sell rating.
[Company Name]
Zoetis Inc.
[Company Description]
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
[Price Movement]
It was 194.6380157470703 on 2023-12-21.
The price of the stock on 2023-12-28 started at 195.09212318475556.
[News since 2023-12-21]
[Financials]
Basic EPS: $5.08
Normalized EBITDA: $3.701000e+09
Net Income: $2.344000e+09
Your answer should look like the following
<think>reasoning about why the stock would go down here.
</think><answer>sell</answer>
or
<think>reasoning about why the stock would go up here.
</think><answer>buy</answer>
Please reason about and provide several reasons for why you think the stock would go up or down in the <think></think> tags. Please provide your answer as a single rating, 'buy' or 'sell', in the <answer></answer> tags, with buy meaning that the stock price will go up,
and sell meaning that the stock price will go down.
|
ZTS | {
"company_info": {
"description": "Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.",
"name": "Zoetis Inc."
},
"current_date": "2023-12-29",
"financials": {
"financials": "{\"Tax Effect Of Unusual Items\": -7105000.0, \"Tax Rate For Calcs\": 0.203, \"Normalized EBITDA\": 3701000000.0, \"Total Unusual Items\": -35000000.0, \"Total Unusual Items Excluding Goodwill\": -35000000.0, \"Net Income From Continuing Operation Net Minority Interest\": 2344000000.0, \"Reconciled Depreciation\": 491000000.0, \"Reconciled Cost Of Revenue\": 2219000000.0, \"EBITDA\": 3666000000.0, \"EBIT\": 3175000000.0, \"Net Interest Income\": -134000000.0, \"Interest Expense\": 239000000.0, \"Interest Income\": 105000000.0, \"Normalized Income\": 2371895000.0, \"Net Income From Continuing And Discontinued Operation\": 2344000000.0, \"Total Expenses\": 5475000000.0, \"Diluted Average Shares\": 462269000.0, \"Basic Average Shares\": 461172000.0, \"Diluted EPS\": 5.07, \"Basic EPS\": 5.08, \"Diluted NI Availto Com Stockholders\": 2344000000.0, \"Net Income Common Stockholders\": 2344000000.0, \"Net Income\": 2344000000.0, \"Minority Interests\": 4000000.0, \"Net Income Including Noncontrolling Interests\": 2340000000.0, \"Net Income Continuous Operations\": 2340000000.0, \"Tax Provision\": 596000000.0, \"Pretax Income\": 2936000000.0, \"Other Income Expense\": 1000000.0, \"Other Non Operating Income Expenses\": 36000000.0, \"Special Income Charges\": 12000000.0, \"Gain On Sale Of Ppe\": 0.0, \"Gain On Sale Of Business\": 101000000.0, \"Write Off\": 2000000.0, \"Impairment Of Capital Assets\": 35000000.0, \"Restructuring And Mergern Acquisition\": 52000000.0, \"Gain On Sale Of Security\": -47000000.0, \"Net Non Operating Interest Income Expense\": -134000000.0, \"Interest Expense Non Operating\": 239000000.0, \"Interest Income Non Operating\": 105000000.0, \"Operating Income\": 3069000000.0, \"Operating Expense\": 2914000000.0, \"Depreciation Amortization Depletion Income Statement\": 149000000.0, \"Depreciation And Amortization In Income Statement\": 149000000.0, \"Amortization\": 149000000.0, \"Amortization Of Intangibles Income Statement\": 149000000.0, \"Research And Development\": 614000000.0, \"Selling General And Administration\": 2151000000.0, \"Gross Profit\": 5983000000.0, \"Cost Of Revenue\": 2561000000.0, \"Total Revenue\": 8544000000.0, \"Operating Revenue\": 8544000000.0}",
"year": "2023-12-31"
},
"news": {
"news_date": "2023-12-22",
"news_headlines": []
},
"price": {
"close": 194.84535217285156,
"close_previous": 192.4859161376953,
"open": 194.16417584401748,
"open_previous": 192.82157848828734,
"previous_date": "2023-12-22",
"price_date": "2023-12-29"
},
"ticker": "ZTS"
} |
You are a seasoned stock market analyst who is trying to predict whether the prices will go down or up over the day, 2023-12-29, for a specific stock, by offering a buy or sell rating.
[Company Name]
Zoetis Inc.
[Company Description]
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
[Price Movement]
It was 194.84535217285156 on 2023-12-22.
The price of the stock on 2023-12-29 started at 194.16417584401748.
[News since 2023-12-22]
[Financials]
Basic EPS: $5.08
Normalized EBITDA: $3.701000e+09
Net Income: $2.344000e+09
Your answer should look like the following
<think>reasoning about why the stock would go down here.
</think><answer>sell</answer>
or
<think>reasoning about why the stock would go up here.
</think><answer>buy</answer>
Please reason about and provide several reasons for why you think the stock would go up or down in the <think></think> tags. Please provide your answer as a single rating, 'buy' or 'sell', in the <answer></answer> tags, with buy meaning that the stock price will go up,
and sell meaning that the stock price will go down.
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.